1
|
Lee CM, Kang JH, Go SI. Clinical implication of megestrol acetate in metastatic gastric cancer: a big data analysis from Health Insurance Review and Assessment (HIRA) database. Support Care Cancer 2024; 32:249. [PMID: 38530439 DOI: 10.1007/s00520-024-08430-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/07/2023] [Accepted: 03/08/2024] [Indexed: 03/28/2024]
Abstract
OBJECTIVE Megestrol acetate (MA) is used to manage anorexia and cachexia in patients with advanced cancer. This study investigated the prescription patterns of MA in patients with metastatic gastric cancer, as well as evaluated its impact on survival outcomes and the incidence of venous thromboembolism (VTE). METHODS A Health Insurance Review and Assessment (HIRA) service database was used to investigate differences in baseline characteristics, survival, and the incidence of VTE according to MA prescription patterns (i.e., prescription vs. no prescription) in patients diagnosed with metastatic gastric cancer from July 2014 to December 2015. RESULTS A total of 1938 patients were included in this study. In total, 65% of the patients were prescribed MA. Older age, treatment in tertiary hospitals, and palliative chemotherapy were statistically significant predictive factors for MA prescription. Continuous prescription of MA was observed in 37% of patients. There was no statistically significant difference in survival between the MA and non-MA prescription groups on multivariate analysis. Among the 1427 patients included in the analysis for VTE incidence, 4.3% and 2.9% were diagnosed with VTE during the follow-up period in the MA and non-MA prescription groups, respectively. However, there was no statistically significant difference in VTE diagnosis between the groups on multivariate analysis. CONCLUSION MA is commonly prescribed for metastatic gastric cancer, especially in elderly patients and those undergoing palliative chemotherapy, without significantly affecting survival or VTE risk.
Collapse
Affiliation(s)
- Chang Min Lee
- Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Jinju, Republic of Korea
| | - Jung Hun Kang
- Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Jinju, Republic of Korea
| | - Se-Il Go
- Division of Hematology/Oncology, Department of Internal Medicine, Institute of Health Science, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, 11 Samjeongja-Ro, Changwon, 51472, Republic of Korea.
| |
Collapse
|
2
|
Oh J, Kang JH, Chae HD, Yoo HJ, Hong SH, Lee DY, Choi JY. Diagnosis of osteochondral lesions of the talus on Dual-layer spectral detector CT arthrography: clinical feasibility of virtual noncontrast images. Clin Radiol 2024:S0009-9260(24)00144-2. [PMID: 38649313 DOI: 10.1016/j.crad.2024.03.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/30/2023] [Revised: 03/05/2024] [Accepted: 03/12/2024] [Indexed: 04/25/2024]
Abstract
AIM To compare the image quality of virtual noncontrast (VNC) and true noncontrast (TNC) CT images and to evaluate the clinical feasibility of VNC CT images for assessing osteochondral lesions of the talus (OLTs). MATERIALS AND METHODS Forty-five OLT patients who underwent ankle CT arthrography (CTA) using dual-layer spectral detector CT were enrolled. Reconstruction of VNC and three-dimensional volume rendering images was performed. Afterward, image noise, the signal-to-noise ratio (SNR), and the contrast-to-noise ratio (CNR) were measured. For the subjective evaluation, two board-certified musculoskeletal radiologists [R2-1] assessed spatial resolution, overall image quality, and lesion conspicuity. The accuracy rate for OLT grading was determined in 23 patients who underwent arthroscopic surgery. RESULTS While VNC images showed significantly less noise than TNC images, TNC images showed better SNRs and CNRs (p<.01). In the subjective analysis, TNC images showed better overall image quality (p<.001). For the 3D volume rendering images, VNC images scored significantly higher for lesion conspicuity (p<.001). The accuracy rates of CTA and CTA with VNC images for OLT grading were 79.2% and 83.3%, respectively. Regarding confidence level, when CTA and VNC images were evaluated together, the confidence level was significantly higher than that when only CTA images were evaluated (p<.001). CONCLUSION VNC imaging can provide better confidence level of OLT grading and evaluation of the integrity of the subchondral bone plate when combined with conventional CTA without additional radiation dose to the patient. In addition, VNC images-based 3D volume rendering reconstruction would be helpful for preoperative planning in OLT patients.
Collapse
Affiliation(s)
- J Oh
- Department of Radiology, Seoul National University Hospital, Seoul, Republic of Korea
| | - J H Kang
- Department of Radiology, Konkuk University Medical Center, Seoul, Republic of Korea
| | - H-D Chae
- Department of Radiology, Seoul National University Hospital, Seoul, Republic of Korea; Department of Radiology, Seoul National University College of Medicine, Seoul, Republic of Korea
| | - H J Yoo
- Department of Radiology, Seoul National University Hospital, Seoul, Republic of Korea; Department of Radiology, Seoul National University College of Medicine, Seoul, Republic of Korea
| | - S H Hong
- Department of Radiology, Seoul National University Hospital, Seoul, Republic of Korea; Department of Radiology, Seoul National University College of Medicine, Seoul, Republic of Korea
| | - D Y Lee
- Department of Orthopedic Surgery, Seoul National University Hospital, Seoul, Republic of Korea
| | - J-Y Choi
- Department of Radiology, Seoul National University Hospital, Seoul, Republic of Korea; Department of Radiology, Seoul National University College of Medicine, Seoul, Republic of Korea.
| |
Collapse
|
3
|
Kim JH, Cha Y, Shin SJ, Park YS, Kang JH, Kim C, Lim SH, Kang MJ, Kim JG, Hwang IG, Choi JK, Shin SH, Kang SY, Lee SC, Lim ST, Kim JS, Jeung HC, Kang MH, Choi IS, Ryu HW, Lee KH, Lee MH, Lee JY, Park JH, Jeon SY, Lee N, Park CY, Kim YH. Treatment Patterns and Prognosis of Palliative Chemotherapy Combined With Targeting Agents in Patients With Unresectable Metastatic Colorectal Cancer: CHOICE, A Multicenter Longitudinal Observational Study. Anticancer Res 2024; 44:347-359. [PMID: 38160001 DOI: 10.21873/anticanres.16818] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/27/2023] [Revised: 12/05/2023] [Accepted: 12/15/2023] [Indexed: 01/03/2024]
Abstract
BACKGROUND/AIM This study investigated the treatment patterns and prognosis of patients with metastatic or unresectable colorectal cancer (mCRC) treated with chemotherapy with targeting agents. PATIENTS AND METHODS This longitudinal multicenter study included 963 patients with mCRC who were treated in Korea between 2016 and 2020. Treatment patterns and efficacy were compared according to the mutation status and clinical factors. RESULTS As first-line therapy, most of the patients (83.5%) received FOLFOX plus bevacizumab (35.4%), followed by FOLFIRI plus bevacizumab (18.8%), FOLFIRI plus cetuximab (17.0%), and FOLFOX plus cetuximab (12.3%). Bevacizumab was the most frequent agent (78.8%) combined with chemotherapy in RAS-mutated CRC, while cetuximab (57.2%) in RAS wild-type CRC. Cetuximab was frequently combined with a doublet regimen in patients with left-sided CRC than in those with right-sided CRC (34.4% vs. 16%). As second-line therapy, most patients (63.4%) also received doublet regimens with bevacizumab, and FOLFIRI plus aflibercept was administered in 15.1%. The objective response rate with FOLFIRI plus cetuximab was significantly higher in patients with left-sided CRC than in those with right-sided CRC (59.2% vs. 30.8%, p=0.008) and marginally higher in patients with RAS wild-type CRC than in those with RAS-mutated CRC (55.6% vs. 0.0%, p=0.092). Progression-free survival (PFS) with FOLFOX plus bevacizumab was significantly shorter than that with FOLFIRI plus bevacizumab (p=0.030) in RAS-mutated CRC, whereas there were no significant differences between regimens in RAS wild-type CRC. CONCLUSION In patients with unresectable metastatic colorectal cancer, doublet chemotherapy with targeting agents is the most common therapy and efficacy depends on the mutation status as well as clinical factors.
Collapse
Affiliation(s)
- Jwa Hoon Kim
- Division of Oncology, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Republic of Korea
| | - Yongjun Cha
- Center for Colon Cancer, National Cancer Center, Goyang, Republic of Korea
| | - Sang Joon Shin
- Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea
| | - Young Suk Park
- Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
| | - Jung Hun Kang
- Department of Internal Medicine, Gyeongsang University Hospital, Jinju, Republic of Korea
| | - Chan Kim
- Department of Medical Oncology, CHA Bundang Medical Center, CHA University, Seongnam, Republic of Korea
| | - Sung Hee Lim
- Division of Hematology-Oncology, Department of Internal Medicine, Soon Chun Hyang University, Bucheon Hospital, Bucheon-si, Republic of Korea
| | - Myoung Joo Kang
- Department of Hemato-oncology, Inje University, Haeundae Paik Hospital, Busan, Republic of Korea
| | - Jong Gwang Kim
- Department of Oncology/Hematology, Kyungpook National University Chilgok Hospital, School of Medicine, Kyungpook National University, Daegu, Republic of Korea
| | - In Gyu Hwang
- Department of Internal Medicine, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Republic of Korea
| | - Jong-Kwon Choi
- Division of Hematology and Medical Oncology, Department of Internal Medicine, Konyang University Hospital, Daejeon, Republic of Korea
| | - Seong Hoon Shin
- Department of Internal Medicine, Kosin University Gospel Hospital, Kosin University College of Medicine, Busan, Republic of Korea
| | - Seok Yun Kang
- Department of Hematology-Oncology, Ajou University School of Medicine, Suwon, Republic of Korea
| | - Sang-Cheol Lee
- Department of Internal Medicine, Soonchunhyang University Cheonan Hospital, Cheonan, Republic of Korea
| | - Seung Taek Lim
- Department of Oncology, Yonsei University Wonju College of Medicine, Wonju, Republic of Korea
| | - Jung Sun Kim
- Division of Hematology/Oncology, Department of Internal Medicine, Korea University Ansan Hospital, Korea University College of Medicine, Gyeonggi-do, Republic of Korea
| | - Hei-Cheul Jeung
- Division of Medical Oncology, Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea
| | - Myoung Hee Kang
- Division of Hematology-Oncology, Department of Internal Medicine, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon, Republic of Korea
| | - In Sil Choi
- Department of Internal Medicine, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul, Republic of Korea
| | - Hye Won Ryu
- Division of Hematology and Oncology, Department of Internal Medicine, Chungnam National University Hospital, Chungnam National University College of Medicine, Daejeon, Republic of Korea
| | - Kyung Hee Lee
- Department of Internal Medicine, Yeungnam University College of Medicine, Daegu, Republic of Korea
| | - Moon Hee Lee
- Department of Hematology-Oncology, Inha University College of Medicine and Hospital, Incheon, Republic of Korea
| | - Ji Young Lee
- Department of Oncology, Inje University Busan Paik Hospital, Inje University College of Medicine, Busan, Republic of Korea
| | - Ji Hyun Park
- Department of Internal Medicine, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, Republic of Korea
| | - So-Yeon Jeon
- Department of Internal Medicine, Jeonbuk National University Medical School, Jeonju, Republic of Korea
| | - Namsu Lee
- Division of Hematology and Oncology, Department of Internal Medicine, Soonchunhyang University Seoul Hospital, Seoul, Republic of Korea
| | - Chi-Young Park
- Department of Internal Medicine, Hemato-oncology, Chosun University Hospital, Gwangju, Republic of Korea
| | - Yeul Hong Kim
- Division of Oncology, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Republic of Korea;
| |
Collapse
|
4
|
Go SI, Choi BH, Park MJ, Park S, Kang MH, Kim HG, Kang JH, Jeong EJ, Lee GW. Prognostic impact of pretreatment skeletal muscle index and CONUT score in diffuse large B-cell Lymphoma. BMC Cancer 2023; 23:1071. [PMID: 37932700 PMCID: PMC10629181 DOI: 10.1186/s12885-023-11590-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/18/2023] [Accepted: 10/30/2023] [Indexed: 11/08/2023] Open
Abstract
BACKGROUND Although the prognostic value of the Controlling Nutritional Status (CONUT) score in diffuse large B-cell lymphoma (DLBCL) has been reported in several previous studies, its clinical relevance for the presence of sarcopenia has not been assessed. METHODS In this study, 305 DLBCL patients were reviewed. They were categorized into normal/mild (n = 219) and moderate/severe (n = 86) CONUT groups. Sarcopenia was assessed using the L3-skeletal muscle index measured by baseline computed tomography imaging. Based on CONUT score and sarcopenia, patients were grouped: A (normal/mild CONUT and no sarcopenia), B (either moderate/severe CONUT or sarcopenia, but not both), and C (both moderate/severe CONUT and sarcopenia). RESULTS The moderate/severe CONUT group showed higher rates of ≥ grade 3 febrile neutropenia, thrombocytopenia, non-hematologic toxicities, and early treatment discontinuation not related to disease progression, compared to the normal/mild CONUT group. The moderate/severe CONUT group had a lower complete response rate (58.1% vs. 80.8%) and shorter median overall survival (18.5 vs. 162.6 months) than the normal/mild group. Group C had the poorest prognosis with a median survival of 8.6 months, while groups A and B showed better outcomes (not reached and 60.1 months, respectively). Combining CONUT score and sarcopenia improved the predictive accuracy of the Cox regression model (C-index: 0.763), compared to the performance of using either CONUT score (C-index: 0.754) or sarcopenia alone (C-index: 0.755). CONCLUSIONS In conclusion, the moderate/severe CONUT group exhibited treatment intolerance, lower response, and poor prognosis. Additionally, combining CONUT score and sarcopenia enhanced predictive accuracy for survival outcomes compared to individual variables.
Collapse
Affiliation(s)
- Se-Il Go
- Division of Hematology-Oncology, Department of Internal Medicine, Institute of Health Science, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon, Korea
| | - Bong-Hoi Choi
- Department of Nuclear Medicine, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Jinju, Korea
| | - Mi Jung Park
- Department of Radiology, Institute of Health Science, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Jinju, Korea
| | - Sungwoo Park
- Division of Hematology-Oncology, Department of Internal Medicine, Institute of Health Science, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Gangnam-ro 79 Jinju, Jinju, 52727, Korea
| | - Myoung Hee Kang
- Division of Hematology-Oncology, Department of Internal Medicine, Institute of Health Science, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon, Korea
| | - Hoon-Gu Kim
- Division of Hematology-Oncology, Department of Internal Medicine, Institute of Health Science, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon, Korea
| | - Jung Hun Kang
- Division of Hematology-Oncology, Department of Internal Medicine, Institute of Health Science, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Gangnam-ro 79 Jinju, Jinju, 52727, Korea
| | - Eun Jeong Jeong
- Division of Hematology-Oncology, Department of Internal Medicine, Institute of Health Science, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Gangnam-ro 79 Jinju, Jinju, 52727, Korea
| | - Gyeong-Won Lee
- Division of Hematology-Oncology, Department of Internal Medicine, Institute of Health Science, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Gangnam-ro 79 Jinju, Jinju, 52727, Korea.
| |
Collapse
|
5
|
Agarwal I, Wang S, Stuart J, Strohmaier S, Schernhammer E, Rich-Edwards J, Kang JH. First-trimester occupational exposures and hypertensive disorders of pregnancy among US nurses. Occup Med (Lond) 2023; 73:419-426. [PMID: 37587907 PMCID: PMC11009503 DOI: 10.1093/occmed/kqad089] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 08/18/2023] Open
Abstract
BACKGROUND Limited and conflicting data exist regarding the impact of first-trimester nursing occupational exposures on hypertensive disorders of pregnancy (HDP). AIMS To investigate whether first-trimester night shift work, work hours and work-related activities are associated with HDP. METHODS We conducted a cross-sectional analysis of 6610 women within the Nurses' Health Study II. We used multiple logistic regression to estimate the odds ratios (ORs) and 95% confidence intervals (CIs) for the relation of occupational exposures to HDP. RESULTS Nine per cent of respondents reported an HDP in the index pregnancy (gestational hypertension: n = 354, 5%, preeclampsia: n = 222, 3%). First-trimester fixed or rotating night shift work was not significantly associated with gestational hypertension or preeclampsia compared to day shift work only. Compared to those working 21-40 h/week, working overtime (≥41 h/week) was not associated with gestational hypertension but was associated with 43% higher odds of preeclampsia (95% CI 1.02, 2.00). For part-time work (≤20 h/week), the OR was 0.76 (95% CI 0.56, 1.02) for gestational hypertension and 0.64 (95% CI 0.43, 0.97) for preeclampsia. The odds of preeclampsia were 3% higher per additional hour worked per week (95% CI 1.01-1.04). Compared to 0-4 h spent standing or walking per day, standing or walking ≥9 h daily was associated with 32% lower odds of gestational hypertension (95% CI 0.47, 0.99) but was not significantly associated with preeclampsia. Frequency of heavy lifting was not associated with either hypertensive disorder or pregnancy. CONCLUSIONS Among nurses, working overtime was associated with higher odds of preeclampsia.
Collapse
Affiliation(s)
- I Agarwal
- Maine Health Institute for Research, Maine Medical Center, Scarborough 04074, MN, USA
| | - S Wang
- Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA
| | - J Stuart
- Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA
- Channing Division of Network Medicine, Brigham and Women’s Hospital, Boston, MA 02115, USA
| | - S Strohmaier
- Department of Epidemiology, Center for Public Health, Medical University of Vienna, Vienna 1090, Austria
| | - E Schernhammer
- Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA
- Channing Division of Network Medicine, Brigham and Women’s Hospital, Boston, MA 02115, USA
- Department of Epidemiology, Center for Public Health, Medical University of Vienna, Vienna 1090, Austria
| | - J Rich-Edwards
- Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA
- Channing Division of Network Medicine, Brigham and Women’s Hospital, Boston, MA 02115, USA
| | - J H Kang
- Channing Division of Network Medicine, Brigham and Women’s Hospital, Boston, MA 02115, USA
| |
Collapse
|
6
|
Won YW, Kang JH, Kwon JH, Koo DH, Kang JH, Maeng CH, Ahn HK, Oh SY, Lee DW, Sohn J, Oh SY, Lee KH, Koh SJ, Lee KS, Kim CK, Kim JY, Ji JH, Kim SB, Ha JY, Kim HY. A Multicenter, Prospective, Observational Study to Evaluate Ethanol-Induced Symptoms in Patients Receiving Docetaxel Chemotherapy. Cancer Res Treat 2023; 55:1096-1103. [PMID: 37054719 PMCID: PMC10582550 DOI: 10.4143/crt.2022.1565] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/29/2022] [Accepted: 04/03/2023] [Indexed: 04/15/2023] Open
Abstract
PURPOSE Several previous studies and case reports have reported ethanol-induced symptoms in patients receiving anticancer drugs containing ethanol. Most docetaxel formulations contain ethanol as a solvent. However, there are insufficient data on ethanol-induced symptoms when docetaxel-containing ethanol is administered. The primary purpose of this study was to investigate the frequency and pattern of ethanol-induced symptoms during and after docetaxel administration. The secondary purpose was to explore the risk factors for ethanol-induced symptoms. MATERIALS AND METHODS This was a prospective, multicenter, observational study. The participants filled out ethanol-induced symptom questionnaire on the day of chemotherapy and the following day. RESULTS Data from 451 patients were analyzed. The overall occurrence rate of ethanol-induced symptoms was 44.3% (200/451 patients). The occurrence rate of facial flushing was highest at 19.7% (89/451 patients), followed by nausea in 18.2% (82/451 patients), and dizziness in 17.5% (79/451 patients). Although infrequent, unsteady walking and impaired balance occurred in 4.2% and 3.3% of patients, respectively. Female sex, presence of underlying disease, younger age, docetaxel dose, and docetaxel-containing ethanol amount were significantly associated with the occurrence of ethanol-induced symptoms. CONCLUSION The occurrence of ethanol-induced symptoms was not low in patients receiving docetaxel-containing ethanol. Physicians need to pay more attention to the occurrence of ethanol-induced symptoms and prescribe ethanol-free or low-ethanol-containing formulations to high-risk patients.
Collapse
Affiliation(s)
- Young-Woong Won
- Division of Hematology and Oncology, Department of Internal Medicine, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri,
Korea
| | - Jin-Hyoung Kang
- Division of Oncology, Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul,
Korea
| | - Jung Hye Kwon
- Division of Hematology and Oncology, Department of Internal Medicine, Chungnam National University Sejong Hospital, Chungnam National University College of Medicine, Sejong,
Korea
| | - Dong-Hoe Koo
- Division of Hematology/Oncology, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul,
Korea
| | - Jung Hun Kang
- Division of Hematology and Oncology, Department of Internal Medicine, Gyeongsang National University College of Medicine, Jinju,
Korea
| | - Chi Hoon Maeng
- Division of Oncology and Hematology, Department of Internal Medicine, Kyung Hee University Hospital, Kyung Hee University College of Medicine, Seoul,
Korea
| | - Hee Kyung Ahn
- Division of Medical Oncology, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon,
Korea
| | - Sung Yong Oh
- Division of Hematology and Oncology, Department of Internal Medicine, Dong-A University College of Medicine, Busan,
Korea
| | - Dae-Won Lee
- Division of Hematology and Oncology, Department of Internal Medicine, Seoul National University Hospital, Seoul,
Korea
| | - Joohyuk Sohn
- Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul,
Korea
| | - So Yeon Oh
- Division of Hematology and Oncology, Department of Internal Medicine, Pusan National University Yangsan Hospital, Pusan University College of Medicine, Yangsan,
Korea
| | - Kyung Hee Lee
- Division of Hematology and Oncology, Department of Internal Medicine, Yeungnam University Hospital, Yeungnam University College of Medicine, Daegu,
Korea
| | - Su-Jin Koh
- Division of Hematology and Oncology, Department of Internal Medicine, Ulsan University Hospital, Ulsan University College of Medicine, Ulsan,
Korea
| | - Keun Seok Lee
- Center for Breast Cancer, Research Institute, National Cancer Center, Goyang,
Korea
| | - Chan-Kyu Kim
- Division of Hematology and Oncology, Department of Internal Medicine, Soonchunhyang University Hospital Bucheon, Soonchunhyang University College of Medicine, Bucheon,
Korea
| | - Ji-Yeon Kim
- Division of Hematology and Oncology, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul,
Korea
| | - Jun Ho Ji
- Division of Hematology and Oncology, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon,
Korea
| | - Sung-Bae Kim
- Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul,
Korea
| | - Joo Young Ha
- Division of Hematology and Oncology, Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul,
Korea
| | - Ho Young Kim
- Division of Hematology and Oncology, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Anyang,
Korea
| |
Collapse
|
7
|
Jang BG, Huh KH, Yeom HG, Kang JH, Kim JE, Yoon HJ, Yi WJ, Heo MS, Lee SS. Differentiation between Chondrosarcoma and Synovial Chondromatosis of the Temporomandibular Joint Using CT and MR Imaging. AJNR Am J Neuroradiol 2023; 44:1176-1183. [PMID: 37652584 PMCID: PMC10549951 DOI: 10.3174/ajnr.a7980] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/21/2023] [Accepted: 08/03/2023] [Indexed: 09/02/2023]
Abstract
BACKGROUND AND PURPOSE Chondrosarcoma and synovial chondromatosis of the temporomandibular joint share overlapping clinical and histopathologic features. We aimed to identify CT and MR imaging features to differentiate chondrosarcoma from synovial chondromatosis of the temporomandibular joint. MATERIALS AND METHODS The CT and MR images of 12 and 35 patients with histopathologically confirmed chondrosarcoma and synovial chondromatosis of the temporomandibular joint, respectively, were retrospectively reviewed. Imaging features including lesion size, center, enhancement, destruction/sclerosis of surrounding bone, infiltration into the tendon of the lateral pterygoid muscle, calcification, periosteal reaction, and osteophyte formation were assessed. A comparison between chondrosarcoma and synovial chondromatosis was performed with a Student t test for quantitative variables and the Fisher exact test or linear-by-linear association test for qualitative variables. Receiver operating characteristic analysis was performed to determine the diagnostic performance for differentiation of chondrosarcoma and synovial chondromatosis based on a composite score obtained by assigning 1 point for each of 9 imaging features. RESULTS High-risk imaging features for chondrosarcoma were the following: lesion centered on the mandibular condyle, destruction of the mandibular condyle, no destruction/sclerosis of the articular eminence/glenoid fossa, infiltration into the tendon of the lateral pterygoid muscle, absent or stippled calcification, periosteal reaction, internal enhancement, and size of ≥30.5 mm. The best cutoff value to discriminate chondrosarcoma from synovial chondromatosis was the presence of any 4 of these high-risk imaging features, with an area under the curve of 0.986 and an accuracy of 95.8%. CONCLUSIONS CT and MR imaging features can distinguish chondrosarcoma from synovial chondromatosis of the temporomandibular joint with improved diagnostic performance when a subcombination of 9 imaging features is used.
Collapse
Affiliation(s)
- B G Jang
- From the Department of Oral and Maxillofacial Radiology and Dental Research Institute (B.G.J., K.H.H., J.E.K., H.J.Y., W.J.Y., M.S.H., S.S.L.), School of Dentistry, Seoul National University, Seoul, Korea
| | - K H Huh
- From the Department of Oral and Maxillofacial Radiology and Dental Research Institute (B.G.J., K.H.H., J.E.K., H.J.Y., W.J.Y., M.S.H., S.S.L.), School of Dentistry, Seoul National University, Seoul, Korea
| | - H G Yeom
- Department of Oral and Maxillofacial Radiology and Wonkwang Dental Research Institute (H.G.Y.), School of Dentistry, Wonkwang University, Iksan, Korea
| | - J H Kang
- Department of Oral and Maxillofacial Radiology (J.H.K.), Seoul National University Dental Hospital, Seoul, Korea
| | - J E Kim
- From the Department of Oral and Maxillofacial Radiology and Dental Research Institute (B.G.J., K.H.H., J.E.K., H.J.Y., W.J.Y., M.S.H., S.S.L.), School of Dentistry, Seoul National University, Seoul, Korea
| | - H J Yoon
- From the Department of Oral and Maxillofacial Radiology and Dental Research Institute (B.G.J., K.H.H., J.E.K., H.J.Y., W.J.Y., M.S.H., S.S.L.), School of Dentistry, Seoul National University, Seoul, Korea
| | - W J Yi
- From the Department of Oral and Maxillofacial Radiology and Dental Research Institute (B.G.J., K.H.H., J.E.K., H.J.Y., W.J.Y., M.S.H., S.S.L.), School of Dentistry, Seoul National University, Seoul, Korea
| | - M S Heo
- From the Department of Oral and Maxillofacial Radiology and Dental Research Institute (B.G.J., K.H.H., J.E.K., H.J.Y., W.J.Y., M.S.H., S.S.L.), School of Dentistry, Seoul National University, Seoul, Korea
| | - S S Lee
- From the Department of Oral and Maxillofacial Radiology and Dental Research Institute (B.G.J., K.H.H., J.E.K., H.J.Y., W.J.Y., M.S.H., S.S.L.), School of Dentistry, Seoul National University, Seoul, Korea
| |
Collapse
|
8
|
Park S, Jeong EJ, Kang JH, Lee GW, Go SI, Lee DH, Koh EH. T/myeloid mixed-phenotype acute leukemia treated with venetoclax and decitabine: A case report. World J Clin Cases 2023; 11:6200-6205. [PMID: 37731550 PMCID: PMC10507568 DOI: 10.12998/wjcc.v11.i26.6200] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/25/2023] [Revised: 07/24/2023] [Accepted: 08/18/2023] [Indexed: 09/08/2023] Open
Abstract
BACKGROUND Mixed-phenotype acute leukemia (MPAL) is characterized by acute undifferentiated leukemia with blasts co-expressing myeloid and lymphoid antigens. However, consensus regarding the ideal management strategy for MPAL is yet to be established, owing to its rarity. CASE SUMMARY A 55-year-old male was diagnosed with T/myeloid MPAL. Vincristine, prednisolone, daunorubicin, and L-asparaginase were administered as induction chemotherapy. Septic shock occurred 10 days after induction, and bone marrow examination following recovery from sepsis revealed refractory disease. Venetoclax and decitabine were administered as chemotherapy-free induction therapy to reduce the infection risk. There were no serious infections, including febrile neutropenia, at the end of the treatment. After receiving two additional cycles of venetoclax/decitabine, the patient underwent haploidentical peripheral blood stem-cell transplantation and achieved complete response (CR) to treatment. CONCLUSION CR was maintained in a patient with MPAL who underwent haploidentical peripheral blood stem-cell transplantation after additional venetoclax/decitabine cycles.
Collapse
Affiliation(s)
- Sungwoo Park
- Division of Hematology and Oncology, Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University School of Medicine, Gyeongsang National University, Jinju 52727, South Korea
| | - Eun Jeong Jeong
- Division of Hematology and Oncology, Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University School of Medicine, Gyeongsang National University, Jinju 52727, South Korea
| | - Jung Hun Kang
- Division of Hematology and Oncology, Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University School of Medicine, Gyeongsang National University, Jinju 52727, South Korea
| | - Gyeong-Won Lee
- Division of Hematology and Oncology, Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University School of Medicine, Gyeongsang National University, Jinju 52727, South Korea
| | - Se-Il Go
- Department of Internal Medicine, Institute of Health Sciences, Gyeongsang National University Changwon Hospital, Gyeongsang National University School of Medicine, Changwon 52828, South Korea
| | - Dong-Hyun Lee
- Department of Laboratory Medicine, Gyeongsang National University Hospital, Gyeongsang National University School of Medicine, Gyeongsang National University, Jinju 52828, South Korea
| | - Eun-Ha Koh
- Department of Laboratory Medicine, Gyeongsang National University Hospital, Gyeongsang National University School of Medicine, Gyeongsang National University, Jinju 52828, South Korea
| |
Collapse
|
9
|
Abdulameer NJ, Acharya U, Adare A, Aidala C, Ajitanand NN, Akiba Y, Akimoto R, Alfred M, Apadula N, Aramaki Y, Asano H, Atomssa ET, Awes TC, Azmoun B, Babintsev V, Bai M, Bandara NS, Bannier B, Barish KN, Bathe S, Bazilevsky A, Beaumier M, Beckman S, Belmont R, Berdnikov A, Berdnikov Y, Bichon L, Black D, Blankenship B, Bok JS, Borisov V, Boyle K, Brooks ML, Bryslawskyj J, Buesching H, Bumazhnov V, Campbell S, Canoa Roman V, Chen CH, Chiu M, Chi CY, Choi IJ, Choi JB, Chujo T, Citron Z, Connors M, Corliss R, Corrales Morales Y, Csanád M, Csörgő T, Datta A, Daugherity MS, David G, Dean CT, DeBlasio K, Dehmelt K, Denisov A, Deshpande A, Desmond EJ, Ding L, Dion A, Doomra V, Do JH, Drees A, Drees KA, Durham JM, Durum A, En'yo H, Enokizono A, Esha R, Fadem B, Fan W, Feege N, Fields DE, Finger M, Finger M, Firak D, Fitzgerald D, Fokin SL, Frantz JE, Franz A, Frawley AD, Gallus P, Gal C, Garg P, Ge H, Giles M, Giordano F, Glenn A, Goto Y, Grau N, Greene SV, Grosse Perdekamp M, Gunji T, Guragain H, Gu Y, Hachiya T, Haggerty JS, Hahn KI, Hamagaki H, Hanks J, Han SY, Harvey M, Hasegawa S, Hemmick TK, He X, Hill JC, Hodges A, Hollis RS, Homma K, Hong B, Hoshino T, Huang J, Ikeda Y, Imai K, Imazu Y, Inaba M, Iordanova A, Isenhower D, Ivanishchev D, Jacak BV, Jeon SJ, Jezghani M, Jiang X, Ji Z, Johnson BM, Joo E, Joo KS, Jouan D, Jumper DS, Kang JH, Kang JS, Kawall D, Kazantsev AV, Key JA, Khachatryan V, Khanzadeev A, Khatiwada A, Kihara K, Kim C, Kim DH, Kim DJ, Kim EJ, Kim HJ, Kim M, Kim T, Kim YK, Kincses D, Kingan A, Kistenev E, Klatsky J, Kleinjan D, Kline P, Koblesky T, Kofarago M, Koster J, Kotov D, Kovacs L, Kurgyis B, Kurita K, Kurosawa M, Kwon Y, Lajoie JG, Larionova D, Lebedev A, Lee KB, Lee SH, Leitch MJ, Leitgab M, Lewis NA, Lim SH, Liu MX, Li X, Loomis DA, Lynch D, Lökös S, Majoros T, Makdisi YI, Makek M, Manion A, Manko VI, Mannel E, McCumber M, McGaughey PL, McGlinchey D, McKinney C, Meles A, Mendoza M, Meredith B, Miake Y, Mignerey AC, Miller AJ, Milov A, Mishra DK, Mitchell JT, Mitrankova M, Mitrankov I, Miyasaka S, Mizuno S, Mondal MM, Montuenga P, Moon T, Morrison DP, Moukhanova TV, Muhammad A, Mulilo B, Murakami T, Murata J, Mwai A, Nagamiya S, Nagle JL, Nagy MI, Nakagawa I, Nakagomi H, Nakano K, Nattrass C, Nelson S, Netrakanti PK, Nihashi M, Niida T, Nouicer R, Novitzky N, Nukazuka G, Nyanin AS, O'Brien E, Ogilvie CA, Oh J, Orjuela Koop JD, Orosz M, Osborn JD, Oskarsson A, Ozawa K, Pak R, Pantuev V, Papavassiliou V, Park JS, Park S, Patel L, Patel M, Pate SF, Peng JC, Peng W, Perepelitsa DV, Perera GDN, Peressounko DY, PerezLara CE, Perry J, Petti R, Pinkenburg C, Pinson R, Pisani RP, Potekhin M, Pun A, Purschke ML, Radzevich PV, Rak J, Ramasubramanian N, Ravinovich I, Read KF, Reynolds D, Riabov V, Riabov Y, Richford D, Riveli N, Roach D, Rolnick SD, Rosati M, Rowan Z, Rubin JG, Runchey J, Saito N, Sakaguchi T, Sako H, Samsonov V, Sarsour M, Sato S, Sawada S, Schaefer B, Schmoll BK, Sedgwick K, Seele J, Seidl R, Sen A, Seto R, Sett P, Sexton A, Sharma D, Shein I, Shibata M, Shibata TA, Shigaki K, Shimomura M, Shi Z, Shukla P, Sickles A, Silva CL, Silvermyr D, Singh BK, Singh CP, Singh V, Slunečka M, Smith KL, Soltz RA, Sondheim WE, Sorensen SP, Sourikova IV, Stankus PW, Stepanov M, Stoll SP, Sugitate T, Sukhanov A, Sumita T, Sun J, Sun Z, Sziklai J, Takahama R, Takahara A, Taketani A, Tanida K, Tannenbaum MJ, Tarafdar S, Taranenko A, Timilsina A, Todoroki T, Tomášek M, Torii H, Towell M, Towell R, Towell RS, Tserruya I, Ueda Y, Ujvari B, van Hecke HW, Vargyas M, Velkovska J, Virius M, Vrba V, Vznuzdaev E, Wang XR, Wang Z, Watanabe D, Watanabe Y, Watanabe YS, Wei F, Whitaker S, Wolin S, Wong CP, Woody CL, Wysocki M, Xia B, Xue L, Yalcin S, Yamaguchi YL, Yanovich A, Yoon I, Younus I, Yushmanov IE, Zajc WA, Zelenski A, Zou L. Measurement of Direct-Photon Cross Section and Double-Helicity Asymmetry at sqrt[s]=510 GeV in p[over →]+p[over →] Collisions. Phys Rev Lett 2023; 130:251901. [PMID: 37418716 DOI: 10.1103/physrevlett.130.251901] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/17/2022] [Revised: 11/04/2022] [Accepted: 04/28/2023] [Indexed: 07/09/2023]
Abstract
We present measurements of the cross section and double-helicity asymmetry A_{LL} of direct-photon production in p[over →]+p[over →] collisions at sqrt[s]=510 GeV. The measurements have been performed at midrapidity (|η|<0.25) with the PHENIX detector at the Relativistic Heavy Ion Collider. At relativistic energies, direct photons are dominantly produced from the initial quark-gluon hard scattering and do not interact via the strong force at leading order. Therefore, at sqrt[s]=510 GeV, where leading-order-effects dominate, these measurements provide clean and direct access to the gluon helicity in the polarized proton in the gluon-momentum-fraction range 0.02<x<0.08, with direct sensitivity to the sign of the gluon contribution.
Collapse
Affiliation(s)
- N J Abdulameer
- Debrecen University, H-4010 Debrecen, Egyetem tér 1, Hungary
| | - U Acharya
- Georgia State University, Atlanta, Georgia 30303, USA
| | - A Adare
- University of Colorado, Boulder, Colorado 80309, USA
| | - C Aidala
- Department of Physics, University of Michigan, Ann Arbor, Michigan 48109-1040, USA
| | - N N Ajitanand
- Chemistry Department, Stony Brook University, SUNY, Stony Brook, New York 11794-3400, USA
| | - Y Akiba
- RIKEN Nishina Center for Accelerator-Based Science, Wako, Saitama 351-0198, Japan
- RIKEN BNL Research Center, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - R Akimoto
- Center for Nuclear Study, Graduate School of Science, University of Tokyo, 7-3-1 Hongo, Bunkyo, Tokyo 113-0033, Japan
| | - M Alfred
- Department of Physics and Astronomy, Howard University, Washington, D.C. 20059, USA
| | - N Apadula
- Iowa State University, Ames, Iowa 50011, USA
- Department of Physics and Astronomy, Stony Brook University, SUNY, Stony Brook, New York 11794-3800, USA
| | - Y Aramaki
- RIKEN Nishina Center for Accelerator-Based Science, Wako, Saitama 351-0198, Japan
| | - H Asano
- Kyoto University, Kyoto 606-8502, Japan
- RIKEN Nishina Center for Accelerator-Based Science, Wako, Saitama 351-0198, Japan
| | - E T Atomssa
- Department of Physics and Astronomy, Stony Brook University, SUNY, Stony Brook, New York 11794-3800, USA
| | - T C Awes
- Oak Ridge National Laboratory, Oak Ridge, Tennessee 37831, USA
| | - B Azmoun
- Physics Department, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - V Babintsev
- IHEP Protvino, State Research Center of Russian Federation, Institute for High Energy Physics, Protvino 142281, Russia
| | - M Bai
- Collider-Accelerator Department, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - N S Bandara
- Department of Physics, University of Massachusetts, Amherst, Massachusetts 01003-9337, USA
| | - B Bannier
- Department of Physics and Astronomy, Stony Brook University, SUNY, Stony Brook, New York 11794-3800, USA
| | - K N Barish
- University of California-Riverside, Riverside, California 92521, USA
| | - S Bathe
- Baruch College, City University of New York, New York, New York 10010, USA
- RIKEN BNL Research Center, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - A Bazilevsky
- Physics Department, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - M Beaumier
- University of California-Riverside, Riverside, California 92521, USA
| | - S Beckman
- University of Colorado, Boulder, Colorado 80309, USA
| | - R Belmont
- University of Colorado, Boulder, Colorado 80309, USA
- Physics and Astronomy Department, University of North Carolina at Greensboro, Greensboro, North Carolina 27412, USA
| | - A Berdnikov
- Saint Petersburg State Polytechnic University, St. Petersburg 195251 Russia
| | - Y Berdnikov
- Saint Petersburg State Polytechnic University, St. Petersburg 195251 Russia
| | - L Bichon
- Vanderbilt University, Nashville, Tennessee 37235, USA
| | - D Black
- University of California-Riverside, Riverside, California 92521, USA
| | - B Blankenship
- Vanderbilt University, Nashville, Tennessee 37235, USA
| | - J S Bok
- New Mexico State University, Las Cruces, New Mexico 88003, USA
| | - V Borisov
- Saint Petersburg State Polytechnic University, St. Petersburg 195251 Russia
| | - K Boyle
- RIKEN BNL Research Center, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - M L Brooks
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - J Bryslawskyj
- Baruch College, City University of New York, New York, New York 10010, USA
- University of California-Riverside, Riverside, California 92521, USA
| | - H Buesching
- Physics Department, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - V Bumazhnov
- IHEP Protvino, State Research Center of Russian Federation, Institute for High Energy Physics, Protvino 142281, Russia
| | - S Campbell
- Columbia University, New York, New York 10027 and Nevis Laboratories, Irvington, New York 10533, USA
- Iowa State University, Ames, Iowa 50011, USA
| | - V Canoa Roman
- Department of Physics and Astronomy, Stony Brook University, SUNY, Stony Brook, New York 11794-3800, USA
| | - C-H Chen
- RIKEN BNL Research Center, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - M Chiu
- Physics Department, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - C Y Chi
- Columbia University, New York, New York 10027 and Nevis Laboratories, Irvington, New York 10533, USA
| | - I J Choi
- University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, USA
| | - J B Choi
- Jeonbuk National University, Jeonju, 54896, Korea
| | - T Chujo
- Tomonaga Center for the History of the Universe, University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - Z Citron
- Weizmann Institute, Rehovot 76100, Israel
| | - M Connors
- Georgia State University, Atlanta, Georgia 30303, USA
| | - R Corliss
- Department of Physics and Astronomy, Stony Brook University, SUNY, Stony Brook, New York 11794-3800, USA
| | | | - M Csanád
- ELTE, Eötvös Loránd University, H-1117 Budapest, Pázmány P. s. 1/A, Hungary
| | - T Csörgő
- MATE, Laboratory of Femtoscopy, Károly Róbert Campus, H-3200 Gyöngyös, Mátraiút 36, Hungary
- Institute for Particle and Nuclear Physics, Wigner Research Centre for Physics, Hungarian Academy of Sciences (Wigner RCP, RMKI) H-1525 Budapest 114, P.O. Box 49, Budapest, Hungary
| | - A Datta
- University of New Mexico, Albuquerque, New Mexico 87131, USA
| | | | - G David
- Physics Department, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
- Department of Physics and Astronomy, Stony Brook University, SUNY, Stony Brook, New York 11794-3800, USA
| | - C T Dean
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - K DeBlasio
- University of New Mexico, Albuquerque, New Mexico 87131, USA
| | - K Dehmelt
- Department of Physics and Astronomy, Stony Brook University, SUNY, Stony Brook, New York 11794-3800, USA
| | - A Denisov
- IHEP Protvino, State Research Center of Russian Federation, Institute for High Energy Physics, Protvino 142281, Russia
| | - A Deshpande
- RIKEN BNL Research Center, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
- Department of Physics and Astronomy, Stony Brook University, SUNY, Stony Brook, New York 11794-3800, USA
| | - E J Desmond
- Physics Department, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - L Ding
- Iowa State University, Ames, Iowa 50011, USA
| | - A Dion
- Department of Physics and Astronomy, Stony Brook University, SUNY, Stony Brook, New York 11794-3800, USA
| | - V Doomra
- Department of Physics and Astronomy, Stony Brook University, SUNY, Stony Brook, New York 11794-3800, USA
| | - J H Do
- Yonsei University, IPAP, Seoul 120-749, Korea
| | - A Drees
- Department of Physics and Astronomy, Stony Brook University, SUNY, Stony Brook, New York 11794-3800, USA
| | - K A Drees
- Collider-Accelerator Department, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - J M Durham
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - A Durum
- IHEP Protvino, State Research Center of Russian Federation, Institute for High Energy Physics, Protvino 142281, Russia
| | - H En'yo
- RIKEN Nishina Center for Accelerator-Based Science, Wako, Saitama 351-0198, Japan
| | - A Enokizono
- RIKEN Nishina Center for Accelerator-Based Science, Wako, Saitama 351-0198, Japan
- Physics Department, Rikkyo University, 3-34-1 Nishi-Ikebukuro, Toshima, Tokyo 171-8501, Japan
| | - R Esha
- Department of Physics and Astronomy, Stony Brook University, SUNY, Stony Brook, New York 11794-3800, USA
| | - B Fadem
- Muhlenberg College, Allentown, Pennsylvania 18104-5586, USA
| | - W Fan
- Department of Physics and Astronomy, Stony Brook University, SUNY, Stony Brook, New York 11794-3800, USA
| | - N Feege
- Department of Physics and Astronomy, Stony Brook University, SUNY, Stony Brook, New York 11794-3800, USA
| | - D E Fields
- University of New Mexico, Albuquerque, New Mexico 87131, USA
| | - M Finger
- Charles University, Faculty of Mathematics and Physics, 180 00 Troja, Prague, Czech Republic
| | - M Finger
- Charles University, Faculty of Mathematics and Physics, 180 00 Troja, Prague, Czech Republic
| | - D Firak
- Debrecen University, H-4010 Debrecen, Egyetem tér 1, Hungary
- Department of Physics and Astronomy, Stony Brook University, SUNY, Stony Brook, New York 11794-3800, USA
| | - D Fitzgerald
- Department of Physics, University of Michigan, Ann Arbor, Michigan 48109-1040, USA
| | - S L Fokin
- National Research Center "Kurchatov Institute," Moscow 123098, Russia
| | - J E Frantz
- Department of Physics and Astronomy, Ohio University, Athens, Ohio 45701, USA
| | - A Franz
- Physics Department, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - A D Frawley
- Florida State University, Tallahassee, Florida 32306, USA
| | - P Gallus
- Czech Technical University, Zikova 4, 166 36 Prague 6, Czech Republic
| | - C Gal
- Department of Physics and Astronomy, Stony Brook University, SUNY, Stony Brook, New York 11794-3800, USA
| | - P Garg
- Department of Physics, Banaras Hindu University, Varanasi 221005, India
- Department of Physics and Astronomy, Stony Brook University, SUNY, Stony Brook, New York 11794-3800, USA
| | - H Ge
- Department of Physics and Astronomy, Stony Brook University, SUNY, Stony Brook, New York 11794-3800, USA
| | - M Giles
- Department of Physics and Astronomy, Stony Brook University, SUNY, Stony Brook, New York 11794-3800, USA
| | - F Giordano
- University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, USA
| | - A Glenn
- Lawrence Livermore National Laboratory, Livermore, California 94550, USA
| | - Y Goto
- RIKEN Nishina Center for Accelerator-Based Science, Wako, Saitama 351-0198, Japan
- RIKEN BNL Research Center, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - N Grau
- Department of Physics, Augustana University, Sioux Falls, South Dakota 57197, USA
| | - S V Greene
- Vanderbilt University, Nashville, Tennessee 37235, USA
| | | | - T Gunji
- Center for Nuclear Study, Graduate School of Science, University of Tokyo, 7-3-1 Hongo, Bunkyo, Tokyo 113-0033, Japan
| | - H Guragain
- Georgia State University, Atlanta, Georgia 30303, USA
| | - Y Gu
- Chemistry Department, Stony Brook University, SUNY, Stony Brook, New York 11794-3400, USA
| | - T Hachiya
- Nara Women's University, Kita-uoya Nishi-machi Nara 630-8506, Japan
- RIKEN Nishina Center for Accelerator-Based Science, Wako, Saitama 351-0198, Japan
- RIKEN BNL Research Center, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - J S Haggerty
- Physics Department, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - K I Hahn
- Ewha Womans University, Seoul 120-750, Korea
| | - H Hamagaki
- Center for Nuclear Study, Graduate School of Science, University of Tokyo, 7-3-1 Hongo, Bunkyo, Tokyo 113-0033, Japan
| | - J Hanks
- Department of Physics and Astronomy, Stony Brook University, SUNY, Stony Brook, New York 11794-3800, USA
| | - S Y Han
- Ewha Womans University, Seoul 120-750, Korea
- Korea University, Seoul 02841, Korea
| | - M Harvey
- Texas Southern University, Houston, Texas 77004, USA
| | - S Hasegawa
- Advanced Science Research Center, Japan Atomic Energy Agency, 2-4 Shirakata Shirane, Tokai-mura, Naka-gun, Ibaraki-ken 319-1195, Japan
| | - T K Hemmick
- Department of Physics and Astronomy, Stony Brook University, SUNY, Stony Brook, New York 11794-3800, USA
| | - X He
- Georgia State University, Atlanta, Georgia 30303, USA
| | - J C Hill
- Iowa State University, Ames, Iowa 50011, USA
| | - A Hodges
- Georgia State University, Atlanta, Georgia 30303, USA
- University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, USA
| | - R S Hollis
- University of California-Riverside, Riverside, California 92521, USA
| | - K Homma
- Hiroshima University, Kagamiyama, Higashi-Hiroshima 739-8526, Japan
| | - B Hong
- Korea University, Seoul 02841, Korea
| | - T Hoshino
- Hiroshima University, Kagamiyama, Higashi-Hiroshima 739-8526, Japan
| | - J Huang
- Physics Department, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - Y Ikeda
- RIKEN Nishina Center for Accelerator-Based Science, Wako, Saitama 351-0198, Japan
| | - K Imai
- Advanced Science Research Center, Japan Atomic Energy Agency, 2-4 Shirakata Shirane, Tokai-mura, Naka-gun, Ibaraki-ken 319-1195, Japan
| | - Y Imazu
- RIKEN Nishina Center for Accelerator-Based Science, Wako, Saitama 351-0198, Japan
| | - M Inaba
- Tomonaga Center for the History of the Universe, University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - A Iordanova
- University of California-Riverside, Riverside, California 92521, USA
| | - D Isenhower
- Abilene Christian University, Abilene, Texas 79699, USA
| | - D Ivanishchev
- PNPI, Petersburg Nuclear Physics Institute, Gatchina, Leningrad region 188300, Russia
| | - B V Jacak
- Department of Physics and Astronomy, Stony Brook University, SUNY, Stony Brook, New York 11794-3800, USA
| | - S J Jeon
- Myongji University, Yongin, Kyonggido 449-728, Korea
| | - M Jezghani
- Georgia State University, Atlanta, Georgia 30303, USA
| | - X Jiang
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - Z Ji
- Department of Physics and Astronomy, Stony Brook University, SUNY, Stony Brook, New York 11794-3800, USA
| | - B M Johnson
- Physics Department, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
- Georgia State University, Atlanta, Georgia 30303, USA
| | - E Joo
- Korea University, Seoul 02841, Korea
| | - K S Joo
- Myongji University, Yongin, Kyonggido 449-728, Korea
| | - D Jouan
- IPN-Orsay, Univ. Paris-Sud, CNRS/IN2P3, Université Paris-Saclay, BP1, F-91406 Orsay, France
| | - D S Jumper
- University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, USA
| | - J H Kang
- Yonsei University, IPAP, Seoul 120-749, Korea
| | - J S Kang
- Hanyang University, Seoul 133-792, Korea
| | - D Kawall
- Department of Physics, University of Massachusetts, Amherst, Massachusetts 01003-9337, USA
| | - A V Kazantsev
- National Research Center "Kurchatov Institute," Moscow 123098, Russia
| | - J A Key
- University of New Mexico, Albuquerque, New Mexico 87131, USA
| | - V Khachatryan
- Department of Physics and Astronomy, Stony Brook University, SUNY, Stony Brook, New York 11794-3800, USA
| | - A Khanzadeev
- PNPI, Petersburg Nuclear Physics Institute, Gatchina, Leningrad region 188300, Russia
| | - A Khatiwada
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - K Kihara
- Tomonaga Center for the History of the Universe, University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - C Kim
- Korea University, Seoul 02841, Korea
| | - D H Kim
- Ewha Womans University, Seoul 120-750, Korea
| | - D J Kim
- Helsinki Institute of Physics and University of Jyväskylä, P.O.Box 35, FI-40014 Jyväskylä, Finland
| | - E-J Kim
- Jeonbuk National University, Jeonju, 54896, Korea
| | - H-J Kim
- Yonsei University, IPAP, Seoul 120-749, Korea
| | - M Kim
- Department of Physics and Astronomy, Seoul National University, Seoul 151-742, Korea
| | - T Kim
- Ewha Womans University, Seoul 120-750, Korea
| | - Y K Kim
- Hanyang University, Seoul 133-792, Korea
| | - D Kincses
- ELTE, Eötvös Loránd University, H-1117 Budapest, Pázmány P. s. 1/A, Hungary
| | - A Kingan
- Department of Physics and Astronomy, Stony Brook University, SUNY, Stony Brook, New York 11794-3800, USA
| | - E Kistenev
- Physics Department, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - J Klatsky
- Florida State University, Tallahassee, Florida 32306, USA
| | - D Kleinjan
- University of California-Riverside, Riverside, California 92521, USA
| | - P Kline
- Department of Physics and Astronomy, Stony Brook University, SUNY, Stony Brook, New York 11794-3800, USA
| | - T Koblesky
- University of Colorado, Boulder, Colorado 80309, USA
| | - M Kofarago
- ELTE, Eötvös Loránd University, H-1117 Budapest, Pázmány P. s. 1/A, Hungary
- Institute for Particle and Nuclear Physics, Wigner Research Centre for Physics, Hungarian Academy of Sciences (Wigner RCP, RMKI) H-1525 Budapest 114, P.O. Box 49, Budapest, Hungary
| | - J Koster
- RIKEN BNL Research Center, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - D Kotov
- PNPI, Petersburg Nuclear Physics Institute, Gatchina, Leningrad region 188300, Russia
- Saint Petersburg State Polytechnic University, St. Petersburg 195251 Russia
| | - L Kovacs
- ELTE, Eötvös Loránd University, H-1117 Budapest, Pázmány P. s. 1/A, Hungary
| | - B Kurgyis
- ELTE, Eötvös Loránd University, H-1117 Budapest, Pázmány P. s. 1/A, Hungary
| | - K Kurita
- Physics Department, Rikkyo University, 3-34-1 Nishi-Ikebukuro, Toshima, Tokyo 171-8501, Japan
| | - M Kurosawa
- RIKEN Nishina Center for Accelerator-Based Science, Wako, Saitama 351-0198, Japan
- RIKEN BNL Research Center, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - Y Kwon
- Yonsei University, IPAP, Seoul 120-749, Korea
| | - J G Lajoie
- Iowa State University, Ames, Iowa 50011, USA
| | - D Larionova
- Saint Petersburg State Polytechnic University, St. Petersburg 195251 Russia
| | - A Lebedev
- Iowa State University, Ames, Iowa 50011, USA
| | - K B Lee
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - S H Lee
- Iowa State University, Ames, Iowa 50011, USA
- Department of Physics, University of Michigan, Ann Arbor, Michigan 48109-1040, USA
- Department of Physics and Astronomy, Stony Brook University, SUNY, Stony Brook, New York 11794-3800, USA
| | - M J Leitch
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - M Leitgab
- University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, USA
| | - N A Lewis
- Department of Physics, University of Michigan, Ann Arbor, Michigan 48109-1040, USA
| | - S H Lim
- Pusan National University, Pusan 46241, Korea
- Yonsei University, IPAP, Seoul 120-749, Korea
| | - M X Liu
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - X Li
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - D A Loomis
- Department of Physics, University of Michigan, Ann Arbor, Michigan 48109-1040, USA
| | - D Lynch
- Physics Department, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - S Lökös
- ELTE, Eötvös Loránd University, H-1117 Budapest, Pázmány P. s. 1/A, Hungary
| | - T Majoros
- Debrecen University, H-4010 Debrecen, Egyetem tér 1, Hungary
| | - Y I Makdisi
- Collider-Accelerator Department, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - M Makek
- Weizmann Institute, Rehovot 76100, Israel
- Department of Physics, Faculty of Science, University of Zagreb, Bijenička c. 32 HR-10002 Zagreb, Croatia
| | - A Manion
- Department of Physics and Astronomy, Stony Brook University, SUNY, Stony Brook, New York 11794-3800, USA
| | - V I Manko
- National Research Center "Kurchatov Institute," Moscow 123098, Russia
| | - E Mannel
- Physics Department, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - M McCumber
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - P L McGaughey
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - D McGlinchey
- University of Colorado, Boulder, Colorado 80309, USA
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - C McKinney
- University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, USA
| | - A Meles
- New Mexico State University, Las Cruces, New Mexico 88003, USA
| | - M Mendoza
- University of California-Riverside, Riverside, California 92521, USA
| | - B Meredith
- Columbia University, New York, New York 10027 and Nevis Laboratories, Irvington, New York 10533, USA
| | - Y Miake
- Tomonaga Center for the History of the Universe, University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - A C Mignerey
- University of Maryland, College Park, Maryland 20742, USA
| | - A J Miller
- Abilene Christian University, Abilene, Texas 79699, USA
| | - A Milov
- Weizmann Institute, Rehovot 76100, Israel
| | - D K Mishra
- Bhabha Atomic Research Centre, Bombay 400 085, India
| | - J T Mitchell
- Physics Department, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - M Mitrankova
- Saint Petersburg State Polytechnic University, St. Petersburg 195251 Russia
| | - Iu Mitrankov
- Saint Petersburg State Polytechnic University, St. Petersburg 195251 Russia
| | - S Miyasaka
- RIKEN Nishina Center for Accelerator-Based Science, Wako, Saitama 351-0198, Japan
- Department of Physics, Tokyo Institute of Technology, Oh-okayama, Meguro, Tokyo 152-8551, Japan
| | - S Mizuno
- RIKEN Nishina Center for Accelerator-Based Science, Wako, Saitama 351-0198, Japan
- Tomonaga Center for the History of the Universe, University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - M M Mondal
- Department of Physics and Astronomy, Stony Brook University, SUNY, Stony Brook, New York 11794-3800, USA
| | - P Montuenga
- University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, USA
| | - T Moon
- Korea University, Seoul 02841, Korea
- Yonsei University, IPAP, Seoul 120-749, Korea
| | - D P Morrison
- Physics Department, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - T V Moukhanova
- National Research Center "Kurchatov Institute," Moscow 123098, Russia
| | - A Muhammad
- Mississippi State University, Mississippi State, Mississippi 39762, USA
| | - B Mulilo
- Korea University, Seoul 02841, Korea
- RIKEN Nishina Center for Accelerator-Based Science, Wako, Saitama 351-0198, Japan
- Department of Physics, School of Natural Sciences, University of Zambia, Great East Road Campus, Box 32379 Lusaka, Zambia
| | - T Murakami
- Kyoto University, Kyoto 606-8502, Japan
- RIKEN Nishina Center for Accelerator-Based Science, Wako, Saitama 351-0198, Japan
| | - J Murata
- RIKEN Nishina Center for Accelerator-Based Science, Wako, Saitama 351-0198, Japan
- Physics Department, Rikkyo University, 3-34-1 Nishi-Ikebukuro, Toshima, Tokyo 171-8501, Japan
| | - A Mwai
- Chemistry Department, Stony Brook University, SUNY, Stony Brook, New York 11794-3400, USA
| | - S Nagamiya
- KEK, High Energy Accelerator Research Organization, Tsukuba, Ibaraki 305-0801, Japan
- RIKEN Nishina Center for Accelerator-Based Science, Wako, Saitama 351-0198, Japan
| | - J L Nagle
- University of Colorado, Boulder, Colorado 80309, USA
| | - M I Nagy
- ELTE, Eötvös Loránd University, H-1117 Budapest, Pázmány P. s. 1/A, Hungary
| | - I Nakagawa
- RIKEN Nishina Center for Accelerator-Based Science, Wako, Saitama 351-0198, Japan
- RIKEN BNL Research Center, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - H Nakagomi
- RIKEN Nishina Center for Accelerator-Based Science, Wako, Saitama 351-0198, Japan
- Tomonaga Center for the History of the Universe, University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - K Nakano
- RIKEN Nishina Center for Accelerator-Based Science, Wako, Saitama 351-0198, Japan
- Department of Physics, Tokyo Institute of Technology, Oh-okayama, Meguro, Tokyo 152-8551, Japan
| | - C Nattrass
- University of Tennessee, Knoxville, Tennessee 37996, USA
| | - S Nelson
- Florida A&M University, Tallahassee, Florida 32307, USA
| | | | - M Nihashi
- Hiroshima University, Kagamiyama, Higashi-Hiroshima 739-8526, Japan
- RIKEN Nishina Center for Accelerator-Based Science, Wako, Saitama 351-0198, Japan
| | - T Niida
- Tomonaga Center for the History of the Universe, University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - R Nouicer
- Physics Department, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
- RIKEN BNL Research Center, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - N Novitzky
- Helsinki Institute of Physics and University of Jyväskylä, P.O.Box 35, FI-40014 Jyväskylä, Finland
- Department of Physics and Astronomy, Stony Brook University, SUNY, Stony Brook, New York 11794-3800, USA
- Tomonaga Center for the History of the Universe, University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - G Nukazuka
- RIKEN Nishina Center for Accelerator-Based Science, Wako, Saitama 351-0198, Japan
- RIKEN BNL Research Center, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - A S Nyanin
- National Research Center "Kurchatov Institute," Moscow 123098, Russia
| | - E O'Brien
- Physics Department, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - C A Ogilvie
- Iowa State University, Ames, Iowa 50011, USA
| | - J Oh
- Pusan National University, Pusan 46241, Korea
| | | | - M Orosz
- Debrecen University, H-4010 Debrecen, Egyetem tér 1, Hungary
| | - J D Osborn
- Department of Physics, University of Michigan, Ann Arbor, Michigan 48109-1040, USA
- Oak Ridge National Laboratory, Oak Ridge, Tennessee 37831, USA
| | - A Oskarsson
- Department of Physics, Lund University, Box 118, SE-221 00 Lund, Sweden
| | - K Ozawa
- KEK, High Energy Accelerator Research Organization, Tsukuba, Ibaraki 305-0801, Japan
- Tomonaga Center for the History of the Universe, University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - R Pak
- Physics Department, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - V Pantuev
- Institute for Nuclear Research of the Russian Academy of Sciences, prospekt 60-letiya Oktyabrya 7a, Moscow 117312, Russia
| | - V Papavassiliou
- New Mexico State University, Las Cruces, New Mexico 88003, USA
| | - J S Park
- Department of Physics and Astronomy, Seoul National University, Seoul 151-742, Korea
| | - S Park
- Mississippi State University, Mississippi State, Mississippi 39762, USA
- Department of Physics and Astronomy, Seoul National University, Seoul 151-742, Korea
- Department of Physics and Astronomy, Stony Brook University, SUNY, Stony Brook, New York 11794-3800, USA
| | - L Patel
- Georgia State University, Atlanta, Georgia 30303, USA
| | - M Patel
- Iowa State University, Ames, Iowa 50011, USA
| | - S F Pate
- New Mexico State University, Las Cruces, New Mexico 88003, USA
| | - J-C Peng
- University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, USA
| | - W Peng
- Vanderbilt University, Nashville, Tennessee 37235, USA
| | - D V Perepelitsa
- Physics Department, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
- University of Colorado, Boulder, Colorado 80309, USA
- Columbia University, New York, New York 10027 and Nevis Laboratories, Irvington, New York 10533, USA
| | - G D N Perera
- New Mexico State University, Las Cruces, New Mexico 88003, USA
| | - D Yu Peressounko
- National Research Center "Kurchatov Institute," Moscow 123098, Russia
| | - C E PerezLara
- Department of Physics and Astronomy, Stony Brook University, SUNY, Stony Brook, New York 11794-3800, USA
| | - J Perry
- Iowa State University, Ames, Iowa 50011, USA
| | - R Petti
- Physics Department, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
- Department of Physics and Astronomy, Stony Brook University, SUNY, Stony Brook, New York 11794-3800, USA
| | - C Pinkenburg
- Physics Department, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - R Pinson
- Abilene Christian University, Abilene, Texas 79699, USA
| | - R P Pisani
- Physics Department, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - M Potekhin
- Physics Department, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - A Pun
- Department of Physics and Astronomy, Ohio University, Athens, Ohio 45701, USA
| | - M L Purschke
- Physics Department, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - P V Radzevich
- Saint Petersburg State Polytechnic University, St. Petersburg 195251 Russia
| | - J Rak
- Helsinki Institute of Physics and University of Jyväskylä, P.O.Box 35, FI-40014 Jyväskylä, Finland
| | - N Ramasubramanian
- Department of Physics and Astronomy, Stony Brook University, SUNY, Stony Brook, New York 11794-3800, USA
| | | | - K F Read
- Oak Ridge National Laboratory, Oak Ridge, Tennessee 37831, USA
- University of Tennessee, Knoxville, Tennessee 37996, USA
| | - D Reynolds
- Chemistry Department, Stony Brook University, SUNY, Stony Brook, New York 11794-3400, USA
| | - V Riabov
- National Research Nuclear University, MEPhI, Moscow Engineering Physics Institute, Moscow 115409, Russia
- PNPI, Petersburg Nuclear Physics Institute, Gatchina, Leningrad region 188300, Russia
| | - Y Riabov
- PNPI, Petersburg Nuclear Physics Institute, Gatchina, Leningrad region 188300, Russia
- Saint Petersburg State Polytechnic University, St. Petersburg 195251 Russia
| | - D Richford
- Baruch College, City University of New York, New York, New York 10010, USA
| | - N Riveli
- Department of Physics and Astronomy, Ohio University, Athens, Ohio 45701, USA
| | - D Roach
- Vanderbilt University, Nashville, Tennessee 37235, USA
| | - S D Rolnick
- University of California-Riverside, Riverside, California 92521, USA
| | - M Rosati
- Iowa State University, Ames, Iowa 50011, USA
| | - Z Rowan
- Baruch College, City University of New York, New York, New York 10010, USA
| | - J G Rubin
- Department of Physics, University of Michigan, Ann Arbor, Michigan 48109-1040, USA
| | - J Runchey
- Iowa State University, Ames, Iowa 50011, USA
| | - N Saito
- KEK, High Energy Accelerator Research Organization, Tsukuba, Ibaraki 305-0801, Japan
| | - T Sakaguchi
- Physics Department, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - H Sako
- Advanced Science Research Center, Japan Atomic Energy Agency, 2-4 Shirakata Shirane, Tokai-mura, Naka-gun, Ibaraki-ken 319-1195, Japan
| | - V Samsonov
- National Research Nuclear University, MEPhI, Moscow Engineering Physics Institute, Moscow 115409, Russia
- PNPI, Petersburg Nuclear Physics Institute, Gatchina, Leningrad region 188300, Russia
| | - M Sarsour
- Georgia State University, Atlanta, Georgia 30303, USA
| | - S Sato
- Advanced Science Research Center, Japan Atomic Energy Agency, 2-4 Shirakata Shirane, Tokai-mura, Naka-gun, Ibaraki-ken 319-1195, Japan
| | - S Sawada
- KEK, High Energy Accelerator Research Organization, Tsukuba, Ibaraki 305-0801, Japan
| | - B Schaefer
- Vanderbilt University, Nashville, Tennessee 37235, USA
| | - B K Schmoll
- University of Tennessee, Knoxville, Tennessee 37996, USA
| | - K Sedgwick
- University of California-Riverside, Riverside, California 92521, USA
| | - J Seele
- RIKEN BNL Research Center, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - R Seidl
- RIKEN Nishina Center for Accelerator-Based Science, Wako, Saitama 351-0198, Japan
- RIKEN BNL Research Center, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - A Sen
- Iowa State University, Ames, Iowa 50011, USA
- University of Tennessee, Knoxville, Tennessee 37996, USA
| | - R Seto
- University of California-Riverside, Riverside, California 92521, USA
| | - P Sett
- Bhabha Atomic Research Centre, Bombay 400 085, India
| | - A Sexton
- University of Maryland, College Park, Maryland 20742, USA
| | - D Sharma
- Department of Physics and Astronomy, Stony Brook University, SUNY, Stony Brook, New York 11794-3800, USA
| | - I Shein
- IHEP Protvino, State Research Center of Russian Federation, Institute for High Energy Physics, Protvino 142281, Russia
| | - M Shibata
- Nara Women's University, Kita-uoya Nishi-machi Nara 630-8506, Japan
| | - T-A Shibata
- RIKEN Nishina Center for Accelerator-Based Science, Wako, Saitama 351-0198, Japan
- Department of Physics, Tokyo Institute of Technology, Oh-okayama, Meguro, Tokyo 152-8551, Japan
| | - K Shigaki
- Hiroshima University, Kagamiyama, Higashi-Hiroshima 739-8526, Japan
| | - M Shimomura
- Iowa State University, Ames, Iowa 50011, USA
- Nara Women's University, Kita-uoya Nishi-machi Nara 630-8506, Japan
| | - Z Shi
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - P Shukla
- Bhabha Atomic Research Centre, Bombay 400 085, India
| | - A Sickles
- Physics Department, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
- University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, USA
| | - C L Silva
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - D Silvermyr
- Department of Physics, Lund University, Box 118, SE-221 00 Lund, Sweden
- Oak Ridge National Laboratory, Oak Ridge, Tennessee 37831, USA
| | - B K Singh
- Department of Physics, Banaras Hindu University, Varanasi 221005, India
| | - C P Singh
- Department of Physics, Banaras Hindu University, Varanasi 221005, India
| | - V Singh
- Department of Physics, Banaras Hindu University, Varanasi 221005, India
| | - M Slunečka
- Charles University, Faculty of Mathematics and Physics, 180 00 Troja, Prague, Czech Republic
| | - K L Smith
- Florida State University, Tallahassee, Florida 32306, USA
| | - R A Soltz
- Lawrence Livermore National Laboratory, Livermore, California 94550, USA
| | - W E Sondheim
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - S P Sorensen
- University of Tennessee, Knoxville, Tennessee 37996, USA
| | - I V Sourikova
- Physics Department, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - P W Stankus
- Oak Ridge National Laboratory, Oak Ridge, Tennessee 37831, USA
| | - M Stepanov
- Department of Physics, University of Massachusetts, Amherst, Massachusetts 01003-9337, USA
| | - S P Stoll
- Physics Department, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - T Sugitate
- Hiroshima University, Kagamiyama, Higashi-Hiroshima 739-8526, Japan
| | - A Sukhanov
- Physics Department, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - T Sumita
- RIKEN Nishina Center for Accelerator-Based Science, Wako, Saitama 351-0198, Japan
| | - J Sun
- Department of Physics and Astronomy, Stony Brook University, SUNY, Stony Brook, New York 11794-3800, USA
| | - Z Sun
- Debrecen University, H-4010 Debrecen, Egyetem tér 1, Hungary
| | - J Sziklai
- Institute for Particle and Nuclear Physics, Wigner Research Centre for Physics, Hungarian Academy of Sciences (Wigner RCP, RMKI) H-1525 Budapest 114, P.O. Box 49, Budapest, Hungary
| | - R Takahama
- Nara Women's University, Kita-uoya Nishi-machi Nara 630-8506, Japan
| | - A Takahara
- Center for Nuclear Study, Graduate School of Science, University of Tokyo, 7-3-1 Hongo, Bunkyo, Tokyo 113-0033, Japan
| | - A Taketani
- RIKEN Nishina Center for Accelerator-Based Science, Wako, Saitama 351-0198, Japan
- RIKEN BNL Research Center, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - K Tanida
- Advanced Science Research Center, Japan Atomic Energy Agency, 2-4 Shirakata Shirane, Tokai-mura, Naka-gun, Ibaraki-ken 319-1195, Japan
- RIKEN BNL Research Center, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
- Department of Physics and Astronomy, Seoul National University, Seoul 151-742, Korea
| | - M J Tannenbaum
- Physics Department, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - S Tarafdar
- Vanderbilt University, Nashville, Tennessee 37235, USA
- Weizmann Institute, Rehovot 76100, Israel
| | - A Taranenko
- National Research Nuclear University, MEPhI, Moscow Engineering Physics Institute, Moscow 115409, Russia
- Chemistry Department, Stony Brook University, SUNY, Stony Brook, New York 11794-3400, USA
| | - A Timilsina
- Iowa State University, Ames, Iowa 50011, USA
| | - T Todoroki
- RIKEN Nishina Center for Accelerator-Based Science, Wako, Saitama 351-0198, Japan
- RIKEN BNL Research Center, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
- Tomonaga Center for the History of the Universe, University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - M Tomášek
- Czech Technical University, Zikova 4, 166 36 Prague 6, Czech Republic
| | - H Torii
- Center for Nuclear Study, Graduate School of Science, University of Tokyo, 7-3-1 Hongo, Bunkyo, Tokyo 113-0033, Japan
| | - M Towell
- Abilene Christian University, Abilene, Texas 79699, USA
| | - R Towell
- Abilene Christian University, Abilene, Texas 79699, USA
| | - R S Towell
- Abilene Christian University, Abilene, Texas 79699, USA
| | - I Tserruya
- Weizmann Institute, Rehovot 76100, Israel
| | - Y Ueda
- Hiroshima University, Kagamiyama, Higashi-Hiroshima 739-8526, Japan
| | - B Ujvari
- Debrecen University, H-4010 Debrecen, Egyetem tér 1, Hungary
| | - H W van Hecke
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - M Vargyas
- ELTE, Eötvös Loránd University, H-1117 Budapest, Pázmány P. s. 1/A, Hungary
- Institute for Particle and Nuclear Physics, Wigner Research Centre for Physics, Hungarian Academy of Sciences (Wigner RCP, RMKI) H-1525 Budapest 114, P.O. Box 49, Budapest, Hungary
| | - J Velkovska
- Vanderbilt University, Nashville, Tennessee 37235, USA
| | - M Virius
- Czech Technical University, Zikova 4, 166 36 Prague 6, Czech Republic
| | - V Vrba
- Czech Technical University, Zikova 4, 166 36 Prague 6, Czech Republic
- Institute of Physics, Academy of Sciences of the Czech Republic, Na Slovance 2, 182 21 Prague 8, Czech Republic
| | - E Vznuzdaev
- PNPI, Petersburg Nuclear Physics Institute, Gatchina, Leningrad region 188300, Russia
| | - X R Wang
- New Mexico State University, Las Cruces, New Mexico 88003, USA
- RIKEN BNL Research Center, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - Z Wang
- Baruch College, City University of New York, New York, New York 10010, USA
| | - D Watanabe
- Hiroshima University, Kagamiyama, Higashi-Hiroshima 739-8526, Japan
| | - Y Watanabe
- RIKEN Nishina Center for Accelerator-Based Science, Wako, Saitama 351-0198, Japan
- RIKEN BNL Research Center, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - Y S Watanabe
- Center for Nuclear Study, Graduate School of Science, University of Tokyo, 7-3-1 Hongo, Bunkyo, Tokyo 113-0033, Japan
- KEK, High Energy Accelerator Research Organization, Tsukuba, Ibaraki 305-0801, Japan
| | - F Wei
- New Mexico State University, Las Cruces, New Mexico 88003, USA
| | - S Whitaker
- Iowa State University, Ames, Iowa 50011, USA
| | - S Wolin
- University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, USA
| | - C P Wong
- Georgia State University, Atlanta, Georgia 30303, USA
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - C L Woody
- Physics Department, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - M Wysocki
- Oak Ridge National Laboratory, Oak Ridge, Tennessee 37831, USA
| | - B Xia
- Department of Physics and Astronomy, Ohio University, Athens, Ohio 45701, USA
| | - L Xue
- Georgia State University, Atlanta, Georgia 30303, USA
| | - S Yalcin
- Department of Physics and Astronomy, Stony Brook University, SUNY, Stony Brook, New York 11794-3800, USA
| | - Y L Yamaguchi
- Center for Nuclear Study, Graduate School of Science, University of Tokyo, 7-3-1 Hongo, Bunkyo, Tokyo 113-0033, Japan
- Department of Physics and Astronomy, Stony Brook University, SUNY, Stony Brook, New York 11794-3800, USA
| | - A Yanovich
- IHEP Protvino, State Research Center of Russian Federation, Institute for High Energy Physics, Protvino 142281, Russia
| | - I Yoon
- Department of Physics and Astronomy, Seoul National University, Seoul 151-742, Korea
| | - I Younus
- Physics Department, Lahore University of Management Sciences, Lahore 54792, Pakistan
| | - I E Yushmanov
- National Research Center "Kurchatov Institute," Moscow 123098, Russia
| | - W A Zajc
- Columbia University, New York, New York 10027 and Nevis Laboratories, Irvington, New York 10533, USA
| | - A Zelenski
- Collider-Accelerator Department, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - L Zou
- University of California-Riverside, Riverside, California 92521, USA
| |
Collapse
|
10
|
Go SI, Kim JH, Kang JH. Treatment of Opioid Withdrawal Syndrome Triggered by Oxycodone/Naloxone with Dexmedetomidine. J Hosp Palliat Care 2023; 26:18-21. [PMID: 37753319 PMCID: PMC10519718 DOI: 10.14475/jhpc.2023.26.1.18] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 01/01/2023] [Revised: 02/07/2023] [Accepted: 02/07/2023] [Indexed: 09/28/2023]
Abstract
The combination of oxycodone and naloxone is useful for cancer pain management. Naloxone, as a pure opioid antagonist, cannot be used simultaneously with opioids. However, owing to its low bioavailability, it can be used in an oral composite formulation. We present the case of a 55-year-old man with gastric cancer who experienced severe opioid withdrawal syndrome (OWS) triggered by oxycodone/naloxone that was successfully managed with dexmedetomidine. He had been in a stable condition on intravenous morphine to alleviate cancer pain. Intravenous morphine was switched to oral oxycodone/naloxone for discharge from the hospital. The patient suddenly developed restlessness, heartburn, and violent behavior 30 minutes after taking oxycodone/naloxone. We attempted sedation with midazolam and propofol, but paradoxical agitation and desaturation occurred. Next, we tried dexmedetomidine and the patient showed a decreased heart rate and reduced agitation. The patient was eventually stabilized by increasing the dose of dexmedetomidine. This report informs clinicians of the possibility of OWS when switching from opioids to oxycodone/naloxone, which can be overcome with the appropriate use of sedatives and dexmedetomidine depending on the patient's condition.
Collapse
Affiliation(s)
- Se-Il Go
- Department of Internal Medicine, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon, Korea
| | - Jung Hoon Kim
- Department of Internal Medicine, Gyeongsang National University College of Medicine, Jinju, Korea
| | - Jung Hun Kang
- Department of Internal Medicine, Gyeongsang National University College of Medicine, Jinju, Korea
| |
Collapse
|
11
|
Ji JH, Lee D, Lee YP, Huh SJ, Go SI, Kim JH, Oh SY, Kang JH, Kim KM. Comparison of survival between de novo stage IV and recurrent stage IV gastric cancer. J Clin Oncol 2023. [DOI: 10.1200/jco.2023.41.4_suppl.304] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023] Open
Abstract
304 Background: The characteristics and prognosis of de novo metastatic gastric cancer and recurrent metastatic gastric cancer have not yet been elucidated. Here, we compare prognosis and characteristics of patients with de novo versus recurrent gastric cancer. Methods: This retrospective study included 301 advanced pathologically confirmed gastric cancer patients who received palliative chemotherapy between 2012 and 2022. The de novo cohort was included of patients who presented with distant metastasis at diagnosis and recurrent metastatic cohort was composed of patients with metastasis after curative gastrectomy. We analyzed prognostic association by Cox regression and compared survival time of both cohorts using the Kaplan-meire method. Results: A total of 167 de novo and 112 recurrent patients were included. There were no differences noted among the patients with de novo disease and recurrent metastatic disease with respect to age, sex, ECOG, primary cancer location and pathologic features. Patients in the recurrent group versus de novo group were longer duration of chemotherapy (1.16 ± 1.18 years versus 0.85 ± 0.84, P = 0.01) and lower mean body mass index. (20.22 ± 2.78 versus 21.93 ± 3.38, p < 0.001) The median overall survival in the de novo group was 11.6 versus s 14.4 months in the recurrent group. ( P = 0.02) In a multivariate analysis, the age of 70 years or older at the time of stage 4 diagnosis was independently associated with shorter survival. Conclusions: De novo and recurrent metastatic gastric cancer characterize distinguished subpopulations. And advanced gastric cancer with distant recurrence has significantly better survival versus those with de novo cohort. This differences between de novo and recurrent gastric cancer could facilitate discussions about patient selection of clinical trial and help with advanced personalized treatment. [Table: see text]
Collapse
Affiliation(s)
- Jun Ho Ji
- Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, South Korea
| | - Danbi Lee
- Asan Liver Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
| | - Yong-Pyo Lee
- Division of Hematology-Oncology, Department of Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, South Korea
| | | | - Se-Il Go
- Gyeongsang National University Changwon Hospital, Changwon-Si, Gyeongsangnam-d, South Korea
| | - Jung Hoon Kim
- Division of Hematology/Oncology, Department of Internal Medicine, Gyeongsang National University Hospital, Jinju-Si, South Korea
| | | | - Jung Hun Kang
- Gyeongsang University Hospital, Jinju-Si, South Korea
| | - Kwang Min Kim
- Division of Gastroenterology, Department of Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, South Korea
| |
Collapse
|
12
|
Chun SH, Kim JH, Kwag SJ, Kang MH, Park JH, Lee GW, Kang JH. Second-line bevacizumab plus FOLFOX in patients with metastatic colorectal cancer previously treated with adjuvant oxaliplatin-based chemotherapy. J Clin Oncol 2023. [DOI: 10.1200/jco.2023.41.4_suppl.157] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023] Open
Abstract
157 Background: There is a rarity of evidence for retreatment with oxaliplatin for metastatic colorectal cancer (mCRC), especially in combination with bevacizumab. This is a retrospective study of second line bevacizumab (Bev) plus FOLFOX (oxaliplatin, 5-fluorouracil, and leucovorin) in patients with metastatic colorectal cancer previously treated with adjuvant oxaliplatin-containing chemotherapy. Methods: Patients with age older than 18 and histologically confirmed metastatic colorectal cancer treated with second line bevacizumab plus FOLFOX in a single institute between 2015 and 2020 were enrolled. History of previous adjuvant chemotherapy regimens in patients with metachronous metastatic colorectal cancer was analyzed. Progression-free survival (PFS) and overall survival (OS) of the second line treatment were calculated using Kaplan-Meier method and compared between patients pretreated with adjuvant oxaliplatin (ReOx) and oxaliplatin-naive patients (control) with the log rank test. Results: A total of 72 patients were included. 23 patients (ReOx) were pretreated with adjuvant oxaliplatin and 49 patients (control) were oxaliplatin-naive before the second line treatment. There was a tendency of younger age in the ReOx group, but not statistically significant. Liver metastasis was significantly more frequent in the control group. The median PFS and OS in the ReOx group and the control group were 4.3 months (95% confidence interval [CI], 3.67–21.50) versus 5.5 months (95% CI, 4.23–8.20, hazard ratio [HR] = 0.84), and 10.5 months (95% CI, 5.40–30.37) versus 9.4 months (95% CI, 6.00–14.9, HR = 1.01) respectively. There was no significant difference of PFS ( p= 0.523) and OS ( p= 0.9745) between two groups. Conclusions: This study suggests a potential survival benefit of bevacizumab plus FOLFOX for mCRC patients previously treated with adjuvant oxaliplatin-containing treatment comparable to oxaliplatin-naive patients. [Table: see text]
Collapse
Affiliation(s)
- Sang Hoon Chun
- Division of Hematology/Oncology, Department of Internal Medicine, Bucheon St.Mary's hospital, Catholic University of Korea, Bucheon-Si, South Korea
| | - Jung Hoon Kim
- Division of Hematology/Oncology, Department of Internal Medicine, Gyeongsang National University Hospital, Jinju-Si, South Korea
| | - Seung-Jin Kwag
- Gyeonsang National University Hospital, Jinju-Si, South Korea
| | - Myoung Hee Kang
- Gyeongsang National University, School of Medicine, Jinju-Si, South Korea
| | - Ji-Ho Park
- Gyeongsang National University, Jinju-Si, South Korea
| | - Gyeong-Won Lee
- Division of Hematology and Oncology, Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University College of Medicin, Jinju, Korea, Republic of (South)
| | - Jung Hun Kang
- Gyeongsang National University, School of Medicine, Jinju-Si, South Korea
| |
Collapse
|
13
|
Hwang IC, Kang JH, Kim WC, Park J, Kim HS, Kim D, Lee KH. Beliefs and Attitudes toward Physician-assisted Suicide among Korean Adults. J Hosp Palliat Care 2022; 25:198-203. [PMID: 37674668 PMCID: PMC10179991 DOI: 10.14475/jhpc.2022.25.4.198] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Received: 10/07/2022] [Revised: 10/19/2022] [Accepted: 10/19/2022] [Indexed: 09/08/2023]
Abstract
Purpose To grasp public opinion accurately, we conducted an opinion poll on beliefs and attitudes toward physician-assisted suicide (PAS). Methods A randomized telephone survey ensuring a representative sample was conducted, 1,007 participants aged 18 years or older (response rate, 9.5%). Results The main results are as follows i) 61.1% of participants thought that the current social support system for terminally ill patients and their families is insufficient; ii) 60% of participants did not recognize the term "hospice and palliative care"; iii) 81.7% of participants would not like to receive life-sustaining treatment if there is no possibility of recovery; iv) 58.4% of participants would like to receive hospice and palliative care if they are diagnosed with a terminal illness; v) the priorities for dignified dying were preparing a support system to reduce the burden of care (28.6%), economic support including reduction of medical expenses (26.7%), expansion of hospice and palliative care services (25.4%), and legalization of PAS (13.6%); and vi) 58.3% of participants agreed that the expansion of hospice and palliative care should precede the legalization of PAS. Conclusion Koreans currently want other efforts, including expansion of hospice and palliative care services, instead of the legalization of PAS.
Collapse
Affiliation(s)
- In Cheol Hwang
- Department of Family Medicine, Gil Medical Center, Gachon University College of Medicine, Incheon, Korea
| | - Jung Hun Kang
- Oncology Division, Department of Internal Medicine, Gyeongsang National University College of Medicine, Jinju, Korea
| | - Won-chul Kim
- Department of Medical Social Services Team, Korea University Anam Hospital, Seoul, Korea
| | - Jeanno Park
- Department of Internal Medicine, Bobath Memorial Hospital, Seongnam, Korea
| | - Hyun Sook Kim
- Department of Nursing, Korea National University of Transportation, Jeungpyeong, Korea
| | - DaeKyun Kim
- Department of Family Medicine, Incheon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Incheon, Korea
| | - Kyung Hee Lee
- Oncology Division, Department of Internal Medicine, Yeungnam University College of Medicine, Daegu, Korea
| |
Collapse
|
14
|
Kim ST, Kim SY, Lee J, Yun SH, Kim HC, Lee WY, Kim TW, Hong YS, Lim SB, Baek JY, Oh JH, Ahn JB, Shin SJ, Han SW, Kim SG, Kang SY, Sym SJ, Zang DY, Kim YH, Choi IS, Kang JH, Kim MJ, Park YS. Oxaliplatin (3 months v 6 months) With 6 Months of Fluoropyrimidine as Adjuvant Therapy in Patients With Stage II/III Colon Cancer: KCSG CO09-07. J Clin Oncol 2022; 40:3868-3877. [PMID: 35772045 PMCID: PMC9671755 DOI: 10.1200/jco.21.02962] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022] Open
Abstract
PURPOSE The combination of oxaliplatin and fluoropyrimidine for 6 months is one of the standard options for adjuvant therapy for high-risk stage II and III colorectal cancers (CRCs). The optimal duration of oxaliplatin to diminish neurotoxicity without compromising efficacy needs to be clarified. PATIENTS AND METHODS This open-label, randomized, phase III, noninferiority trial randomly assigned patients with high-risk stage II and III CRC to 3 and 6 months of oxaliplatin with 6 months of fluoropyrimidine groups (3- and 6-month arms, respectively). The primary end point was disease-free survival (DFS), and the noninferiority margin was a hazard ratio (HR) of 1.25. RESULTS In total, 1,788 patients were randomly assigned to the 6-month (n = 895) and 3-month (n = 893) arms, and 83.6% in the 6-month arm and 85.7% in the 3-month arm completed the treatment. The neuropathy rates with any grade were higher in the 6-month arm than in the 3-month arm (69.5% v 58.3%; P < .0001). The 3-year DFS rates were 83.7% and 84.7% in the 6-month and 3-month arms, respectively, with an HR of 0.953 (95% CI, 0.769 to 1.180; test for noninferiority, P = .0065) within the noninferiority margin. Among patients with stage III CRC treated by capecitabine plus oxaliplatin, the 3-year DFS of the 3-month arm was noninferior as compared with that of the 6-month arm with an HR of 0.713 (95% CI, 0.530 to 0.959; P = .0009). However, among patients with high-risk stage II and stage III CRC treated by infusional fluorouracil, leucovorin, and oxaliplatin, the noninferiority of the 3-month arm compared with the 6-month arm was not proven. CONCLUSION This study suggests that adding 3 months of oxaliplatin to 6 months of capecitabine could be considered an alternative adjuvant treatment for stage III CRC (ClinicalTrials.gov identifier: NCT01092481).
Collapse
Affiliation(s)
- Seung Tae Kim
- Sungkyunkwan University School of Medicine, Samsung Medical Centre, Seoul, South Korea
| | - Sun Young Kim
- Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea,Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea
| | - Jeeyun Lee
- Sungkyunkwan University School of Medicine, Samsung Medical Centre, Seoul, South Korea
| | - Seong Hyeon Yun
- Sungkyunkwan University School of Medicine, Samsung Medical Centre, Seoul, South Korea
| | - Hee Cheol Kim
- Sungkyunkwan University School of Medicine, Samsung Medical Centre, Seoul, South Korea
| | - Woo Yong Lee
- Sungkyunkwan University School of Medicine, Samsung Medical Centre, Seoul, South Korea
| | - Tae Won Kim
- Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
| | - Yong Sang Hong
- Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
| | - Seok-Byung Lim
- Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
| | - Ji Yeon Baek
- Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea
| | - Jae Hwan Oh
- Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea
| | | | | | - Sae-Won Han
- Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea
| | | | - Seok Yun Kang
- Ajou University School of Medicine, Suwon, South Korea
| | - Sun Jin Sym
- Gachon University Gil Hospital, Incheon, Korea
| | - Dae Young Zang
- Hallym University Medical Center, Hallym University, Anyang, Korea, South Korea
| | - Yeul Hong Kim
- Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea
| | - In Sil Choi
- Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul, Korea
| | | | - Min-Ji Kim
- Statistics and Data Center, Research Institute for Future Medicine, Samsung Medical Center, Seoul, South Korea
| | - Young Suk Park
- Sungkyunkwan University School of Medicine, Samsung Medical Centre, Seoul, South Korea,Young Suk Park, MD, PhD, Division of Hematology/Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro Gangnam-gu, Seoul 0635, Korea; e-mail:
| |
Collapse
|
15
|
Kang JH, Katsumata YK, Lennie TAL, Chung MLC, Biddle MJB, Miller JM, Moser DKM. Sustained effect on diet quality of a self-care intervention to reduce cardiovascular disease risk among informal rural caregivers of people with chronic illnesses: does health literacy matter? Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.2739] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
Abstract
Background/Introduction
Rural caregivers of those with chronic illnesses have higher cardiovascular disease (CVD) risk than urban caregivers. Diet is a major lifestyle factor that contributes to CVD risk. However, interventions are often not constructed with health literacy in mind. We previously found a moderation effect of health literacy on short-term (4-month) diet quality from a self-care intervention to reduce cardiovascular disease risk (RICHH) among rural caregivers. The RICHH intervention was designed to be equally effective in caregivers with marginal or adequate health literacy.
Purpose
To compare the impact of RICHH intervention on 12-month diet quality in rural caregivers with marginal versus adequate health literacy.
Methods
A total of 296 rural caregivers (54.5±13.7 years old, 76% female) of individuals with chronic illnesses participated. The newest vital sign (NVS) and Healthy Eating Index-2015 (HEI-2015) were used to determine health literacy and diet quality, respectively. The NVS was dichotomized using a cutoff score of 4. The HEI-2015 was computed based on food frequency questionnaires at baseline, 4-month, and 12-month. The RICHH intervention was delivered using video conferencing technology by nurse interventionists once a week for 12 weeks followed by bi-weekly and monthly booster sessions. A piecewise linear mixed-effect model, controlling for age, education, smoking status, and perceived stress, was used to evaluate the impact of the intervention on diet quality between the two health literacy groups.
Results
There was a significant difference in improvement in the HEI-2015 total scores at 4 months between control and intervention in the marginal health literacy group (beta estimate = 1.56, SE=0.74, P=0.039) but not in the adequate health literacy group (beta estimate = 0.27, SE=0.38, P=0.475). The improvement in the marginal health literacy group was sustained at 12-months (beta estimate = 8.12, SE=3.57, P=0.022).
Conclusions
The results of our study indicate that an intervention designed to address health literacy is effective in producing a sustained improvement in diet quality to reduce CVD risk in rural caregivers with marginal health literacy.
Funding Acknowledgement
Type of funding sources: Public grant(s) – National budget only. Main funding source(s): National Institutes of Health National Institute of Nursing Research
Collapse
Affiliation(s)
- J H Kang
- University of Kentucky , Lexington , United States of America
| | - Y K Katsumata
- University of Kentucky , Lexington , United States of America
| | - T A L Lennie
- University of Kentucky , Lexington , United States of America
| | - M L C Chung
- University of Kentucky , Lexington , United States of America
| | - M J B Biddle
- University of Kentucky , Lexington , United States of America
| | - J M Miller
- University of Kentucky , Lexington , United States of America
| | - D K M Moser
- University of Kentucky , Lexington , United States of America
| |
Collapse
|
16
|
Go SI, Park S, Kang MH, Kim HG, Kang JH, Kim JH, Lee GW. Endothelial activation and stress index (EASIX) as a predictive biomarker in small cell lung cancer. Cancer Biomark 2022; 35:217-225. [PMID: 36120771 DOI: 10.3233/cbm-220032] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
BACKGROUND Endothelial activation and insult may contribute to the aggressive clinical course of small-cell lung cancer (SCLC); however, no predictive biomarker for this pathogenesis has been identified. OBJECTIVE To evaluate the clinical impact of the endothelial activation and stress index (EASIX) in SCLC. METHODS In this retrospective study, the EASIX was calculated from measurements of serum lactate dehydrogenase, creatinine, and platelet levels. A total of 264 patients with SCLC treated with platinum-based chemotherapy were stratified into high and low EASIX groups. RESULTS Complete and objective response rates in the limited-stage (LD) were 19.5% vs. 33.3% (P= 0.050) and 85.4% vs. 97.9% (P= 0.028) in the high and low EASIX groups, respectively. There was no significant difference in the response rate between the two groups in the extensive-stage (ED). The median overall survival was 9.8 vs. 40.5 months in LD (P< 0.001) and 7.2 vs. 11.9 months in ED (P< 0.001) in the high and low EASIX groups, respectively. In multivariate analyses, a high EASIX level was an independent prognostic factor for worse progression-free and overall survival irrespective of stage. CONCLUSION EASIX may be a potential predictive biomarker of SCLC.
Collapse
Affiliation(s)
- Se-Il Go
- Division of Hematology-Oncology, Department of Internal Medicine, Institute of Health Science, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon, Korea
| | - Sungwoo Park
- Division of Hematology-Oncology, Department of Internal Medicine, Institute of Health Science, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Jinju, Korea
| | - Myoung Hee Kang
- Division of Hematology-Oncology, Department of Internal Medicine, Institute of Health Science, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon, Korea
| | - Hoon-Gu Kim
- Division of Hematology-Oncology, Department of Internal Medicine, Institute of Health Science, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon, Korea
| | - Jung Hun Kang
- Division of Hematology-Oncology, Department of Internal Medicine, Institute of Health Science, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Jinju, Korea
| | - Jung Hoon Kim
- Division of Hematology-Oncology, Department of Internal Medicine, Institute of Health Science, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Jinju, Korea
| | - Gyeong-Won Lee
- Division of Hematology-Oncology, Department of Internal Medicine, Institute of Health Science, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Jinju, Korea
| |
Collapse
|
17
|
Lim DH, Casadei-Gardini A, Lee MA, Lonardi S, Kim JW, Masi G, Chon HJ, Rimini M, Kim I, Cheon J, Hwang JE, Kang JH, Lim HY, Yoo C. Prognostic implication of serum AFP in patients with hepatocellular carcinoma treated with regorafenib. Future Oncol 2022; 18:3021-3030. [PMID: 35903991 DOI: 10.2217/fon-2022-0524] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Abstract
Background: This multicenter study investigated the predictive value of baseline AFP and on-treatment AFP response for survival in hepatocellular carcinoma (HCC) patients with regorafenib. Materials & methods: A total of 578 patients with HCC treated with regorafenib from 12 institutions in South Korea and Italy were included. Baseline AFP (cutoff, 400 ng/ml) and AFP response (20% reduction from baseline) were analyzed for overall survival (OS) and progression-free survival (PFS). Results: Baseline AFP below 400 ng/ml was a significant factor that was independently associated with longer OS and PFS. AFP response was also a significant factor independently associated with longer OS and PFS. Conclusion: Baseline AFP and AFP response may be used as prognostic factors for survival in HCC treated with regorafenib.
Collapse
Affiliation(s)
- Dong-Hoon Lim
- University of Ulsan College of Medicine, Seoul, 05505, South Korea
| | - Andrea Casadei-Gardini
- Vita-Salute San Raffaele University School of Medicine, Milan, 20132, Italy.,Department of Medical Oncology, IRCCS San Raffaele Scientific Institute, Milan, 20132, Italy
| | - Myung Ah Lee
- Division of Hematology-Oncology, Department of Internal Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, 06591, South Korea
| | - Sara Lonardi
- Oncology Unit 3, Veneto Institute of Oncology IOV-IRCCS, Padua, 35128, Italy
| | - Jin Won Kim
- Division of Hematology-Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, 13620, South Korea
| | - Gianluca Masi
- Department of Translational Research & New Technologies in Medicine & Surgery, University of Pisa, Pisa, 56126, Italy
| | - Hong Jae Chon
- Division of Hematology-Oncology, Department of Internal Medicine, Bundang CHA Hospital, Seongnam-si, Gyeonggi-do, 13496, South Korea
| | - Margherita Rimini
- Department of Medical Oncology, IRCCS San Raffaele Scientific Institute, Milan, 20132, Italy
| | - Ilhwan Kim
- Division of Oncology, Department of Internal Medicine, Haeundae Paik Hospital, Inje University College of Medicine, Busan, 48108, South Korea
| | - Jaekyung Cheon
- Division of Hematology-Oncology, Department of Internal Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, 44033, South Korea
| | - Jun-Eul Hwang
- Division of Hematology-Oncology, Department of Internal Medicine, Chonnam National University Medical School, Gwangju, 61469, South Korea
| | - Jung Hun Kang
- Division of Hematology-Oncology, Department of Internal Medicine, Gyeongsang National University, Jinju, 52727, South Korea
| | - Ho Yeong Lim
- Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, 06351, South Korea
| | - Changhoon Yoo
- Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, 05505, South Korea
| |
Collapse
|
18
|
Kim HR, Kang JH, Kim SH, Kim ST, Kim I, Min YJ, Shin SH, Oh SY, Lee GW, Lee JH, Ji JH, Huh SJ, Lee S. Changes of Immune Cell Fractions in Patients Treated with Immune Checkpoint Inhibitors. Cancers (Basel) 2022; 14:cancers14143440. [PMID: 35884501 PMCID: PMC9315861 DOI: 10.3390/cancers14143440] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/19/2022] [Revised: 07/10/2022] [Accepted: 07/13/2022] [Indexed: 11/16/2022] Open
Abstract
Simple Summary Immune checkpoint inhibitors (ICIs) are currently widely used in many types of cancer. However, some patients could not benefit from ICIs. In addition, a standardized biomarker for predicting the efficacy of ICIs is currently unavailable. Thus, we determined whether peripheral blood immune cells could be predicting markers. In contrast with previous studies, we focused on changes in immune cell fraction and the relationship between efficacy of ICIs including response rate and survival outcomes. Results revealed significant correlations between changes in NKp46-/CD56+ NK cell fraction and treatment outcomes with ICIs. Abstract Background: With the development of immunology, immune checkpoint inhibitors (ICIs) have been widely used in various cancer treatments. Although some patients can benefit from ICIs, other patients have no response to ICIs or suffer from hyperprogression. There has been no biomarker for predicting the efficacy of ICIs. Thus, the objective of this study was to find biomarkers for predicting the efficacy of ICIs using peripheral blood. Methods: Adults patients planned to be treated with ICIs were enrolled in this study. Blood sampling was carried out before and after administration of ICIs. Changes of immune cell fraction were analyzed for each patient. Results: Among 182 patients enrolled, immune cell analysis was performed for 90 patients. The objective response rate was 14.4% (n = 13/90). The median progression-free survival (PFS) was 6.0 months (95% CI: 3.1–8.9 months), and the median overall survival (OS) was 13.9 months (95% CI: 5.6–22.2 months). Significant benefits in ORR and OS were shown for patients with increased NKp46-/CD56+ NK cells (p = 0.033 and p = 0.013, respectively). The PFS tended to be longer in these patients, although the difference was not statistically significant (p = 0.050). Conclusion: Changes of immune cell fraction before and after administration of ICIs could be a novel biomarker for predicting the efficacy of immunotherapy.
Collapse
Affiliation(s)
- Hye Ryeon Kim
- Department of Internal Medicine, Dong-A University College of Medicine, Busan 49201, Korea; (H.R.K.); (S.H.K.); (S.Y.O.); (J.H.L.); (S.J.H.)
| | - Jung Hun Kang
- Division of Hematology-Oncology, Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Jinju 52727, Korea; (J.H.K.); (G.-W.L.)
| | - Sung Hyun Kim
- Department of Internal Medicine, Dong-A University College of Medicine, Busan 49201, Korea; (H.R.K.); (S.H.K.); (S.Y.O.); (J.H.L.); (S.J.H.)
| | - Seung Tae Kim
- Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea;
| | - Ilhwan Kim
- Division of Hematology-Oncology, Department of Internal Medicine, Haeundae Paik Hospital, Inje University College of Medicine, Busan 48108, Korea;
| | - Young Joo Min
- Division of Hematology-Oncology, Department of Internal Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan 44033, Korea;
| | - Seong Hoon Shin
- Division of Medical Oncology, Department of Internal Medicine, Kosin University Gospel Hospital, Busan 49267, Korea;
| | - Sung Yong Oh
- Department of Internal Medicine, Dong-A University College of Medicine, Busan 49201, Korea; (H.R.K.); (S.H.K.); (S.Y.O.); (J.H.L.); (S.J.H.)
| | - Gyeong-Won Lee
- Division of Hematology-Oncology, Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Jinju 52727, Korea; (J.H.K.); (G.-W.L.)
| | - Ji Hyun Lee
- Department of Internal Medicine, Dong-A University College of Medicine, Busan 49201, Korea; (H.R.K.); (S.H.K.); (S.Y.O.); (J.H.L.); (S.J.H.)
| | - Jun Ho Ji
- Division of Hematology and Oncology, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon 51353, Korea;
| | - Seok Jae Huh
- Department of Internal Medicine, Dong-A University College of Medicine, Busan 49201, Korea; (H.R.K.); (S.H.K.); (S.Y.O.); (J.H.L.); (S.J.H.)
| | - Suee Lee
- Department of Internal Medicine, Dong-A University College of Medicine, Busan 49201, Korea; (H.R.K.); (S.H.K.); (S.Y.O.); (J.H.L.); (S.J.H.)
- Correspondence: ; Tel.: +82-51-240-2729
| |
Collapse
|
19
|
Hong YL, Zhang YS, Ye F, Liu ZJ, Kang JH, Wang JA, Zeng Q. [Value of dual-layer spectral detector CT in preoperative prediction of lymph node metastasis of gastric cancer]. Zhonghua Yi Xue Za Zhi 2022; 102:1747-1752. [PMID: 35705478 DOI: 10.3760/cma.j.cn112137-20220207-00245] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/15/2023]
Abstract
Objective: To investigate the value of dual-layer spectral detector CT(SDCT) in preoperative prediction of lymph node (LN) metastasis of gastric cancer. Methods: From January 2019 to January 2021, the clinical and imaging data of 130 gastric cancer patients(93 males and 37 females, aged from 37 to 84 years)confirmed by pathology in the Zhongshan hospital of Xiamen University were retrospectively collected. According to the status of lymph node metastasis, those patients were divided into metastatic LNs group (n=104) and nonmetastatic LNs group (n=26). The maximum diameter of gastric cancer on spectral CT images, CT Values of lesions in 40, 50, 60, 70. KeV monoenergetic image of arterial and Venous phase (CT40 keV, CT50 keV, CT60 keV, CT70 keV), iodine concentration (IC) and effective atomic number (Zeff) were measured, then the normalized IC(NIC) and spectral curve(K(40-70)) value were calculated. The differences of each parameter derived from spectral CT between the two groups were compared, and a logistic regression model was constructed. The ROC curves and area under the curve (AUC) were conducted to evaluate the diagnostic performance of each parameter and Delong test was used to compare the difference of each AUC. Results: Compared to nonmetastatic LNs group, metastatic LNs group had higher maximum diameter of tumor, CT40 keV, CT50 keV, CT60 keV, CT70 keV, IC, NIC, Zeff, and K(40-70) values on venous phase (the representative parameter is Zeff: 8.4 (8.2, 8.5) vs 8.2 (8.1, 8.3)) (all P<0.05). The proportion of patients with lower histology differentiated degree, higher T grade and positive carcino embryonic antigen (CEA)were higher than that in nonmetastatic LNs (the representative parameter was CEA: 34.6%(36/104) vs 7.7%(2/26) (all P<0.05). The regression model constructed by CEA and Zeff had the highest predictive value in predicting metastatic LNs, with an AUC of 0.835(0.759-0.894), sensitivity and specificity of 83.65% and 73.08%, respectively. Conclusion: SDCT quantitative parameters on venous phase and CEA facilitate the accurate prediction of metastatic LNs in patients with gastric cancer, and the multi-parameter regression model has the highest diagnostic performance.
Collapse
Affiliation(s)
- Y L Hong
- Department of Radiology, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen 361000, China
| | - Y S Zhang
- Department of Radiology, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen 361000, China
| | - F Ye
- Department of Radiology, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen 361000, China
| | - Z J Liu
- Department of Pathology, Zhongshan Hospital of Xiamen University, School of medicine, Xiamen University, Xiamen 361000, China
| | - J H Kang
- Department of Radiology, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen 361000, China
| | - J A Wang
- Department of Radiology, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen 361000, China
| | - Q Zeng
- Department of Radiology, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen 361000, China
| |
Collapse
|
20
|
Oh SY, Park K, Koh SJ, Kang JH, Chang MH, Lee KH. Survey of Opioid Risk Tool Among Cancer Patients Receiving Opioid Analgesics. J Korean Med Sci 2022; 37:e185. [PMID: 35698838 PMCID: PMC9194487 DOI: 10.3346/jkms.2022.37.e185] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/10/2022] [Accepted: 05/11/2022] [Indexed: 12/03/2022] Open
Abstract
BACKGROUND The risk of opioid-related aberrant behavior (OAB) in Korean cancer patients has not been previously evaluated. The purpose of this study is to investigate the Opioid Risk Tool (ORT) in Korean cancer patients receiving opioid treatment. METHODS Data were obtained from a multicenter, cross-sectional, nationwide observational study regarding breakthrough cancer pain. The study was conducted in 33 South Korean institutions from March 2016 to December 2017. Patients were eligible if they had cancer-related pain within the past 7 days, which was treated with strong opioids in the previous 7 days. RESULTS We analyzed ORT results of 946 patients. Only one patient in each sex (0.2%) was classified as high risk for OAB. Moderate risk was observed in 18 males (3.3%) and in three females (0.7%). Scores above 0 were primarily derived from positive responses for personal or familial history of alcohol abuse (in men), or depression (in women). In patients with an ORT score of 1 or higher (n = 132, 14%), the score primarily represented positive responses for personal history of depression (in females), personal or family history of alcohol abuse (in males), or 16-45 years age range. These patients had more severe worst and average pain intensity (proportion of numeric rating scale ≥ 4: 20.5% vs. 11.4%, P < 0.001) and used rescue analgesics more frequently than patients with ORT scores of 0. The proportion of moderate- or high-risk patients according to ORT was lower in patients receiving low doses of long-acting opioids than in those receiving high doses (2.0% vs. 6.6%, P = 0.031). Moderate or high risk was more frequent when ORT was completed in an isolated room than in an open, busy place (2.7% vs. 0.6%, P = 0.089). CONCLUSIONS The score of ORT was very low in cancer patients receiving strong opioids for analgesia. Higher pain intensity may associate with positive response to one or more ORT item.
Collapse
Affiliation(s)
- So Yeon Oh
- Medical Oncology and Hematology, Department of Internal Medicine, Pusan National University Yangsan Hospital, Yangsan, Korea
| | - Kwonoh Park
- Medical Oncology and Hematology, Department of Internal Medicine, Pusan National University Yangsan Hospital, Yangsan, Korea
| | - Su-Jin Koh
- Department of Hematology and Oncology, Ulsan University Hospital, Ulsan University College of Medicine, Ulsan, Korea
| | - Jung Hun Kang
- Hematology and Oncology, Department of Internal medicine, Gyeongsang National University College of Medicine, Jinju, Korea
| | - Myung Hee Chang
- Oncology and Hematology, Department of Internal Medicine, National Health Insurance Service Ilsan Hospital, Goyang, Korea
| | - Kyung Hee Lee
- Hematology and Oncology, Department of Internal Medicine, Yeungnam University College of Medicine, Daegu, Korea.
| |
Collapse
|
21
|
Lee SH, Kwon JH, Won YW, Kang JH. Palliative Sedation in End-of-Life Patients in Eastern Asia: A Narrative Review. Cancer Res Treat 2022; 54:644-650. [PMID: 35436813 PMCID: PMC9296933 DOI: 10.4143/crt.2022.187] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/23/2022] [Accepted: 04/17/2022] [Indexed: 11/21/2022] Open
Abstract
Although palliative sedation (PS) is a common practice in the palliative care of cancer patients in Western countries, there is little related research on the practice in Korea. PS can be classified into several categories according to sedation level and continuity. PS is clearly distinct from euthanasia. While euthanasia is illegal and regarded as unethical in Korea, there is little ethical and legal controversy about PS in terms of the doctrine of double effect. Most studies have asserted that PS does not shorten the survival of terminal cancer patients. Since preference for PS heavily depends on stakeholder value, it should be preceded by shared decision-making through full communication among the patient, family members, and medical team. This is a narrative review article analyzing previous studies, especially from the three Eastern Asian countries, Korea, Japan and Taiwan, which share similar cultures compared with Western countries. Practical issues concerning PS—for example, prevalence, type and dosage of medications, salvage medication, timing of its initiation, and assessment—are described in detail.
Collapse
Affiliation(s)
- Seung Hun Lee
- Department of Family Medicine, Pusan National University Hospital, Busan, Korea
| | - Jung Hye Kwon
- Department of Internal Medicine, College of Medicine, Chungnam National University, Chungnam National University Sejong Hospital, Sejong, Korea
| | - Young-Woong Won
- Department of Internal Medicine, Hanyang University Guri Hospital, Guri, Korea
| | - Jung Hun Kang
- Department of Internal Medicine, College of Medicine, Gyeongsang National University, Jinju, Korea
| |
Collapse
|
22
|
Lee HJ, Kim YA, Ryu SY, Chun M, Yim CY, Kang HT, Kang JH, Huh JS, Kim JH, Lim KH, Jung SY, Kwon HC, Goh E, Lee YS, Ju HY, Yun EH, Chang YJ. The Positive Effects of Cancer Survivor Support Service on Distress in South Korea: A Nationwide Prospective Study. Front Med (Lausanne) 2022; 9:769221. [PMID: 35237619 PMCID: PMC8882982 DOI: 10.3389/fmed.2022.769221] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/01/2021] [Accepted: 01/21/2022] [Indexed: 11/23/2022] Open
Abstract
Background and Aim Cancer survivors are gradually increasing, however, they suffer from various difficulties. We aimed to investigate the characteristics of cancer survivors and the effects of the services of the Korean Cancer Survivorship Center Pilot Project launched by the South Korean government on distress. Methods A prospective observational cohort study was performed on cancer survivors who completed primary treatment. Cancer survivors' distress and symptoms such as fatigue, pain, depressive mood, anxiety, and insomnia were evaluated by well-trained nurses. Regarding their needs, medical and psychosocial support services were provided. Results This study included 1,921 cancer survivors, with a mean age of 57.3 years (68.7% females). Breast cancer was most common, followed by stomach and colorectal cancer. Psychosocial and medical support decreased the percentage of the high-distress group from 50.9 to 30.5% and decreased the percentage of cancer survivors with high scores in fatigue, pain, anxiety, depressive mood, and insomnia. The independent predictors of a low distress level after the use of the services were older age, the relief of fatigue, pain, and insomnia. Conclusion This study showed that psychosocial and medical support is associated with the lower distress and physical and mental symptoms of cancer survivors. Psychosocial and medical support could contribute to distress relief in cancer survivors. Further management strategies for fatigue, pain and insomnia are required.
Collapse
Affiliation(s)
- Hyun Jeong Lee
- Division of Cancer Control and Policy, National Cancer Center, Goyang, South Korea
- National Cancer Survivorship Center, National Cancer Center, Goyang, South Korea
- Department of Psychiatry and Behavioral Science, National Cancer Center, Goyang, South Korea
- Department of Psychiatry, Seoul National University, Seoul, South Korea
| | - Young Ae Kim
- Division of Cancer Control and Policy, National Cancer Center, Goyang, South Korea
- National Cancer Survivorship Center, National Cancer Center, Goyang, South Korea
- *Correspondence: Young Ae Kim
| | - Seong Yeob Ryu
- Department of Surgery, Chonnam National University Medical School, Gwangju, South Korea
| | - Mison Chun
- Department of Radiation Oncology, Ajou University School of Medicine, Suwon, South Korea
| | - Chang-Yeol Yim
- Department of Internal Medicine, Chonbuk National University Medical School, Research Institute of Clinical Medicine of Chonbuk National University, Jeonju, South Korea
- Biomedical Research Institute of Chonbuk National University Hospital, Jeonju, South Korea
| | - Hee-Taik Kang
- Department of Family Medicine, Chungbuk National University Hospital, Cheongju, South Korea
- Department of Family Medicine, Chungbuk National University College of Medicine, Cheongju, South Korea
| | - Jung Hun Kang
- Division of Hematology-Oncology, Department of Internal Medicine, College of Medicine, Gyeong-Sang National University, Jinju, South Korea
- Department of Medicine, Gyeongsang National University Hospital, Jinju, South Korea
| | - Jung-Sik Huh
- Department of Urology, School of Medicine, Jeju National University, Jeju, South Korea
| | - Jong-Heun Kim
- Department of Psychiatry and Behavioral Science, National Cancer Center, Goyang, South Korea
| | - Kyu-Hyoung Lim
- Department of Internal Medicine, Kangwon National University Hospital, Kangwon National University School of Medicine, Chuncheon, South Korea
| | - So-Youn Jung
- Breast Cancer Center, National Cancer Center, Goyang, South Korea
| | - Hyoung-Cheol Kwon
- Department of Radiation Oncology, Chonbuk National University Hospital, Jeonju, South Korea
- Institute of Clinical Medicine of Chonbuk National University-Biomedical Research Institute, Chonbuk National University Hospital, Jeonju, South Korea
- Department of Radiation Oncology, Chonbuk National University Medical School, Jeonju, South Korea
| | - Eurah Goh
- Department of Family Medicine, Postgraduate College of Medicine, Kangwon National University, Chuncheon, South Korea
| | - Yeon-Seung Lee
- Division of Cancer Control and Policy, National Cancer Center, Goyang, South Korea
| | - Hee Young Ju
- Cancer Survivorship Branch, National Cancer Center, Goyang, South Korea
- Department of Pediatrics, Samsung Medical Center, Seoul, South Korea
| | - E. Hwa Yun
- Division of Cancer Control and Policy, National Cancer Center, Goyang, South Korea
- National Cancer Survivorship Center, National Cancer Center, Goyang, South Korea
- Division of Cancer Registration and Surveillance, National Cancer Center, Goyang, South Korea
| | - Yoon Jung Chang
- Division of Cancer Control and Policy, National Cancer Center, Goyang, South Korea
- National Cancer Survivorship Center, National Cancer Center, Goyang, South Korea
- Center for Cancer Prevention and Detection, National Cancer Center, Goyang, South Korea
- National Hospice Center, National Cancer Center, Goyang, South Korea
- Department of Cancer Control and Population Health, National Cancer Center Graduate School of Cancer Science and Policy, Goyang, South Korea
| |
Collapse
|
23
|
Go SI, Won YW, Kang JH. Safe use of opioids. J Korean Med Assoc 2022. [DOI: 10.5124/jkma.2022.65.1.57] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
Abstract
Background: Opioids are effective analgesics for cancer pain and refractory non-cancer pain. Although they are essential medication, problematic issues on aberrant behavior and adverse events have rapidly emerged as social problems in Korea. This study aimed to describe the mechanisms, efficacy, and adverse events, especially how to deal with opioid dependency.Current Concepts: Opioid-induced aberrant behavior includes physical and psychological dependences (addiction), abuse, and diversion (giving prescribed opioids to another person). Most physicians are unfamiliar with how to handle patients presenting these problematic issues. Physical and psychological dependences develop through different pathophysiologic mechanisms, i.e., noradrenergic and dopaminergic pathways, respectively. Motivational enhancement therapy, psychosocial support, substitution therapy with buprenorphine, and adjunctive medications, including alpha-2 adrenergic agonist, antidepressants, and non-steroidal antiinflammatory drugs, are the mainstay of treatment for opioid dependency. Constipation, nausea/vomiting, drowsiness/sedation, delirium, itching sensation, voiding difficulty, dry mouth, opioid-induced hyperalgesia, and respiratory depression are well-known physical side effects of opioid consumption.Discussion and Conclusion: Research on the development history, epidemiology of opioid dependency, and its treatment are warranted to avoid an opioid crisis in Korea. Above all, thorough knowledge for physicians and patients is urgently needed.
Collapse
|
24
|
Kang JH, Jung CY, Park KS, Huh JS, Oh SY, Kwon JH. Community Care for Cancer Patients in Rural Areas: An Integrated Regional Cancer Center and Public Health Center Partnership Model. J Hosp Palliat Care 2021; 24:226-234. [PMID: 37674641 PMCID: PMC10180073 DOI: 10.14475/jhpc.2021.24.4.226] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 06/05/2021] [Revised: 09/21/2021] [Accepted: 09/22/2021] [Indexed: 09/08/2023]
Abstract
Purpose The accessibility of medical facilities for cancer patients affects both their comfort and survival. Patients in rural areas have a higher socioeconomic burden and are more vulnerable to emergency situations than urban dwellers. This study examined the feasibility and effectiveness of a cancer care model integrating a regional cancer center (RCC) and public health center (PHC). Methods This study analyzed the construction of a safety care network for cancer patients that integrated an RCC and PHC. Two public health institutions (an RCC in Gyeongnam and a PHC in Geochang County) collaborated on the development of the community care model. The study lasted 13 months beginning in February 2019 to February 2020. Results The RCC developed the protocol for evaluating and measuring 27 cancer-related symptoms, conducted education for PHC nurses, and administered case counseling. The staff at the PHC registered, evaluated, and routinely monitored patients through home visits. A smartphone application and regular video conferences were incorporated to facilitate mutual communication. In total, 177 patients (mean age 70.9 years; men 59%) were enrolled from February 2019 to February 2020. Patients' greatest unmet need was the presence of a nearby cancer treatment hospital (83%). In total, 28 (33%) and 44 (52%) participants answered that the care model was very helpful or helpful, respectively. Conclusion We confirmed that a combined RCC-PHC program for cancer patients in rural areas is feasible and can bring satisfaction to patients as a safety care network. This program could mitigate health inequalities caused by accessibility issues.
Collapse
Affiliation(s)
- Jung Hun Kang
- Department of Internal Medicine, College of Medicine, Gyeongsang National University, Jinju, Korea
| | - Chang Yoon Jung
- National Cancer Control Institute, National Cancer Center, Goyang, Korea
| | - Ki-Soo Park
- Department of Preventive Medicine, Institute of Health Sciences, College of Medicine, Gyeongsang National University, Jinju, Korea
| | - Jung Sik Huh
- Department of Urology, Jeju National University, Jeju, Korea
| | - Sung Yong Oh
- Department of Internal Medicine, College of Medicine, Dong-A University, Busan, Korea
| | - Jung Hye Kwon
- Department of Internal Medicine, College of Medicine, Chungnam National University, Daejeon, Korea
| |
Collapse
|
25
|
Go SI, Park MJ, Park S, Kang MH, Kim HG, Kang JH, Kim JH, Lee GW. Cachexia index as a potential biomarker for cancer cachexia and a prognostic indicator in diffuse large B-cell lymphoma. J Cachexia Sarcopenia Muscle 2021; 12:2211-2219. [PMID: 34676685 PMCID: PMC8718032 DOI: 10.1002/jcsm.12837] [Citation(s) in RCA: 20] [Impact Index Per Article: 6.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/30/2021] [Accepted: 09/19/2021] [Indexed: 01/06/2023] Open
Abstract
BACKGROUND Cancer cachexia is known to adversely affect the clinical course in patients with malignant lymphoma. The cachexia index (CXI) is a potential biomarker of cancer cachexia, and its implications for the prognosis and treatment outcome of lung cancer and aggressive lymphoma has been assessed in previous studies. METHODS A total of 267 patients diagnosed with diffuse large B-cell lymphoma who were treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) immunochemotherapy were retrospectively reviewed. The CXI was calculated as the skeletal muscle index (SMI) × serum albumin/neutrophil-lymphocyte ratio (NLR). Although previous studies measured the SMI using the muscles of the L3 vertebral level, the present study used both the L3 vertebral muscles and the pectoralis muscles (PM) at the T4 vertebral level to measure the SMI. Depending on the type of muscles used, the CXI was termed the L3-CXI or PM-CXI. Using sex-specific cutoff values for CXI, the patients were categorized as follows: (i) high-CXI group (high L3-CXI and high PM-CXI), (ii) intermediate-CXI group (high L3-CXI and low PM-CXI), and (iii) low-CXI group (low L3-CXI and low PM-CXI). RESULTS Complete responses to R-CHOP were obtained in 145/173 (83.8%), 25/36 (69.4%), and 27/57 (47.4%) patients in the high-CXI, intermediate-CXI, and low-CXI groups, respectively (P < 0.001). Treatment-related anaemia (15.6%, 30.6%, and 26.3%, P = 0.038), thrombocytopenia (21.4%, 36.1%, and 43.9%, P < 0.001), febrile neutropenia (23.7%, 44.4%, and 36.8%, P = 0.022), and any nonhaematologic toxicity (31.2%, 44.4%, and 54.4%, P = 0.001) of Grade 3 or more were more common in the lower CXI groups than in the higher-CXI groups. Early treatment discontinuation for reasons other than lymphoma progression also occurred more frequently in the low-CXI group (24/57, 42.1%) compared with the intermediate-CXI (5/36, 13.9%) and high-CXI (18/173, 10.4%) groups (P < 0.001). Median overall survival in the high-CXI, intermediate-CXI, and low-CXI groups was not reached, 50.6 months, and 14.5 months, respectively (p < 0.001). Multivariable analysis showed that low CXI was an independent negative prognostic factor for overall survival (hazard ratio 2.103, 95% confidence interval 1.278-3.460, P = 0.003). CONCLUSIONS We suggest that in patients with diffuse large B-cell lymphoma, the CXI is a biomarker for cancer cachexia that can predict survival, treatment response, treatment-related toxicity, and compliance with R-CHOP. Patients were more clearly stratified by this new CXI category compared with the classifications described in previous studies.
Collapse
Affiliation(s)
- Se-Il Go
- Division of Hematology-Oncology, Department of Internal Medicine, Institute of Health Science, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon, Republic of Korea
| | - Mi Jung Park
- Department of Radiology, Institute of Health Science, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Jinju, Republic of Korea
| | - Sungwoo Park
- Division of Hematology-Oncology, Department of Internal Medicine, Institute of Health Science, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Jinju, Republic of Korea
| | - Myoung Hee Kang
- Division of Hematology-Oncology, Department of Internal Medicine, Institute of Health Science, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon, Republic of Korea
| | - Hoon-Gu Kim
- Division of Hematology-Oncology, Department of Internal Medicine, Institute of Health Science, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon, Republic of Korea
| | - Jung Hun Kang
- Division of Hematology-Oncology, Department of Internal Medicine, Institute of Health Science, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Jinju, Republic of Korea
| | - Jung Hoon Kim
- Division of Hematology-Oncology, Department of Internal Medicine, Institute of Health Science, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Jinju, Republic of Korea
| | - Gyeong-Won Lee
- Division of Hematology-Oncology, Department of Internal Medicine, Institute of Health Science, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Jinju, Republic of Korea
| |
Collapse
|
26
|
Acharya UA, Aidala C, Akiba Y, Alfred M, Andrieux V, Apadula N, Asano H, Azmoun B, Babintsev V, Bandara NS, Barish KN, Bathe S, Bazilevsky A, Beaumier M, Belmont R, Berdnikov A, Berdnikov Y, Bichon L, Blankenship B, Blau DS, Bok JS, Brooks ML, Bryslawskyj J, Bumazhnov V, Campbell S, Canoa Roman V, Cervantes R, Chi CY, Chiu M, Choi IJ, Choi JB, Citron Z, Connors M, Corliss R, Corrales Morales Y, Cronin N, Csanád M, Csörgő T, Danley TW, Daugherity MS, David G, DeBlasio K, Dehmelt K, Denisov A, Deshpande A, Desmond EJ, Dion A, Dixit D, Do JH, Drees A, Drees KA, Durham JM, Durum A, Enokizono A, En'yo H, Esha R, Esumi S, Fadem B, Fan W, Feege N, Fields DE, Finger M, Finger M, Fitzgerald D, Fokin SL, Frantz JE, Franz A, Frawley AD, Fukuda Y, Gal C, Gallus P, Garg P, Ge H, Giles M, Giordano F, Goto Y, Grau N, Greene SV, Grosse Perdekamp M, Gunji T, Guragain H, Hachiya T, Haggerty JS, Hahn KI, Hamagaki H, Hamilton HF, Han SY, Hanks J, Harvey M, Hasegawa S, Haseler TOS, He X, Hemmick TK, Hill JC, Hill K, Hodges A, Hollis RS, Homma K, Hong B, Hoshino T, Hotvedt N, Huang J, Huang S, Imai K, Inaba M, Iordanova A, Isenhower D, Ivanishchev D, Jacak BV, Jezghani M, Ji Z, Jiang X, Johnson BM, Jouan D, Jumper DS, Kang JH, Kapukchyan D, Karthas S, Kawall D, Kazantsev AV, Khachatryan V, Khanzadeev A, Khatiwada A, Kim C, Kim EJ, Kim M, Kincses D, Kingan A, Kistenev E, Klatsky J, Kline P, Koblesky T, Kotov D, Kudo S, Kurgyis B, Kurita K, Kwon Y, Lajoie JG, Larionova D, Lebedev A, Lee S, Lee SH, Leitch MJ, Leung YH, Lewis NA, Li X, Lim SH, Liu MX, Loggins VR, Lökös S, Loomis DA, Lovasz K, Lynch D, Majoros T, Makdisi YI, Makek M, Manko VI, Mannel E, McCumber M, McGaughey PL, McGlinchey D, McKinney C, Mendoza M, Mignerey AC, Milov A, Mishra DK, Mitchell JT, Mitrankov I, Mitrankova M, Mitsuka G, Miyasaka S, Mizuno S, Mondal MM, Montuenga P, Moon T, Morrison DP, Mulilo B, Murakami T, Murata J, Nagai K, Nagashima K, Nagashima T, Nagle JL, Nagy MI, Nakagawa I, Nakano K, Nattrass C, Nelson S, Niida T, Nouicer R, Novák T, Novitzky N, Nukazuka G, Nyanin AS, O'Brien E, Ogilvie CA, Orjuela Koop JD, Osborn JD, Oskarsson A, Ottino GJ, Ozawa K, Pantuev V, Papavassiliou V, Park JS, Park S, Pate SF, Patel M, Peng W, Perepelitsa DV, Perera GDN, Peressounko DY, PerezLara CE, Perry J, Petti R, Phipps M, Pinkenburg C, Pisani RP, Potekhin M, Pun A, Purschke ML, Radzevich PV, Ramasubramanian N, Read KF, Reynolds D, Riabov V, Riabov Y, Richford D, Rinn T, Rolnick SD, Rosati M, Rowan Z, Runchey J, Safonov AS, Sakaguchi T, Sako H, Samsonov V, Sarsour M, Sato S, Schaefer B, Schmoll BK, Sedgwick K, Seidl R, Sen A, Seto R, Sexton A, Sharma D, Sharma D, Shein I, Shibata TA, Shigaki K, Shimomura M, Shioya T, Shukla P, Sickles A, Silva CL, Silvermyr D, Singh BK, Singh CP, Singh V, Slunečka M, Smith KL, Snowball M, Soltz RA, Sondheim WE, Sorensen SP, Sourikova IV, Stankus PW, Stoll SP, Sugitate T, Sukhanov A, Sumita T, Sun J, Sun Z, Sziklai J, Tanida K, Tannenbaum MJ, Tarafdar S, Taranenko A, Tarnai G, Tieulent R, Timilsina A, Todoroki T, Tomášek M, Towell CL, Towell RS, Tserruya I, Ueda Y, Ujvari B, van Hecke HW, Velkovska J, Virius M, Vrba V, Vukman N, Wang XR, Watanabe YS, Wong CP, Woody CL, Xu C, Xu Q, Xue L, Yalcin S, Yamaguchi YL, Yamamoto H, Yanovich A, Yoo JH, Yoon I, Yu H, Yushmanov IE, Zajc WA, Zelenski A, Zharko S, Zou L. Probing Gluon Spin-Momentum Correlations in Transversely Polarized Protons through Midrapidity Isolated Direct Photons in p^{↑}+p Collisions at sqrt[s]=200 GeV. Phys Rev Lett 2021; 127:162001. [PMID: 34723614 DOI: 10.1103/physrevlett.127.162001] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/01/2021] [Revised: 07/26/2021] [Accepted: 08/10/2021] [Indexed: 06/13/2023]
Abstract
Studying spin-momentum correlations in hadronic collisions offers a glimpse into a three-dimensional picture of proton structure. The transverse single-spin asymmetry for midrapidity isolated direct photons in p^{↑}+p collisions at sqrt[s]=200 GeV is measured with the PHENIX detector at the Relativistic Heavy Ion Collider (RHIC). Because direct photons in particular are produced from the hard scattering and do not interact via the strong force, this measurement is a clean probe of initial-state spin-momentum correlations inside the proton and is in particular sensitive to gluon interference effects within the proton. This is the first time direct photons have been used as a probe of spin-momentum correlations at RHIC. The uncertainties on the results are a 50-fold improvement with respect to those of the one prior measurement for the same observable, from the Fermilab E704 experiment. These results constrain gluon spin-momentum correlations in transversely polarized protons.
Collapse
Affiliation(s)
- U A Acharya
- Georgia State University, Atlanta, Georgia 30303, USA
| | - C Aidala
- Department of Physics, University of Michigan, Ann Arbor, Michigan 48109-1040, USA
| | - Y Akiba
- RIKEN Nishina Center for Accelerator-Based Science, Wako, Saitama 351-0198, Japan
- RIKEN BNL Research Center, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - M Alfred
- Department of Physics and Astronomy, Howard University, Washington, D.C. 20059, USA
| | - V Andrieux
- Department of Physics, University of Michigan, Ann Arbor, Michigan 48109-1040, USA
| | - N Apadula
- Iowa State University, Ames, Iowa 50011, USA
| | - H Asano
- Kyoto University, Kyoto 606-8502, Japan
- RIKEN Nishina Center for Accelerator-Based Science, Wako, Saitama 351-0198, Japan
| | - B Azmoun
- Physics Department, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - V Babintsev
- IHEP Protvino, State Research Center of Russian Federation, Institute for High Energy Physics, Protvino 142281, Russia
| | - N S Bandara
- Department of Physics, University of Massachusetts, Amherst, Massachusetts 01003-9337, USA
| | - K N Barish
- University of California-Riverside, Riverside, California 92521, USA
| | - S Bathe
- Baruch College, City University of New York, New York, New York 10010, USA
- RIKEN BNL Research Center, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - A Bazilevsky
- Physics Department, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - M Beaumier
- University of California-Riverside, Riverside, California 92521, USA
| | - R Belmont
- University of Colorado, Boulder, Colorado 80309, USA
- Physics and Astronomy Department, University of North Carolina at Greensboro, Greensboro, North Carolina 27412, USA
| | - A Berdnikov
- Saint Petersburg State Polytechnic University, St. Petersburg 195251, Russia
| | - Y Berdnikov
- Saint Petersburg State Polytechnic University, St. Petersburg 195251, Russia
| | - L Bichon
- Vanderbilt University, Nashville, Tennessee 37235, USA
| | - B Blankenship
- Vanderbilt University, Nashville, Tennessee 37235, USA
| | - D S Blau
- National Research Center "Kurchatov Institute," Moscow, 123098 Russia
- National Research Nuclear University, MEPhI, Moscow Engineering Physics Institute, Moscow 115409, Russia
| | - J S Bok
- New Mexico State University, Las Cruces, New Mexico 88003, USA
| | - M L Brooks
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - J Bryslawskyj
- Baruch College, City University of New York, New York, New York 10010, USA
- University of California-Riverside, Riverside, California 92521, USA
| | - V Bumazhnov
- IHEP Protvino, State Research Center of Russian Federation, Institute for High Energy Physics, Protvino 142281, Russia
| | - S Campbell
- Columbia University, New York, New York 10027 and Nevis Laboratories, Irvington, New York 10533, USA
| | - V Canoa Roman
- Department of Physics and Astronomy, Stony Brook University, SUNY, Stony Brook, New York 11794-3800, USA
| | - R Cervantes
- Department of Physics and Astronomy, Stony Brook University, SUNY, Stony Brook, New York 11794-3800, USA
| | - C Y Chi
- Columbia University, New York, New York 10027 and Nevis Laboratories, Irvington, New York 10533, USA
| | - M Chiu
- Physics Department, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - I J Choi
- University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, USA
| | - J B Choi
- Jeonbuk National University, Jeonju 54896, Korea
| | - Z Citron
- Weizmann Institute, Rehovot 76100, Israel
| | - M Connors
- Georgia State University, Atlanta, Georgia 30303, USA
- RIKEN BNL Research Center, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - R Corliss
- Department of Physics and Astronomy, Stony Brook University, SUNY, Stony Brook, New York 11794-3800, USA
| | | | - N Cronin
- Department of Physics and Astronomy, Stony Brook University, SUNY, Stony Brook, New York 11794-3800, USA
| | - M Csanád
- ELTE, Eötvös Loránd University, H-1117 Budapest, Pázmány P. s. 1/A, Hungary
| | - T Csörgő
- Eszterházy Károly University, Károly Róbert Campus, H-3200 Gyöngyös, Mátrai út 36, Hungary
- Institute for Particle and Nuclear Physics, Wigner Research Centre for Physics, Hungarian Academy of Sciences (Wigner RCP, RMKI) H-1525 Budapest 114, P.O. Box 49, Budapest, Hungary
| | - T W Danley
- Department of Physics and Astronomy, Ohio University, Athens, Ohio 45701, USA
| | | | - G David
- Physics Department, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
- Department of Physics and Astronomy, Stony Brook University, SUNY, Stony Brook, New York 11794-3800, USA
| | - K DeBlasio
- University of New Mexico, Albuquerque, New Mexico 87131, USA
| | - K Dehmelt
- Department of Physics and Astronomy, Stony Brook University, SUNY, Stony Brook, New York 11794-3800, USA
| | - A Denisov
- IHEP Protvino, State Research Center of Russian Federation, Institute for High Energy Physics, Protvino 142281, Russia
| | - A Deshpande
- RIKEN BNL Research Center, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
- Department of Physics and Astronomy, Stony Brook University, SUNY, Stony Brook, New York 11794-3800, USA
| | - E J Desmond
- Physics Department, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - A Dion
- Department of Physics and Astronomy, Stony Brook University, SUNY, Stony Brook, New York 11794-3800, USA
| | - D Dixit
- Department of Physics and Astronomy, Stony Brook University, SUNY, Stony Brook, New York 11794-3800, USA
| | - J H Do
- Yonsei University, IPAP, Seoul 120-749, Korea
| | - A Drees
- Department of Physics and Astronomy, Stony Brook University, SUNY, Stony Brook, New York 11794-3800, USA
| | - K A Drees
- Collider-Accelerator Department, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - J M Durham
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - A Durum
- IHEP Protvino, State Research Center of Russian Federation, Institute for High Energy Physics, Protvino 142281, Russia
| | - A Enokizono
- RIKEN Nishina Center for Accelerator-Based Science, Wako, Saitama 351-0198, Japan
- Physics Department, Rikkyo University, 3-34-1 Nishi-Ikebukuro, Toshima, Tokyo 171-8501, Japan
| | - H En'yo
- RIKEN Nishina Center for Accelerator-Based Science, Wako, Saitama 351-0198, Japan
| | - R Esha
- Department of Physics and Astronomy, Stony Brook University, SUNY, Stony Brook, New York 11794-3800, USA
| | - S Esumi
- Tomonaga Center for the History of the Universe, University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - B Fadem
- Muhlenberg College, Allentown, Pennsylvania 18104-5586, USA
| | - W Fan
- Department of Physics and Astronomy, Stony Brook University, SUNY, Stony Brook, New York 11794-3800, USA
| | - N Feege
- Department of Physics and Astronomy, Stony Brook University, SUNY, Stony Brook, New York 11794-3800, USA
| | - D E Fields
- University of New Mexico, Albuquerque, New Mexico 87131, USA
| | - M Finger
- Charles University, Ovocný trh 5, Praha 1, 116 36 Prague, Czech Republic
| | - M Finger
- Charles University, Ovocný trh 5, Praha 1, 116 36 Prague, Czech Republic
| | - D Fitzgerald
- Department of Physics, University of Michigan, Ann Arbor, Michigan 48109-1040, USA
| | - S L Fokin
- National Research Center "Kurchatov Institute," Moscow, 123098 Russia
| | - J E Frantz
- Department of Physics and Astronomy, Ohio University, Athens, Ohio 45701, USA
| | - A Franz
- Physics Department, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - A D Frawley
- Florida State University, Tallahassee, Florida 32306, USA
| | - Y Fukuda
- Tomonaga Center for the History of the Universe, University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - C Gal
- Department of Physics and Astronomy, Stony Brook University, SUNY, Stony Brook, New York 11794-3800, USA
| | - P Gallus
- Czech Technical University, Zikova 4, 166 36 Prague 6, Czech Republic
| | - P Garg
- Department of Physics, Banaras Hindu University, Varanasi 221005, India
- Department of Physics and Astronomy, Stony Brook University, SUNY, Stony Brook, New York 11794-3800, USA
| | - H Ge
- Department of Physics and Astronomy, Stony Brook University, SUNY, Stony Brook, New York 11794-3800, USA
| | - M Giles
- Department of Physics and Astronomy, Stony Brook University, SUNY, Stony Brook, New York 11794-3800, USA
| | - F Giordano
- University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, USA
| | - Y Goto
- RIKEN Nishina Center for Accelerator-Based Science, Wako, Saitama 351-0198, Japan
- RIKEN BNL Research Center, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - N Grau
- Department of Physics, Augustana University, Sioux Falls, South Dakota 57197, USA
| | - S V Greene
- Vanderbilt University, Nashville, Tennessee 37235, USA
| | | | - T Gunji
- Center for Nuclear Study, Graduate School of Science, University of Tokyo, 7-3-1 Hongo, Bunkyo, Tokyo 113-0033, Japan
| | - H Guragain
- Georgia State University, Atlanta, Georgia 30303, USA
| | - T Hachiya
- Nara Women's University, Kita-uoya Nishi-machi Nara 630-8506, Japan
- RIKEN Nishina Center for Accelerator-Based Science, Wako, Saitama 351-0198, Japan
- RIKEN BNL Research Center, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - J S Haggerty
- Physics Department, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - K I Hahn
- Ewha Womans University, Seoul 120-750, Korea
| | - H Hamagaki
- Center for Nuclear Study, Graduate School of Science, University of Tokyo, 7-3-1 Hongo, Bunkyo, Tokyo 113-0033, Japan
| | - H F Hamilton
- Abilene Christian University, Abilene, Texas 79699, USA
| | - S Y Han
- Ewha Womans University, Seoul 120-750, Korea
- Korea University, Seoul 02841, Korea
| | - J Hanks
- Department of Physics and Astronomy, Stony Brook University, SUNY, Stony Brook, New York 11794-3800, USA
| | - M Harvey
- Texas Southern University, Houston, Texas 77004, USA
| | - S Hasegawa
- Advanced Science Research Center, Japan Atomic Energy Agency, 2-4 Shirakata Shirane, Tokai-mura, Naka-gun, Ibaraki-ken 319-1195, Japan
| | - T O S Haseler
- Georgia State University, Atlanta, Georgia 30303, USA
| | - X He
- Georgia State University, Atlanta, Georgia 30303, USA
| | - T K Hemmick
- Department of Physics and Astronomy, Stony Brook University, SUNY, Stony Brook, New York 11794-3800, USA
| | - J C Hill
- Iowa State University, Ames, Iowa 50011, USA
| | - K Hill
- University of Colorado, Boulder, Colorado 80309, USA
| | - A Hodges
- Georgia State University, Atlanta, Georgia 30303, USA
| | - R S Hollis
- University of California-Riverside, Riverside, California 92521, USA
| | - K Homma
- Hiroshima University, Kagamiyama, Higashi-Hiroshima 739-8526, Japan
| | - B Hong
- Korea University, Seoul 02841, Korea
| | - T Hoshino
- Hiroshima University, Kagamiyama, Higashi-Hiroshima 739-8526, Japan
| | - N Hotvedt
- Iowa State University, Ames, Iowa 50011, USA
| | - J Huang
- Physics Department, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - S Huang
- Vanderbilt University, Nashville, Tennessee 37235, USA
| | - K Imai
- Advanced Science Research Center, Japan Atomic Energy Agency, 2-4 Shirakata Shirane, Tokai-mura, Naka-gun, Ibaraki-ken 319-1195, Japan
| | - M Inaba
- Tomonaga Center for the History of the Universe, University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - A Iordanova
- University of California-Riverside, Riverside, California 92521, USA
| | - D Isenhower
- Abilene Christian University, Abilene, Texas 79699, USA
| | - D Ivanishchev
- PNPI, Petersburg Nuclear Physics Institute, Gatchina, Leningrad region 188300, Russia
| | - B V Jacak
- Department of Physics and Astronomy, Stony Brook University, SUNY, Stony Brook, New York 11794-3800, USA
| | - M Jezghani
- Georgia State University, Atlanta, Georgia 30303, USA
| | - Z Ji
- Department of Physics and Astronomy, Stony Brook University, SUNY, Stony Brook, New York 11794-3800, USA
| | - X Jiang
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - B M Johnson
- Physics Department, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
- Georgia State University, Atlanta, Georgia 30303, USA
| | - D Jouan
- IPN-Orsay, Univ. Paris-Sud, CNRS/IN2P3, Université Paris-Saclay, BP1, F-91406 Orsay, France
| | - D S Jumper
- University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, USA
| | - J H Kang
- Yonsei University, IPAP, Seoul 120-749, Korea
| | - D Kapukchyan
- University of California-Riverside, Riverside, California 92521, USA
| | - S Karthas
- Department of Physics and Astronomy, Stony Brook University, SUNY, Stony Brook, New York 11794-3800, USA
| | - D Kawall
- Department of Physics, University of Massachusetts, Amherst, Massachusetts 01003-9337, USA
| | - A V Kazantsev
- National Research Center "Kurchatov Institute," Moscow, 123098 Russia
| | - V Khachatryan
- Department of Physics and Astronomy, Stony Brook University, SUNY, Stony Brook, New York 11794-3800, USA
| | - A Khanzadeev
- PNPI, Petersburg Nuclear Physics Institute, Gatchina, Leningrad region 188300, Russia
| | - A Khatiwada
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - C Kim
- University of California-Riverside, Riverside, California 92521, USA
- Korea University, Seoul 02841, Korea
| | - E-J Kim
- Jeonbuk National University, Jeonju 54896, Korea
| | - M Kim
- Department of Physics and Astronomy, Seoul National University, Seoul 151-742, Korea
| | - D Kincses
- ELTE, Eötvös Loránd University, H-1117 Budapest, Pázmány P. s. 1/A, Hungary
| | - A Kingan
- Department of Physics and Astronomy, Stony Brook University, SUNY, Stony Brook, New York 11794-3800, USA
| | - E Kistenev
- Physics Department, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - J Klatsky
- Florida State University, Tallahassee, Florida 32306, USA
| | - P Kline
- Department of Physics and Astronomy, Stony Brook University, SUNY, Stony Brook, New York 11794-3800, USA
| | - T Koblesky
- University of Colorado, Boulder, Colorado 80309, USA
| | - D Kotov
- PNPI, Petersburg Nuclear Physics Institute, Gatchina, Leningrad region 188300, Russia
- Saint Petersburg State Polytechnic University, St. Petersburg 195251, Russia
| | - S Kudo
- Tomonaga Center for the History of the Universe, University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - B Kurgyis
- ELTE, Eötvös Loránd University, H-1117 Budapest, Pázmány P. s. 1/A, Hungary
| | - K Kurita
- Physics Department, Rikkyo University, 3-34-1 Nishi-Ikebukuro, Toshima, Tokyo 171-8501, Japan
| | - Y Kwon
- Yonsei University, IPAP, Seoul 120-749, Korea
| | - J G Lajoie
- Iowa State University, Ames, Iowa 50011, USA
| | - D Larionova
- Saint Petersburg State Polytechnic University, St. Petersburg 195251, Russia
| | - A Lebedev
- Iowa State University, Ames, Iowa 50011, USA
| | - S Lee
- Yonsei University, IPAP, Seoul 120-749, Korea
| | - S H Lee
- Iowa State University, Ames, Iowa 50011, USA
- Department of Physics, University of Michigan, Ann Arbor, Michigan 48109-1040, USA
- Department of Physics and Astronomy, Stony Brook University, SUNY, Stony Brook, New York 11794-3800, USA
| | - M J Leitch
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - Y H Leung
- Department of Physics and Astronomy, Stony Brook University, SUNY, Stony Brook, New York 11794-3800, USA
| | - N A Lewis
- Department of Physics, University of Michigan, Ann Arbor, Michigan 48109-1040, USA
| | - X Li
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - S H Lim
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
- Pusan National University, Pusan 46241, Korea
- Yonsei University, IPAP, Seoul 120-749, Korea
| | - M X Liu
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - V-R Loggins
- University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, USA
| | - S Lökös
- ELTE, Eötvös Loránd University, H-1117 Budapest, Pázmány P. s. 1/A, Hungary
| | - D A Loomis
- Department of Physics, University of Michigan, Ann Arbor, Michigan 48109-1040, USA
| | - K Lovasz
- Debrecen University, H-4010 Debrecen, Egyetem tér 1, Hungary
| | - D Lynch
- Physics Department, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - T Majoros
- Debrecen University, H-4010 Debrecen, Egyetem tér 1, Hungary
| | - Y I Makdisi
- Collider-Accelerator Department, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - M Makek
- Department of Physics, Faculty of Science, University of Zagreb, Bijenička c. 32 HR-10002 Zagreb, Croatia
| | - V I Manko
- National Research Center "Kurchatov Institute," Moscow, 123098 Russia
| | - E Mannel
- Physics Department, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - M McCumber
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - P L McGaughey
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - D McGlinchey
- University of Colorado, Boulder, Colorado 80309, USA
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - C McKinney
- University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, USA
| | - M Mendoza
- University of California-Riverside, Riverside, California 92521, USA
| | - A C Mignerey
- University of Maryland, College Park, Maryland 20742, USA
| | - A Milov
- Weizmann Institute, Rehovot 76100, Israel
| | - D K Mishra
- Bhabha Atomic Research Centre, Bombay 400 085, India
| | - J T Mitchell
- Physics Department, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - Iu Mitrankov
- Saint Petersburg State Polytechnic University, St. Petersburg 195251, Russia
| | - M Mitrankova
- Saint Petersburg State Polytechnic University, St. Petersburg 195251, Russia
| | - G Mitsuka
- KEK, High Energy Accelerator Research Organization, Tsukuba, Ibaraki 305-0801, Japan
- RIKEN BNL Research Center, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - S Miyasaka
- RIKEN Nishina Center for Accelerator-Based Science, Wako, Saitama 351-0198, Japan
- Department of Physics, Tokyo Institute of Technology, Oh-okayama, Meguro, Tokyo 152-8551, Japan
| | - S Mizuno
- RIKEN Nishina Center for Accelerator-Based Science, Wako, Saitama 351-0198, Japan
- Tomonaga Center for the History of the Universe, University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - M M Mondal
- Department of Physics and Astronomy, Stony Brook University, SUNY, Stony Brook, New York 11794-3800, USA
| | - P Montuenga
- University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, USA
| | - T Moon
- Korea University, Seoul 02841, Korea
- Yonsei University, IPAP, Seoul 120-749, Korea
| | - D P Morrison
- Physics Department, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - B Mulilo
- Korea University, Seoul 02841, Korea
- RIKEN Nishina Center for Accelerator-Based Science, Wako, Saitama 351-0198, Japan
| | - T Murakami
- Kyoto University, Kyoto 606-8502, Japan
- RIKEN Nishina Center for Accelerator-Based Science, Wako, Saitama 351-0198, Japan
| | - J Murata
- RIKEN Nishina Center for Accelerator-Based Science, Wako, Saitama 351-0198, Japan
- Physics Department, Rikkyo University, 3-34-1 Nishi-Ikebukuro, Toshima, Tokyo 171-8501, Japan
| | - K Nagai
- Department of Physics, Tokyo Institute of Technology, Oh-okayama, Meguro, Tokyo 152-8551, Japan
| | - K Nagashima
- Hiroshima University, Kagamiyama, Higashi-Hiroshima 739-8526, Japan
| | - T Nagashima
- Physics Department, Rikkyo University, 3-34-1 Nishi-Ikebukuro, Toshima, Tokyo 171-8501, Japan
| | - J L Nagle
- University of Colorado, Boulder, Colorado 80309, USA
| | - M I Nagy
- ELTE, Eötvös Loránd University, H-1117 Budapest, Pázmány P. s. 1/A, Hungary
| | - I Nakagawa
- RIKEN Nishina Center for Accelerator-Based Science, Wako, Saitama 351-0198, Japan
- RIKEN BNL Research Center, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - K Nakano
- RIKEN Nishina Center for Accelerator-Based Science, Wako, Saitama 351-0198, Japan
- Department of Physics, Tokyo Institute of Technology, Oh-okayama, Meguro, Tokyo 152-8551, Japan
| | - C Nattrass
- University of Tennessee, Knoxville, Tennessee 37996, USA
| | - S Nelson
- Florida A&M University, Tallahassee, Florida 32307, USA
| | - T Niida
- Tomonaga Center for the History of the Universe, University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - R Nouicer
- Physics Department, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
- RIKEN BNL Research Center, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - T Novák
- Eszterházy Károly University, Károly Róbert Campus, H-3200 Gyöngyös, Mátrai út 36, Hungary
- Institute for Particle and Nuclear Physics, Wigner Research Centre for Physics, Hungarian Academy of Sciences (Wigner RCP, RMKI) H-1525 Budapest 114, P.O. Box 49, Budapest, Hungary
| | - N Novitzky
- Department of Physics and Astronomy, Stony Brook University, SUNY, Stony Brook, New York 11794-3800, USA
- Tomonaga Center for the History of the Universe, University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - G Nukazuka
- RIKEN Nishina Center for Accelerator-Based Science, Wako, Saitama 351-0198, Japan
- RIKEN BNL Research Center, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - A S Nyanin
- National Research Center "Kurchatov Institute," Moscow, 123098 Russia
| | - E O'Brien
- Physics Department, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - C A Ogilvie
- Iowa State University, Ames, Iowa 50011, USA
| | | | - J D Osborn
- Department of Physics, University of Michigan, Ann Arbor, Michigan 48109-1040, USA
- Oak Ridge National Laboratory, Oak Ridge, Tennessee 37831, USA
| | - A Oskarsson
- Department of Physics, Lund University, Box 118, SE-221 00 Lund, Sweden
| | - G J Ottino
- University of New Mexico, Albuquerque, New Mexico 87131, USA
| | - K Ozawa
- KEK, High Energy Accelerator Research Organization, Tsukuba, Ibaraki 305-0801, Japan
- Tomonaga Center for the History of the Universe, University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - V Pantuev
- Institute for Nuclear Research of the Russian Academy of Sciences, prospekt 60-letiya Oktyabrya 7a, Moscow 117312, Russia
| | - V Papavassiliou
- New Mexico State University, Las Cruces, New Mexico 88003, USA
| | - J S Park
- Department of Physics and Astronomy, Seoul National University, Seoul 151-742, Korea
| | - S Park
- RIKEN Nishina Center for Accelerator-Based Science, Wako, Saitama 351-0198, Japan
- Department of Physics and Astronomy, Seoul National University, Seoul 151-742, Korea
- Department of Physics and Astronomy, Stony Brook University, SUNY, Stony Brook, New York 11794-3800, USA
| | - S F Pate
- New Mexico State University, Las Cruces, New Mexico 88003, USA
| | - M Patel
- Iowa State University, Ames, Iowa 50011, USA
| | - W Peng
- Vanderbilt University, Nashville, Tennessee 37235, USA
| | - D V Perepelitsa
- Physics Department, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
- University of Colorado, Boulder, Colorado 80309, USA
| | - G D N Perera
- New Mexico State University, Las Cruces, New Mexico 88003, USA
| | - D Yu Peressounko
- National Research Center "Kurchatov Institute," Moscow, 123098 Russia
| | - C E PerezLara
- Department of Physics and Astronomy, Stony Brook University, SUNY, Stony Brook, New York 11794-3800, USA
| | - J Perry
- Iowa State University, Ames, Iowa 50011, USA
| | - R Petti
- Physics Department, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - M Phipps
- Physics Department, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
- University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, USA
| | - C Pinkenburg
- Physics Department, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - R P Pisani
- Physics Department, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - M Potekhin
- Physics Department, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - A Pun
- Department of Physics and Astronomy, Ohio University, Athens, Ohio 45701, USA
| | - M L Purschke
- Physics Department, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - P V Radzevich
- Saint Petersburg State Polytechnic University, St. Petersburg 195251, Russia
| | - N Ramasubramanian
- Department of Physics and Astronomy, Stony Brook University, SUNY, Stony Brook, New York 11794-3800, USA
| | - K F Read
- Oak Ridge National Laboratory, Oak Ridge, Tennessee 37831, USA
- University of Tennessee, Knoxville, Tennessee 37996, USA
| | - D Reynolds
- Chemistry Department, Stony Brook University, SUNY, Stony Brook, New York 11794-3400, USA
| | - V Riabov
- National Research Nuclear University, MEPhI, Moscow Engineering Physics Institute, Moscow 115409, Russia
- PNPI, Petersburg Nuclear Physics Institute, Gatchina, Leningrad region 188300, Russia
| | - Y Riabov
- PNPI, Petersburg Nuclear Physics Institute, Gatchina, Leningrad region 188300, Russia
- Saint Petersburg State Polytechnic University, St. Petersburg 195251, Russia
| | - D Richford
- Baruch College, City University of New York, New York, New York 10010, USA
| | - T Rinn
- University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, USA
- Iowa State University, Ames, Iowa 50011, USA
| | - S D Rolnick
- University of California-Riverside, Riverside, California 92521, USA
| | - M Rosati
- Iowa State University, Ames, Iowa 50011, USA
| | - Z Rowan
- Baruch College, City University of New York, New York, New York 10010, USA
| | - J Runchey
- Iowa State University, Ames, Iowa 50011, USA
| | - A S Safonov
- Saint Petersburg State Polytechnic University, St. Petersburg 195251, Russia
| | - T Sakaguchi
- Physics Department, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - H Sako
- Advanced Science Research Center, Japan Atomic Energy Agency, 2-4 Shirakata Shirane, Tokai-mura, Naka-gun, Ibaraki-ken 319-1195, Japan
| | - V Samsonov
- National Research Nuclear University, MEPhI, Moscow Engineering Physics Institute, Moscow 115409, Russia
- PNPI, Petersburg Nuclear Physics Institute, Gatchina, Leningrad region 188300, Russia
| | - M Sarsour
- Georgia State University, Atlanta, Georgia 30303, USA
| | - S Sato
- Advanced Science Research Center, Japan Atomic Energy Agency, 2-4 Shirakata Shirane, Tokai-mura, Naka-gun, Ibaraki-ken 319-1195, Japan
| | - B Schaefer
- Vanderbilt University, Nashville, Tennessee 37235, USA
| | - B K Schmoll
- University of Tennessee, Knoxville, Tennessee 37996, USA
| | - K Sedgwick
- University of California-Riverside, Riverside, California 92521, USA
| | - R Seidl
- RIKEN Nishina Center for Accelerator-Based Science, Wako, Saitama 351-0198, Japan
- RIKEN BNL Research Center, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - A Sen
- Iowa State University, Ames, Iowa 50011, USA
- University of Tennessee, Knoxville, Tennessee 37996, USA
| | - R Seto
- University of California-Riverside, Riverside, California 92521, USA
| | - A Sexton
- University of Maryland, College Park, Maryland 20742, USA
| | - D Sharma
- Department of Physics and Astronomy, Stony Brook University, SUNY, Stony Brook, New York 11794-3800, USA
| | - D Sharma
- Department of Physics and Astronomy, Stony Brook University, SUNY, Stony Brook, New York 11794-3800, USA
| | - I Shein
- IHEP Protvino, State Research Center of Russian Federation, Institute for High Energy Physics, Protvino 142281, Russia
| | - T-A Shibata
- RIKEN Nishina Center for Accelerator-Based Science, Wako, Saitama 351-0198, Japan
- Department of Physics, Tokyo Institute of Technology, Oh-okayama, Meguro, Tokyo 152-8551, Japan
| | - K Shigaki
- Hiroshima University, Kagamiyama, Higashi-Hiroshima 739-8526, Japan
| | - M Shimomura
- Iowa State University, Ames, Iowa 50011, USA
- Nara Women's University, Kita-uoya Nishi-machi Nara 630-8506, Japan
| | - T Shioya
- Tomonaga Center for the History of the Universe, University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - P Shukla
- Bhabha Atomic Research Centre, Bombay 400 085, India
| | - A Sickles
- University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, USA
| | - C L Silva
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - D Silvermyr
- Department of Physics, Lund University, Box 118, SE-221 00 Lund, Sweden
| | - B K Singh
- Department of Physics, Banaras Hindu University, Varanasi 221005, India
| | - C P Singh
- Department of Physics, Banaras Hindu University, Varanasi 221005, India
| | - V Singh
- Department of Physics, Banaras Hindu University, Varanasi 221005, India
| | - M Slunečka
- Charles University, Ovocný trh 5, Praha 1, 116 36 Prague, Czech Republic
| | - K L Smith
- Florida State University, Tallahassee, Florida 32306, USA
| | - M Snowball
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - R A Soltz
- Lawrence Livermore National Laboratory, Livermore, California 94550, USA
| | - W E Sondheim
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - S P Sorensen
- University of Tennessee, Knoxville, Tennessee 37996, USA
| | - I V Sourikova
- Physics Department, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - P W Stankus
- Oak Ridge National Laboratory, Oak Ridge, Tennessee 37831, USA
| | - S P Stoll
- Physics Department, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - T Sugitate
- Hiroshima University, Kagamiyama, Higashi-Hiroshima 739-8526, Japan
| | - A Sukhanov
- Physics Department, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - T Sumita
- RIKEN Nishina Center for Accelerator-Based Science, Wako, Saitama 351-0198, Japan
| | - J Sun
- Department of Physics and Astronomy, Stony Brook University, SUNY, Stony Brook, New York 11794-3800, USA
| | - Z Sun
- Debrecen University, H-4010 Debrecen, Egyetem tér 1, Hungary
| | - J Sziklai
- Institute for Particle and Nuclear Physics, Wigner Research Centre for Physics, Hungarian Academy of Sciences (Wigner RCP, RMKI) H-1525 Budapest 114, P.O. Box 49, Budapest, Hungary
| | - K Tanida
- Advanced Science Research Center, Japan Atomic Energy Agency, 2-4 Shirakata Shirane, Tokai-mura, Naka-gun, Ibaraki-ken 319-1195, Japan
- RIKEN BNL Research Center, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
- Department of Physics and Astronomy, Seoul National University, Seoul 151-742, Korea
| | - M J Tannenbaum
- Physics Department, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - S Tarafdar
- Vanderbilt University, Nashville, Tennessee 37235, USA
- Weizmann Institute, Rehovot 76100, Israel
| | - A Taranenko
- National Research Nuclear University, MEPhI, Moscow Engineering Physics Institute, Moscow 115409, Russia
| | - G Tarnai
- Debrecen University, H-4010 Debrecen, Egyetem tér 1, Hungary
| | - R Tieulent
- Georgia State University, Atlanta, Georgia 30303, USA
- IPNL, CNRS/IN2P3, Univ Lyon, Universit Lyon 1, F-69622 Villeurbanne, France
| | - A Timilsina
- Iowa State University, Ames, Iowa 50011, USA
| | - T Todoroki
- RIKEN Nishina Center for Accelerator-Based Science, Wako, Saitama 351-0198, Japan
- RIKEN BNL Research Center, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
- Tomonaga Center for the History of the Universe, University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - M Tomášek
- Czech Technical University, Zikova 4, 166 36 Prague 6, Czech Republic
| | - C L Towell
- Abilene Christian University, Abilene, Texas 79699, USA
| | - R S Towell
- Abilene Christian University, Abilene, Texas 79699, USA
| | - I Tserruya
- Weizmann Institute, Rehovot 76100, Israel
| | - Y Ueda
- Hiroshima University, Kagamiyama, Higashi-Hiroshima 739-8526, Japan
| | - B Ujvari
- Debrecen University, H-4010 Debrecen, Egyetem tér 1, Hungary
| | - H W van Hecke
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - J Velkovska
- Vanderbilt University, Nashville, Tennessee 37235, USA
| | - M Virius
- Czech Technical University, Zikova 4, 166 36 Prague 6, Czech Republic
| | - V Vrba
- Czech Technical University, Zikova 4, 166 36 Prague 6, Czech Republic
- Institute of Physics, Academy of Sciences of the Czech Republic, Na Slovance 2, 182 21 Prague 8, Czech Republic
| | - N Vukman
- Department of Physics, Faculty of Science, University of Zagreb, Bijenička c. 32 HR-10002 Zagreb, Croatia
| | - X R Wang
- New Mexico State University, Las Cruces, New Mexico 88003, USA
- RIKEN BNL Research Center, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - Y S Watanabe
- Center for Nuclear Study, Graduate School of Science, University of Tokyo, 7-3-1 Hongo, Bunkyo, Tokyo 113-0033, Japan
| | - C P Wong
- Georgia State University, Atlanta, Georgia 30303, USA
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - C L Woody
- Physics Department, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - C Xu
- New Mexico State University, Las Cruces, New Mexico 88003, USA
| | - Q Xu
- Vanderbilt University, Nashville, Tennessee 37235, USA
| | - L Xue
- Georgia State University, Atlanta, Georgia 30303, USA
| | - S Yalcin
- Department of Physics and Astronomy, Stony Brook University, SUNY, Stony Brook, New York 11794-3800, USA
| | - Y L Yamaguchi
- Department of Physics and Astronomy, Stony Brook University, SUNY, Stony Brook, New York 11794-3800, USA
| | - H Yamamoto
- Tomonaga Center for the History of the Universe, University of Tsukuba, Tsukuba, Ibaraki 305, Japan
| | - A Yanovich
- IHEP Protvino, State Research Center of Russian Federation, Institute for High Energy Physics, Protvino 142281, Russia
| | - J H Yoo
- Korea University, Seoul 02841, Korea
| | - I Yoon
- Department of Physics and Astronomy, Seoul National University, Seoul 151-742, Korea
| | - H Yu
- New Mexico State University, Las Cruces, New Mexico 88003, USA
- Peking University, Beijing 100871, People's Republic of China
| | - I E Yushmanov
- National Research Center "Kurchatov Institute," Moscow, 123098 Russia
| | - W A Zajc
- Columbia University, New York, New York 10027 and Nevis Laboratories, Irvington, New York 10533, USA
| | - A Zelenski
- Collider-Accelerator Department, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - S Zharko
- Saint Petersburg State Polytechnic University, St. Petersburg 195251, Russia
| | - L Zou
- University of California-Riverside, Riverside, California 92521, USA
| |
Collapse
|
27
|
Go SI, Lee SC, Bae WK, Zang DY, Lee HW, Jang JS, Ji JH, Kim JH, Park S, Sym SJ, Yang Y, Jeon SY, Hwang IG, Oh SY, Kang JH. Modified FOLFIRINOX versus S-1 as second-line chemotherapy in gemcitabine-failed metastatic pancreatic cancer patients: A randomised controlled trial (MPACA-3). Eur J Cancer 2021; 157:21-30. [PMID: 34464782 DOI: 10.1016/j.ejca.2021.08.002] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/19/2021] [Revised: 07/08/2021] [Accepted: 08/03/2021] [Indexed: 12/27/2022]
Abstract
BACKGROUND The efficacy of modified FOLFIRINOX (mFOLFIRINOX) as a second-line chemotherapy treatment for metastatic pancreatic adenocarcinoma (mPAC), remains unclear. This multi-center randomised phase III trial aimed to elucidate the efficacy of mFOLFIRINOX as a second-line chemotherapy treatment for mPAC patients with good performance status. PATIENTS AND METHODS Eighty mPAC patients (age, 19-75 years) refractory to first-line gemcitabine-based chemotherapy were randomly selected to receive mFOLFIRINOX or S-1. mFOLFIRINOX comprised oxaliplatin (65 mg/m2), irinotecan (135 mg/m2), and leucovorin (400 mg/m2) on day 1 and continuous 5-FU infusion (1000 mg/m2) over 24 h on days 1-2 every 2 weeks. S-1 comprised body surface area-dependent oral S-1, divided into two doses per day on days 1-28 every 6 weeks. RESULTS Overall survival was the primary endpoint. The objective response and disease control rates were higher in the mFOLFIRINOX than in the S-1 group (15% versus 2%; p = .04 and 67% versus 37%; p = .007). The median progression-free survival rates were 5.2 and 2.2 months in the mFOLFIRINOX and S-1 groups, respectively (adjusted hazard ratio [HR]: .4; 95% confidence interval [CI]: .2-.6; p < .001). The median overall survival rates were 9.2 and 4.9 months in the mFOLFIRINOX and S-1 groups, respectively (adjusted HR: .4; 95% CI: .2-.7; p = .002). Grade 3-4 adverse events occurred in 56% and 17% of the patients in the mFOLFIRINOX and S-1 groups, respectively (p < .001). CONCLUSION Administration of mFOLFIRINOX as a second-line chemotherapy treatment for mPAC patients refractory to gemcitabine-based chemotherapy resulted in increased survival rates than S-1 treatment alone.
Collapse
Affiliation(s)
- Se-Il Go
- Division of Hematology and Oncology, Department of Internal Medicine, Institute of Health Science, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon, Republic of Korea
| | - Sang-Cheol Lee
- Division of Hematology and Oncology, Department of Internal Medicine, Soonchunhyang University Hospital Cheonan, Cheonan, Republic of Korea
| | - Woo Kyun Bae
- Division of Hematology-Oncology, Department of Internal Medicine, Chonnam National University Medical School and Hwasun Hospital, Hwasun, Republic of Korea
| | - Dae Young Zang
- Division of Hematology-Oncology, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Anyang, Republic of Korea
| | - Hyun Woo Lee
- Department of Hematology-Oncology, Ajou University School of Medicine, Suwon, Republic of Korea
| | - Joung Soon Jang
- Division of Hematology/Oncology, Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Republic of Korea
| | - Jun Ho Ji
- Division of Hematology-Oncology, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Republic of Korea
| | - Jung Hoon Kim
- Division of Hematology/Oncology, Department of Internal Medicine, Institute of Health Science, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Jinju, Republic of Korea
| | - Sanggon Park
- Department of Internal Medicine, Hemato-oncology, Chosun University Hospital, Gwangju, Republic of Korea
| | - Sun Jin Sym
- Division of Medical Oncology, Department of Internal Medicine, Gil Medical Center, Gachon University College of Medicine, Incheon, Republic of Korea
| | - Yaewon Yang
- Department of Internal Medicine, Chungbuk University Hospital, Chungbuk University College of Medicine, Cheongju, Republic of Korea
| | - So Yeon Jeon
- Department of Internal Medicine, Chonbuk National University Medical School, Jeonju, Republic of Korea
| | - In Gyu Hwang
- Division of Hematology/Oncology, Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Republic of Korea
| | - Sung Yong Oh
- Department of Internal Medicine, Dong-A University Hospital, Busan, Republic of Korea.
| | - Jung Hun Kang
- Division of Hematology/Oncology, Department of Internal Medicine, Institute of Health Science, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Jinju, Republic of Korea.
| |
Collapse
|
28
|
Oh SN, Yun YH, Keam B, Kim YS, Koh SJ, Kim YJ, Kang JH, Lee K, Hwang IC, Oh HS, Song EK, Shim JY. Korean Version of the Patient Dignity Inventory: Translation and Validation in Patients With Advanced Cancer. J Pain Symptom Manage 2021; 62:416-424.e2. [PMID: 33484796 DOI: 10.1016/j.jpainsymman.2021.01.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/11/2020] [Revised: 12/13/2020] [Accepted: 01/10/2021] [Indexed: 11/28/2022]
Abstract
CONTEXT The goal of palliative care is to maximize the quality of life and thus maintain the dignity of patients facing problems associated with a life-threatening illness. The Patient Dignity Inventory (PDI) is an instrument used to measure various sources of distress that can impact patients' sense of dignity at the end of life. OBJECTIVES We aimed to obtain a Korean translation of the PDI (PDI-K) and evaluate its psychometric properties in patients with advanced cancer. METHODS Translation and cultural adaptation of the PDI were performed to obtain the Korean version. In a sample of 131 inpatients and outpatients with advanced cancer, psychometric properties, including factor structure, internal consistency, and concurrent validity, were examined. Concurrent validity was evaluated using the Edmonton Symptom Assessment System, the Hospital Anxiety and Depression Scale, and the 12-item Functional Assessment of Chronic Illness Therapy-Spiritual Well-Being. RESULTS Cronbach's α for the PDI-K was 0.96. Four factors were identified by exploratory factor analysis, accounting for 68.7% of the overall variance: Dependency and Physical Symptoms, Psychological Distress, Existential Distress, and SocialSupport. Concurrent validity was confirmed by significant correlations between PDI-K and Edmonton Symptom Assessment System (r = 0.40 to 0.59, P < 0.001), Hospital Anxiety and Depression Scale (r = 0.78 to 0.81, P < 0.001), and Functional Assessment of Chronic Illness Therapy-Spiritual Well-Being (r = -0.32 to -0.57, P < 0.001). CONCLUSION Our findings indicate that the PDI-K is a valid and reliable instrument to measure dignity-related distress in patients with advanced cancer. This tool provides a four-factor Korean language alternative to the PDI.
Collapse
Affiliation(s)
- Si Nae Oh
- Department of Family Medicine, Seoul National University Hospital, Seoul, Republic of Korea; Department of Medicine, Yonsei University Graduate School, Seoul, Korea; Department of Hospice and Palliative Service, National Cancer Center, Goyang, Korea
| | - Young Ho Yun
- Department of Family Medicine, Seoul National University Hospital, Seoul, Republic of Korea; Department of Biomedical Science, Seoul National University College of Medicine, Seoul, Republic of Korea; Seoul National University Cancer Research Institute, Seoul, Republic of Korea
| | - Bhumsuk Keam
- Seoul National University Cancer Research Institute, Seoul, Republic of Korea; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea
| | - Young Sung Kim
- Department of Family Medicine, National Health Insurance Ilsan Hospital, Goyang, Republic of Korea
| | - Su-Jin Koh
- Division of Hematology and Oncology, Department of International Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Republic of Korea
| | - Yu Jung Kim
- Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Republic of Korea
| | - Jung Hun Kang
- Department of Internal Medicine, College of Medicine, Gyeongsang National University, Jinju, Republic of Korea
| | - Kangkook Lee
- Division of Hematology-Oncology, Department of Medicine, Dongsan Medical Center, Keimyung University School of Medicine, Daegu, Republic of Korea
| | - In Cheol Hwang
- Department of Family Medicine, Gil Medical Center, Gachon University College of Medicine, Incheon, South Korea
| | - Ho-Suk Oh
- Department of Internal Medicine, GangNeung Asan Hospital, University of Ulsan College of Medicine, Gangneung, Republic of Korea
| | - Eun-Kee Song
- Division of Hematology/Oncology, Jeonbuk National University Medical School, Jeonju, Korea
| | - Jae Yong Shim
- Department of Family Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea.
| |
Collapse
|
29
|
Jang MS, Suh KS, Kwon DI, Jung JH, Seong SH, Lee KH, Kang JH, Park JB. Successful treatment with narrowband ultraviolet B phototherapy in prurigo pigmentosa. J Eur Acad Dermatol Venereol 2021; 35:e796-e798. [PMID: 34166545 DOI: 10.1111/jdv.17477] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Affiliation(s)
- M S Jang
- Department of Dermatology, Kosin University College of Medicine, Busan, Korea
| | - K S Suh
- Department of Dermatology, Kosin University College of Medicine, Busan, Korea
| | - D I Kwon
- Department of Dermatology, Kosin University College of Medicine, Busan, Korea
| | - J H Jung
- Department of Dermatology, Kosin University College of Medicine, Busan, Korea
| | - S H Seong
- Department of Dermatology, Kosin University College of Medicine, Busan, Korea
| | - K H Lee
- Department of Dermatology, Kosin University College of Medicine, Busan, Korea
| | - J H Kang
- Department of Dermatology, Kosin University College of Medicine, Busan, Korea
| | - J B Park
- Department of Dermatology, Kosin University College of Medicine, Busan, Korea
| |
Collapse
|
30
|
Go SI, Lee SC, Bae WK, Zang DY, Lee HW, Jang JS, Ji JH, Kim JH, Park S, Sym SJ, Yang Y, Jeon SY, Oh SY, Kang JH. Modified FOLFIRINOX versus S-1 as second-line chemotherapy in patients with gemcitabine-failed metastatic pancreatic cancer: A randomized phase III trial (MPACA-3). J Clin Oncol 2021. [DOI: 10.1200/jco.2021.39.15_suppl.4119] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
4119 Background: Modified FOLFIRINOX (mFOLFIRINOX) consisting of 5-fluorouracil/leucovorin, irinotecan, and oxaliplatin has been assessed as second-line treatment of patients with advanced pancreatic cancer in retrospective and phase II studies. However, the result was not confirmed by randomized controlled trial. Methods: A randomized, open-label, phase III trial was conducted at 9 institutions in Korea. Patients with metastatic pancreatic adenocarcinoma (mPAC) and Eastern Cooperative Oncology Group performance status of 0-1 who failed to first-line gemcitabine-based chemotherapy were randomly assigned to receive mFOLFIRINOX or S-1. The primary endpoint was overall survival. Results: A total of 80 patients were enrolled from March 2017 to December 2019. The accrual of patients was early terminated due to clear difference of efficacy in the interim analysis and expectation of poor recruitment due to conflicting adjuvant regimens. Objective response and disease control rates were 15.4% vs. 2.4% ( p= 0.041) and 66.7% vs. 36.6% ( p= 0.007) in the mFOLFIRINOX and S-1 arms, respectively. The median progression-free survival was 5.2 and 2.2 months in the mFOLFIRINOX and S-1 arms, respectively ( p= 0.002). The median overall survival was 9.2 and 4.9 months in the mFOLFIRINOX and S-1 arms, respectively ( p= 0.048). The adjusted hazard ratio of the mFOLFIRINOX arm to the S-1 arm for overall survival was 0.402 (95% confidence interval 0.223-0.725, p= 0.002). All grade 3-4 adverse events occurred in 56.5% and 17.1% in the mFOLFIRINOX and S-1 arms, respectively ( p< 0.001). However, only one patient in each arm prematurely discontinued treatment due to toxicity and there was no treatment-related mortality in both arms. Minimally important differences in the health-related quality of life were not observed in both arms. Conclusions: mFOLFIRINOX as second-line treatment in mPAC patients failed to gemcitabine-based chemotherapy demonstrated a survival benefit versus S-1 alone with acceptable toxicities. Clinical trial information: KCT0003534.
Collapse
Affiliation(s)
- Se-Il Go
- Division of Hematology/Oncology, Department of Internal Medicine, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon, South Korea
| | - Sang-Cheol Lee
- Division of Hematology-Oncology, Department of Internal Medicine, Soonchunhyang University Hospital Cheonan, Soonchunhyang University College of Medicine, Cheonan, South Korea
| | - Woo Kyun Bae
- Department of Medical Oncology, Chonnam National University Hwasun Hospital, Hwasun, South Korea
| | - Dae Young Zang
- Division of Hematology-Oncology, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Anyang, South Korea
| | - Hyun Woo Lee
- Department of Hematology-Oncology, Ajou University School of Medicine, Suwon, South Korea
| | - Joung Soon Jang
- Department of Internal Medicine, Chung-Ang University Hospital, Seoul, South Korea
| | - Jun Ho Ji
- Division of Hematology-Oncology, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, South Korea
| | - Jung Hoon Kim
- Division of Hematology/Oncology, Department of Internal Medicine, Gyeongsang National University Hospital, Jinju, South Korea
| | - Sanggon Park
- Division of Medical Oncology, Department of Internal Medicine, Chosun University Hospital, Gwangju, South Korea
| | - Sun Jin Sym
- Division of Hematology and Oncology, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, South Korea
| | - Yaewon Yang
- Department of Internal Medicine, Chungbuk Univeristy Hospital, Chungbuk University College of Medicine, Cheongju, South Korea
| | - So Yeon Jeon
- Department of Internal Medicine, Chonbuk National University Medical School, Jeonju, South Korea
| | - Sung Yong Oh
- Department of Internal Medicine, Dong-A University Hospital, Busan, South Korea
| | - Jung Hun Kang
- Division of Hematology/Oncology, Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Jinju, South Korea
| |
Collapse
|
31
|
Park HS, Kang B, Chon HJ, Im HS, Lee CK, Kim I, Kang MJ, Hwang JE, Bae WK, Cheon J, Park JO, Hong JY, Kang JH, Kim JH, Lim SH, Kim JW, Kim JW, Yoo C, Choi HJ. Liposomal irinotecan plus fluorouracil/leucovorin versus FOLFIRINOX as the second-line chemotherapy for patients with metastatic pancreatic cancer: a multicenter retrospective study of the Korean Cancer Study Group (KCSG). ESMO Open 2021; 6:100049. [PMID: 33578192 PMCID: PMC7878976 DOI: 10.1016/j.esmoop.2021.100049] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/23/2020] [Revised: 12/31/2020] [Accepted: 01/03/2021] [Indexed: 12/16/2022] Open
Abstract
Background There is no clear consensus on the recommended second-line treatment for patients with metastatic pancreatic cancer who have disease progression following gemcitabine-based therapy. We retrospectively evaluated the clinical outcomes of liposomal irinotecan (nal-IRI) plus fluorouracil/leucovorin (FL) and FOLFIRINOX (fluorouracil, leucovorin, irinotecan, and oxaliplatin) in patients who had failed on the first-line gemcitabine-based therapy. Patients and methods From January 2015 to August 2019, 378 patients with MPC who had received nal-IRI/FL (n = 104) or FOLFIRINOX (n = 274) as second-line treatment across 11 institutions were included in this retrospective study. Results There were no significant differences in baseline characteristics between groups, except age and first-line regimens. With a median follow-up of 6 months, the median progression-free survival (PFS) was 3.7 months with nal-IRI/FL versus 4.6 months with FOLFIRINOX (P = 0.44). Median overall survival (OS) was 7.7 months with nal-IRI/FL versus 9.7 months with FOLFRINOX (P = 0.13). There was no significant difference in PFS and OS between the two regimens in the univariate and multivariate analyses. The subgroup analysis revealed that younger age (<70 years) was associated with better OS with FOLFIRINOX. In contrast, older age (≥70 years) was associated with better survival outcomes with nal-IRI/FL. Adverse events were manageable with both regimens; however, the incidence of grade 3 or higher neutropenia and peripheral neuropathy was higher in patients treated with FOLFIRINOX than with nal-IRI/FL. Conclusions Second-line nal-IRI/FL and FOLFIRINOX showed similar effectiveness outcomes after progression following first-line gemcitabine-based therapy. Age could be the determining factor for choosing the appropriate second-line therapy. This multicenter retrospective study investigated nal-IRI/FL and FOLFIRINOX outcomes after gemcitabine-based therapy. We found no significant differences in outcome between nal-IRI/FL and FOLFIRINOX treatment. Both regimens were well tolerated; however, neutropenia and peripheral neuropathy were more frequent with FOLFIRINOX. Age (cut-off, 70 years) showed differential efficacy between chemotherapy regimens.
Collapse
Affiliation(s)
- H S Park
- Division of Medical Oncology, Department of Internal Medicine, St. Vincent's Hospital, The Catholic University of Korea, Seoul, Korea
| | - B Kang
- Medical Oncology, CHA Bundang Medical Center, CHA University, Seongnam, Korea
| | - H J Chon
- Medical Oncology, CHA Bundang Medical Center, CHA University, Seongnam, Korea
| | - H-S Im
- Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
| | - C-K Lee
- Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea
| | - I Kim
- Department of Internal Medicine, Inje University Haeundae Paik Hospital, Inje University College of Medicine, Busan, Korea
| | - M J Kang
- Department of Internal Medicine, Inje University Haeundae Paik Hospital, Inje University College of Medicine, Busan, Korea
| | - J E Hwang
- Division of Hematology-Oncology, Department of Internal Medicine, Chonnam National University Medical School and Hwasun Hospital, Gwangju, Korea
| | - W K Bae
- Division of Hematology-Oncology, Department of Internal Medicine, Chonnam National University Medical School and Hwasun Hospital, Gwangju, Korea
| | - J Cheon
- Department of Hematology and Oncology, Ulsan University Hospital, Ulsan University College of Medicine, Ulsan, Korea
| | - J O Park
- Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University College of Medicine, Seoul, Korea
| | - J Y Hong
- Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University College of Medicine, Seoul, Korea
| | - J H Kang
- Department of Internal Medicine, Gyeongsang National University School of Medicine, Jinju, Korea
| | - J H Kim
- Department of Internal Medicine, Gyeongsang National University School of Medicine, Jinju, Korea
| | - S H Lim
- Division of Hematology-Oncology, Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Bucheon, Korea
| | - J W Kim
- Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea
| | - J-W Kim
- Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea
| | - C Yoo
- Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
| | - H J Choi
- Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.
| |
Collapse
|
32
|
Vaswani C, Kang JH, Mootz M, Luo L, Yang X, Sundahl C, Cheng D, Huang C, Kim RHJ, Liu Z, Collantes YG, Hellstrom EE, Perakis IE, Eom CB, Wang J. Light quantum control of persisting Higgs modes in iron-based superconductors. Nat Commun 2021; 12:258. [PMID: 33431843 PMCID: PMC7801641 DOI: 10.1038/s41467-020-20350-6] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/23/2020] [Accepted: 11/30/2020] [Indexed: 11/28/2022] Open
Abstract
The Higgs mechanism, i.e., spontaneous symmetry breaking of the quantum vacuum, is a cross-disciplinary principle, universal for understanding dark energy, antimatter and quantum materials, from superconductivity to magnetism. Unlike one-band superconductors (SCs), a conceptually distinct Higgs amplitude mode can arise in multi-band, unconventional superconductors via strong interband Coulomb interaction, but is yet to be accessed. Here we discover such hybrid Higgs mode and demonstrate its quantum control by light in iron-based high-temperature SCs. Using terahertz (THz) two-pulse coherent spectroscopy, we observe a tunable amplitude mode coherent oscillation of the complex order parameter from coupled lower and upper bands. The nonlinear dependence of the hybrid Higgs mode on the THz driving fields is distinct from any known SC results: we observe a large reversible modulation of resonance strength, yet with a persisting mode frequency. Together with quantum kinetic modeling of a hybrid Higgs mechanism, distinct from charge-density fluctuations and without invoking phonons or disorder, our result provides compelling evidence for a light-controlled coupling between the electron and hole amplitude modes assisted by strong interband quantum entanglement. Such light-control of Higgs hybridization can be extended to probe many-body entanglement and hidden symmetries in other complex systems. A collective excitation called Higgs mode may arise in multi-band superconductors via strong interband interaction, but it is yet to be accessed. Here, the authors observe a tunable coherent amplitude oscillation of the order parameter in Ba(Fe1−xCox)2As2, suggesting appearance and control of the Higgs mode by light tuning interband interaction.
Collapse
Affiliation(s)
- C Vaswani
- Department of Physics and Astronomy, Iowa State University, and Ames Laboratory, Ames, IA, 50011, USA
| | - J H Kang
- Department of Materials Science and Engineering, University of Wisconsin-Madison, Madison, WI, 53706, USA
| | - M Mootz
- Department of Physics, University of Alabama at Birmingham, Birmingham, AL, 35294-1170, USA
| | - L Luo
- Department of Physics and Astronomy, Iowa State University, and Ames Laboratory, Ames, IA, 50011, USA
| | - X Yang
- Department of Physics and Astronomy, Iowa State University, and Ames Laboratory, Ames, IA, 50011, USA
| | - C Sundahl
- Department of Materials Science and Engineering, University of Wisconsin-Madison, Madison, WI, 53706, USA
| | - D Cheng
- Department of Physics and Astronomy, Iowa State University, and Ames Laboratory, Ames, IA, 50011, USA
| | - C Huang
- Department of Physics and Astronomy, Iowa State University, and Ames Laboratory, Ames, IA, 50011, USA
| | - R H J Kim
- Department of Physics and Astronomy, Iowa State University, and Ames Laboratory, Ames, IA, 50011, USA
| | - Z Liu
- Department of Physics and Astronomy, Iowa State University, and Ames Laboratory, Ames, IA, 50011, USA
| | - Y G Collantes
- Applied Superconductivity Center, National High Magnetic Field Laboratory, Florida State University, Tallahassee, FL, 32310, USA
| | - E E Hellstrom
- Applied Superconductivity Center, National High Magnetic Field Laboratory, Florida State University, Tallahassee, FL, 32310, USA
| | - I E Perakis
- Department of Physics, University of Alabama at Birmingham, Birmingham, AL, 35294-1170, USA
| | - C B Eom
- Department of Materials Science and Engineering, University of Wisconsin-Madison, Madison, WI, 53706, USA
| | - J Wang
- Department of Physics and Astronomy, Iowa State University, and Ames Laboratory, Ames, IA, 50011, USA.
| |
Collapse
|
33
|
Oh SN, Kim YA, Kim YJ, Shim HJ, Song EK, Kang JH, Kwon JH, Lee JL, Lee SN, Maeng CH, Kang EJ, Do YR, Yun HJ, Jung KH, Yun YH. The Attitudes of Physicians and the General Public toward Prognostic Disclosure of Different Serious Illnesses: a Korean Nationwide Study. J Korean Med Sci 2020; 35:e401. [PMID: 33289368 PMCID: PMC7721562 DOI: 10.3346/jkms.2020.35.e401] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/15/2020] [Accepted: 09/14/2020] [Indexed: 11/20/2022] Open
Abstract
BACKGROUND Although international guidelines recommend palliative care approaches for many serious illnesses, the palliative needs of patients with serious illnesses other than cancer are often unmet, mainly due to insufficient prognosis-related discussion. We investigated physicians' and the general public's respective attitudes toward prognostic disclosure for several serious illnesses. METHODS We conducted a cross-sectional survey of 928 physicians, sourced from 12 hospitals and the Korean Medical Association, and 1,005 members of the general public, sourced from all 17 administrative divisions in Korea. RESULTS For most illnesses, most physicians (adjusted proportions - end-organ failure, 99.0%; incurable genetic or neurologic disease, 98.5%; acquired immune deficiency syndrome [AIDS], 98.4%; stroke or Parkinson's disease, 96.0%; and dementia, 89.6%) and members of the general public (end-organ failure, 92.0%; incurable genetic or neurologic disease, 92.5%; AIDS, 91.5%; stroke or Parkinson's disease, 92.1%; and dementia, 86.9%) wanted to be informed if they had a terminal prognosis. For physicians and the general public, the primary factor to consider when disclosing terminal status was "the patient's right to know his/her condition" (31.0%). Yet, the general public was less likely to prefer prognostic disclosure than physicians. Particularly, when their family members were patients, more than 10% of the general public did not want patients to be informed of their terminal prognosis. For the general public, the main reason for not disclosing prognosis was "psychological burden such as anxiety and depression" (35.8%), while for the physicians it was "disclosure would have no beneficial effect" (42.4%). CONCLUSION Most Physicians and the general public agreed that disclosure of a terminal prognosis respects patient autonomy for several serious illnesses. The low response rate of physicians might limit the generalizability of the results.
Collapse
Affiliation(s)
- Si Nae Oh
- Department of Family Medicine, Seoul National University Hospital, Seoul, Korea
- Department of Medicine, Yonsei University Graduate School, Seoul, Korea
| | - Young Ae Kim
- Hospice & Palliative Care Branch, National Cancer Control Institute, National Cancer Center, Goyang, Korea
| | - Yu Jung Kim
- Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea
| | - Hyun Jeong Shim
- Division of Hematology and Medical Oncology, Department of Internal Medicine, Chonnam National University School of Medicine, Hwasun, Korea
| | - Eun Kee Song
- Division of Hematology/Oncology, Jeonbuk National University Medical School, Jeonju, Korea
| | - Jung Hun Kang
- Department of Internal Medicine, College of Medicine, Gyeongsang National University, Jinju, Korea
| | - Jung Hye Kwon
- Department of Internal Medicine, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea
| | - Jung Lim Lee
- Department of Hemato-oncology, Daegu Fatima Hospital, Daegu, Korea
| | - Soon Nam Lee
- Department of Internal Medicine, Ewha Womans University School of Medicine, Seoul, Korea
| | - Chi Hoon Maeng
- Division of Medical Oncology and Hematology, Department of Internal Medicine, Kyung Hee University Hospital, College of Medicine, Kyung Hee University, Seoul, Korea
| | - Eun Joo Kang
- Division of Medical Oncology, Department of Internal Medicine, Korea University College of Medicine, Korea University Guro Hospital, Seoul, Korea
| | - Young Rok Do
- Department of Internal Medicine, Dongsan Medical Center, Keimyung University School of Medicine, Daegu, Korea
| | - Hwan Jung Yun
- Department of Internal Medicine, Chungnam National University Hospital, Daejeon, Korea
| | - Kyung Hae Jung
- Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
| | - Young Ho Yun
- Department of Family Medicine, Seoul National University Hospital, Seoul, Korea
- Department of Biomedical Science, Seoul National University College of Medicine, Seoul, Korea
- Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
| |
Collapse
|
34
|
Park SH, Lim DH, Sohn TS, Lee J, Zang DY, Kim ST, Kang JH, Oh SY, Hwang IG, Ji JH, Shin DB, Yu JI, Kim KM, An JY, Choi MG, Lee JH, Kim S, Hong JY, Park JO, Park YS, Lim HY, Bae JM, Kang WK. A randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients with node-positive gastric cancer after D2 resection: the ARTIST 2 trial ☆. Ann Oncol 2020; 32:368-374. [PMID: 33278599 DOI: 10.1016/j.annonc.2020.11.017] [Citation(s) in RCA: 123] [Impact Index Per Article: 30.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/11/2020] [Revised: 11/22/2020] [Accepted: 11/23/2020] [Indexed: 12/14/2022] Open
Abstract
BACKGROUND Adjuvant chemotherapy and chemoradiotherapy are some of the standards of care for gastric cancer (GC). The Adjuvant chemoRadioTherapy In Stomach Tumors (ARTIST) 2 trial compares two adjuvant chemotherapy regimens and chemoradiotherapy in patients with D2-resected, stage II or III, node-positive GC. PATIENTS AND METHODS The ARTIST 2 compared, in a 1:1:1 ratio, three adjuvant regimens: oral S-1 (40-60 mg twice daily 4 weeks on/2 weeks off) for 1 year, S-1 (2 weeks on/1 week off) plus oxaliplatin 130 mg/m2 every 3 weeks (SOX) for 6 months, and SOX plus chemoradiotherapy 45 Gy (SOXRT). Randomization was stratified according to surgery type (total or subtotal gastrectomy), pathologic stage (II or III), and Lauren histologic classification (diffuse or intestinal/mixed). The primary endpoint was disease-free survival (DFS) at 3 years; a reduction of 33% in the hazard ratio (HR) for DFS with SOX or SOXRT, when compared with S-1, was considered clinically meaningful. The trial is registered at clinicaltrials.gov (NCT0176146). RESULTS A total of 546 patients were recruited between February 2013 and January 2018 with 182, 181, and 183 patients in the S-1, SOX, and SOXRT arms, respectively. Median follow-up period was 47 months, with 178 DFS events observed. Estimated 3-year DFS rates were 64.8%, 74.3%, and 72.8% in the S-1, SOX, and SOXRT arms, respectively. HR for DFS in the control arm (S-1) was shorter than that in the SOX and SOXRT arms: S-1 versus SOX, 0.692 (P = 0.042) and S-1 versus SOXRT, 0.724 (P = 0.074). No difference in DFS was found between SOX and SOXRT (HR 0.971; P = 0.879). Adverse events were as anticipated in each arm, and were generally well-tolerated and manageable. CONCLUSIONS In patients with curatively D2-resected, stage II/III, node-positive GC, adjuvant SOX or SOXRT was effective in prolonging DFS, when compared with S-1 monotherapy. The addition of radiotherapy to SOX did not significantly reduce the rate of recurrence after D2 gastrectomy.
Collapse
Affiliation(s)
- S H Park
- Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
| | - D H Lim
- Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
| | - T S Sohn
- Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
| | - J Lee
- Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
| | - D Y Zang
- Division of Hematology-Oncology, Department of Internal Medicine, Hallym University Medical Center, Hallym University College of Medicine, Anyang-si, Gyeonggi-do, Korea
| | - S T Kim
- Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
| | - J H Kang
- Department of Internal Medicine, Gyeongsang National University School of Medicine, Jinju, Korea
| | - S Y Oh
- Department of Hematology-Oncology, Dong-A University, Busan, Korea
| | - I G Hwang
- Department of Internal Medicine, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Korea
| | - J H Ji
- Department of Internal Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Korea
| | - D B Shin
- Division of Hematology and Oncology, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, Korea
| | - J I Yu
- Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
| | - K-M Kim
- Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
| | - J Y An
- Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
| | - M G Choi
- Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
| | - J H Lee
- Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
| | - S Kim
- Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
| | - J Y Hong
- Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
| | - J O Park
- Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
| | - Y S Park
- Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
| | - H Y Lim
- Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
| | - J M Bae
- Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
| | - W K Kang
- Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
| | | |
Collapse
|
35
|
Oh S, Yun YH, Kim YA, Kim YJ, Shim H, Song E, Kang JH, Kwon JH, Lee JL, Lee SN, Maeng CH, Kang EJ, Do YR, Yun H, Jung KH. The attitudes of physicians and the general public toward prognostic disclosure of different serious illnesses: A nationwide survey. Alzheimers Dement 2020. [DOI: 10.1002/alz.038772] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- Sinae Oh
- Seoul National University Hospital Seoul South Korea
| | - Young Ho Yun
- Seoul National University College of Medicine Seoul South Korea
| | | | - Yu Jung Kim
- Seoul National University Bundang Hospital Seongnam South Korea
| | - Hyun‐Jeong Shim
- Chonnam National University School of Medicine Hwasun South Korea
| | - Eun‐Kee Song
- Chonbuk National University Medical School Jeonju South Korea
| | | | - Jung Hye Kwon
- Hallym University College of Medicine Seoul South Korea
| | | | - Soon Nam Lee
- Ewha Woman’s University College of Medicine Seoul South Korea
| | - Chi Hoon Maeng
- Kyung Hee University College of Medicine Seoul South Korea
| | - Eun Joo Kang
- Korea University College of Medicine Seoul South Korea
| | - Young Rok Do
- Keimyung University School of Medicine Daegu South Korea
| | - Hwan‐Jung Yun
- Chungnam National University Hospital Daejeon South Korea
| | | |
Collapse
|
36
|
Affiliation(s)
- Sung Yong Oh
- Department of Internal Medicine, Division of Hematology/Oncology, Dong-A University Medical Center, Busan, Republic of Korea
| | - Jung Hun Kang
- Department of Internal Medicine, College of Medicine, Gyeongsand National University, Jinju, Republic of Korea
| |
Collapse
|
37
|
Kim HD, Bang Y, Lee MA, Kim JW, Kim JH, Chon HJ, Kang B, Kang MJ, Kim I, Cheon J, Hwang JE, Kang JH, Byeon S, Hong JY, Ryoo BY, Lim HY, Yoo C. Regorafenib in patients with advanced Child-Pugh B hepatocellular carcinoma: A multicentre retrospective study. Liver Int 2020; 40:2544-2552. [PMID: 32563213 DOI: 10.1111/liv.14573] [Citation(s) in RCA: 29] [Impact Index Per Article: 7.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/04/2020] [Revised: 06/11/2020] [Accepted: 06/12/2020] [Indexed: 12/18/2022]
Abstract
INTRODUCTION Regorafenib is an approved agent in patients with advanced hepatocellular carcinoma (HCC) who progressed on sorafenib, but little is known about its clinical outcomes in Child-Pugh B patients. We aimed to investigate the safety and effectiveness of regorafenib in Child-Pugh B HCC patients. METHODS This multicentre retrospective study included 59 patients with Child-Pugh B HCC who received regorafenib. Comparative analyses were performed with an independent cohort of Child-Pugh class A patients from the same registry (n = 440). RESULTS The median age was 58 years (range, 19-83). All patients had progression on prior sorafenib. Regorafenib was given as 2nd line, and 3rd-4th line systemic therapy in 37 (62.7%) and 22 (37.3%) patients respectively. Compared to Child-Pugh A cohort, grade 3-4 AEs were more common in the Child-Pugh B cohort (27.1% vs 14.1%, P = .017). The median progression-free survival (PFS) and overall survival (OS) were 1.8 and 4.6 months, respectively, and these were significantly poorer than the Child-Pugh A cohort (P = .008 and P < .001 respectively). Child-Pugh B patients with albumin-bilirubin (ALBI) grade 3 had a significantly higher frequency of increased bilirubin (P = .01 for any grade and P = .01 for grade 3-4) and showed significantly poorer OS (P = .021), compared to those with ALBI grade 1 or 2. CONCLUSION Regorafenib's poor clinical outcomes and increased frequency of severe adverse events lead us to discourage its use in the Child-Pugh B population. In particular, regorafenib should not be used in Child-Pugh B patients with ALBI grade 3.
Collapse
Affiliation(s)
- Hyung-Don Kim
- Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
| | - Yeonghak Bang
- Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
| | - Myung Ah Lee
- Division of Hematology-Oncology, Department of Internal Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea
| | - Jin Won Kim
- Division of Hematology-Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea
| | - Jee Hyun Kim
- Division of Hematology-Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea
| | - Hong Jae Chon
- Division of Hematology-Oncology, Department of Internal Medicine, Bundang CHA Hospital, Seongnam, Korea
| | - Beodeul Kang
- Division of Hematology-Oncology, Department of Internal Medicine, Bundang CHA Hospital, Seongnam, Korea
| | - Myoung Joo Kang
- Division of Oncology, Department of Internal Medicine, Inje University College of Medicine, Haeundae Paik Hospital, Busan, Korea
| | - Ilhwan Kim
- Division of Oncology, Department of Internal Medicine, Inje University College of Medicine, Haeundae Paik Hospital, Busan, Korea
| | - Jaekyung Cheon
- Division of Hematology-Oncology, Department of Internal Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea
| | - Jun-Eul Hwang
- Division of Hematology-Oncology, Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea
| | - Jung Hun Kang
- Division of Hematology-Oncology, Department of Internal Medicine, Gyeongsang National University, Jinju, Korea
| | - Seonggyu Byeon
- Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
| | - Jung Yong Hong
- Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
| | - Baek-Yeol Ryoo
- Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
| | - Ho Yeong Lim
- Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
| | - Changhoon Yoo
- Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
| |
Collapse
|
38
|
Shin J, Chang YJ, Park SJ, Choi JY, Kim SH, Choi YS, Kim NH, Yum HK, Nam EM, Park MH, Moon N, Moon JY, Kang HT, Kang JH, Park JM, Lee CW, Kim SY, Lee EJ, Koh SJ, Kim Y, Cho MA, Song Y, Shim JY. Clinical Practice Guideline for Care in the Last Days of Life. Hanguk Hosupisu Wanhwa Uiryo Hakhoe Chi 2020; 23:103-113. [PMID: 37497368 PMCID: PMC10332720 DOI: 10.14475/kjhpc.2020.23.3.103] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Received: 04/16/2020] [Revised: 06/19/2020] [Accepted: 06/24/2020] [Indexed: 07/28/2023]
Abstract
A clinical practice guideline for patients in the dying process in general wards and their families, developed through an evidence-based process, is presented herein. The purpose of this guideline is to enable a peaceful death based on an understanding of suitable management of patients' physical and mental symptoms, psychological support, appropriate decision-making, family care, and clearly-defined team roles. Although there are limits to the available evidence regarding medical issues in patients facing death, the final recommendations were determined from expert advice and feedback, considering values and preferences related to medical treatment, benefits and harms, and applicability in the real world. This guideline should be applied in a way that takes into account specific health care environments, including the resources of medical staff and differences in the available resources of each institution. This guideline can be used by all medical institutions in South Korea.
Collapse
Affiliation(s)
- Jinyoung Shin
- Department of Family Medicine, Konkuk University School of Medicine, Seoul, Korea
| | - Yoon Jung Chang
- National Hospice Center, National Cancer Center, Goyang, Korea
| | - So-Jung Park
- National Hospice Center, National Cancer Center, Goyang, Korea
| | - Jin Young Choi
- National Hospice Center, National Cancer Center, Goyang, Korea
| | - Sun-Hyun Kim
- Department of Family Medicine, International St. Mary’s Hospital College of Medicine, Catholic Kwandong University, Incheon, Korea
| | - Youn Seon Choi
- Department of Family Medicine, Korea University Guro Hospital, Seoul, Korea
| | | | - Ho-Kee Yum
- Department of Internal Medicine, Seoul Paik Hospital, Inje University, Seoul, Korea
| | - Eun Mi Nam
- Department of Internal Medicine, Ewha Womans University College of Medicine, Seoul, Korea
| | - Myung Hee Park
- Hospice & Palliative Care Unit, The Catholic University of Korea, Seoul St. Mary’s Hospital, Seoul, Korea
| | - Nayeon Moon
- Department of Family Medicine, VHS Medical Center, Seoul, Korea
| | - Jee Youn Moon
- Department of Anesthesiology and Pain Medicine, Seoul National University School of Medicine, Seoul, Korea
| | - Hee-Taik Kang
- Department of Family Medicine, Chungbuk National University College of Medicine, Cheongju, Korea
| | - Jung Hun Kang
- Department of Internal Medicine, Gyeongsang National University College of Medicine, Jinju, Seoul, Korea
| | - Jae-Min Park
- Department of Family Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
| | - Chung-Woo Lee
- Department of Family Medicine, Korea University, College of Medicine, Seoul, Korea
| | - Seon-Young Kim
- Department of Psychiatry, Chonnam National University Medical School, Gwangju, Korea
| | - Eun Jeong Lee
- Hospice & Palliative Care Center, Korea University Guro Hospital, Seoul, Korea
| | - Su-Jin Koh
- Department of Hematology and Oncology, Ulsan University College of Medicine, Ulsan University Hospital, Ulsan, Korea
| | - Yonghwan Kim
- Department of Family Medicine, Chungbuk National University Hospital, Cheongju, Korea
| | | | - Youhyun Song
- Department of Family Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
| | - Jae Yong Shim
- Department of Family Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
| |
Collapse
|
39
|
Adare A, Afanasiev S, Aidala C, Ajitanand NN, Akiba Y, Akimoto R, Al-Ta'ani H, Alexander J, Angerami A, Aoki K, Apadula N, Aramaki Y, Asano H, Aschenauer EC, Atomssa ET, Awes TC, Azmoun B, Babintsev V, Bai M, Bannier B, Barish KN, Bassalleck B, Bathe S, Baublis V, Baumgart S, Bazilevsky A, Belmont R, Berdnikov A, Berdnikov Y, Bing X, Blau DS, Boyle K, Brooks ML, Buesching H, Bumazhnov V, Butsyk S, Campbell S, Castera P, Chen CH, Chi CY, Chiu M, Choi IJ, Choi JB, Choi S, Choudhury RK, Christiansen P, Chujo T, Chvala O, Cianciolo V, Citron Z, Cole BA, Connors M, Csanád M, Csörgő T, Dairaku S, Datta A, Daugherity MS, David G, Denisov A, Deshpande A, Desmond EJ, Dharmawardane KV, Dietzsch O, Ding L, Dion A, Donadelli M, Drapier O, Drees A, Drees KA, Durham JM, Durum A, D'Orazio L, Edwards S, Efremenko YV, Engelmore T, Enokizono A, Esumi S, Eyser KO, Fadem B, Fields DE, Finger M, Finger M, Fleuret F, Fokin SL, Frantz JE, Franz A, Frawley AD, Fukao Y, Fusayasu T, Gainey K, Gal C, Garishvili A, Garishvili I, Glenn A, Gong X, Gonin M, Goto Y, Granier de Cassagnac R, Grau N, Greene SV, Grosse Perdekamp M, Gunji T, Guo L, Gustafsson HÅ, Hachiya T, Haggerty JS, Hahn KI, Hamagaki H, Hanks J, Hashimoto K, Haslum E, Hayano R, He X, Hemmick TK, Hester T, Hill JC, Hollis RS, Homma K, Hong B, Horaguchi T, Hori Y, Huang S, Ichihara T, Iinuma H, Ikeda Y, Imrek J, Inaba M, Iordanova A, Isenhower D, Issah M, Isupov A, Ivanischev D, Jacak BV, Javani M, Jia J, Jiang X, Johnson BM, Joo KS, Jouan D, Kamin J, Kaneti S, Kang BH, Kang JH, Kang JS, Kapustinsky J, Karatsu K, Kasai M, Kawall D, Kazantsev AV, Kempel T, Khanzadeev A, Kijima KM, Kim BI, Kim C, Kim DJ, Kim EJ, Kim HJ, Kim KB, Kim YJ, Kim YK, Kinney E, Kiss Á, Kistenev E, Klatsky J, Kleinjan D, Kline P, Komatsu Y, Komkov B, Koster J, Kotchetkov D, Kotov D, Král A, Krizek F, Kunde GJ, Kurita K, Kurosawa M, Kwon Y, Kyle GS, Lacey R, Lai YS, Lajoie JG, Lebedev A, Lee B, Lee DM, Lee J, Lee KB, Lee KS, Lee SH, Lee SR, Leitch MJ, Leite MAL, Leitgab M, Lewis B, Lim SH, Linden Levy LA, Litvinenko A, Liu MX, Love B, Maguire CF, Makdisi YI, Makek M, Malakhov A, Manion A, Manko VI, Mannel E, Masumoto S, McCumber M, McGaughey PL, McGlinchey D, McKinney C, Mendoza M, Meredith B, Miake Y, Mibe T, Mignerey AC, Milov A, Mishra DK, Mitchell JT, Miyachi Y, Miyasaka S, Mohanty AK, Moon HJ, Morrison DP, Motschwiller S, Moukhanova TV, Murakami T, Murata J, Nagae T, Nagamiya S, Nagle JL, Nagy MI, Nakagawa I, Nakamiya Y, Nakamura KR, Nakamura T, Nakano K, Nattrass C, Nederlof A, Nihashi M, Nouicer R, Novitzky N, Nyanin AS, O'Brien E, Ogilvie CA, Okada K, Oskarsson A, Ouchida M, Ozawa K, Pak R, Pantuev V, Papavassiliou V, Park BH, Park IH, Park SK, Pate SF, Patel L, Pei H, Peng JC, Pereira H, Peresedov V, Peressounko DY, Petti R, Pinkenburg C, Pisani RP, Proissl M, Purschke ML, Qu H, Rak J, Ravinovich I, Read KF, Reynolds R, Riabov V, Riabov Y, Richardson E, Roach D, Roche G, Rolnick SD, Rosati M, Rukoyatkin P, Sahlmueller B, Saito N, Sakaguchi T, Samsonov V, Sano M, Sarsour M, Sawada S, Sedgwick K, Seidl R, Sen A, Seto R, Sharma D, Shein I, Shibata TA, Shigaki K, Shimomura M, Shoji K, Shukla P, Sickles A, Silva CL, Silvermyr D, Sim KS, Singh BK, Singh CP, Singh V, Slunečka M, Soltz RA, Sondheim WE, Sorensen SP, Soumya M, Sourikova IV, Stankus PW, Stenlund E, Stepanov M, Ster A, Stoll SP, Sugitate T, Sukhanov A, Sun J, Sziklai J, Takagui EM, Takahara A, Taketani A, Tanaka Y, Taneja S, Tanida K, Tannenbaum MJ, Tarafdar S, Taranenko A, Tennant E, Themann H, Todoroki T, Tomášek L, Tomášek M, Torii H, Towell RS, Tserruya I, Tsuchimoto Y, Tsuji T, Vale C, van Hecke HW, Vargyas M, Vazquez-Zambrano E, Veicht A, Velkovska J, Vértesi R, Virius M, Vossen A, Vrba V, Vznuzdaev E, Wang XR, Watanabe D, Watanabe K, Watanabe Y, Watanabe YS, Wei F, Wei R, White SN, Winter D, Wolin S, Woody CL, Wysocki M, Yamaguchi YL, Yang R, Yanovich A, Ying J, Yokkaichi S, You Z, Younus I, Yushmanov IE, Zajc WA, Zelenski A, Zolin L. Erratum: Evolution of π^{0} Suppression in Au+Au Collisions from sqrt[s_{NN}]=39 to 200 GeV [Phys. Rev. Lett. 109, 152301 (2012)]. Phys Rev Lett 2020; 125:049901. [PMID: 32794791 DOI: 10.1103/physrevlett.125.049901] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/30/2020] [Indexed: 06/11/2023]
Abstract
This corrects the article DOI: 10.1103/PhysRevLett.109.152301.
Collapse
|
40
|
Vaswani C, Mootz M, Sundahl C, Mudiyanselage DH, Kang JH, Yang X, Cheng D, Huang C, Kim RHJ, Liu Z, Luo L, Perakis IE, Eom CB, Wang J. Terahertz Second-Harmonic Generation from Lightwave Acceleration of Symmetry-Breaking Nonlinear Supercurrents. Phys Rev Lett 2020; 124:207003. [PMID: 32501057 DOI: 10.1103/physrevlett.124.207003] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/03/2019] [Revised: 03/29/2020] [Accepted: 04/23/2020] [Indexed: 06/11/2023]
Abstract
We report terahertz (THz) light-induced second harmonic generation, in superconductors with inversion symmetry that forbid even-order nonlinearities. The THz second harmonic emission vanishes above the superconductor critical temperature and arises from precession of twisted Anderson pseudospins at a multicycle, THz driving frequency that is not allowed by equilibrium symmetry. We explain the microscopic physics by a dynamical symmetry breaking principle at sub-THz-cycle by using quantum kinetic modeling of the interplay between strong THz-lightwave nonlinearity and pulse propagation. The resulting nonzero integrated pulse area inside the superconductor leads to light-induced nonlinear supercurrents due to subcycle Cooper pair acceleration, in contrast to dc-biased superconductors, which can be controlled by the band structure and THz driving field below the superconducting gap.
Collapse
Affiliation(s)
- C Vaswani
- Department of Physics and Astronomy and Ames Laboratory-U.S. DOE, Iowa State University, Ames, Iowa 50011, USA
| | - M Mootz
- Department of Physics, University of Alabama at Birmingham, Birmingham, Alabama 35294-1170, USA
| | - C Sundahl
- Department of Materials Science and Engineering, University of Wisconsin-Madison, Madison, Wisconsin 53706, USA
| | - D H Mudiyanselage
- Department of Physics and Astronomy and Ames Laboratory-U.S. DOE, Iowa State University, Ames, Iowa 50011, USA
| | - J H Kang
- Department of Materials Science and Engineering, University of Wisconsin-Madison, Madison, Wisconsin 53706, USA
| | - X Yang
- Department of Physics and Astronomy and Ames Laboratory-U.S. DOE, Iowa State University, Ames, Iowa 50011, USA
| | - D Cheng
- Department of Physics and Astronomy and Ames Laboratory-U.S. DOE, Iowa State University, Ames, Iowa 50011, USA
| | - C Huang
- Department of Physics and Astronomy and Ames Laboratory-U.S. DOE, Iowa State University, Ames, Iowa 50011, USA
| | - R H J Kim
- Department of Physics and Astronomy and Ames Laboratory-U.S. DOE, Iowa State University, Ames, Iowa 50011, USA
| | - Z Liu
- Department of Physics and Astronomy and Ames Laboratory-U.S. DOE, Iowa State University, Ames, Iowa 50011, USA
| | - L Luo
- Department of Physics and Astronomy and Ames Laboratory-U.S. DOE, Iowa State University, Ames, Iowa 50011, USA
| | - I E Perakis
- Department of Physics, University of Alabama at Birmingham, Birmingham, Alabama 35294-1170, USA
| | - C B Eom
- Department of Materials Science and Engineering, University of Wisconsin-Madison, Madison, Wisconsin 53706, USA
| | - J Wang
- Department of Physics and Astronomy and Ames Laboratory-U.S. DOE, Iowa State University, Ames, Iowa 50011, USA
| |
Collapse
|
41
|
Kim JH, Oh SY, Kang JH, Kang MH, Jeong CY, Ji JH. The prognostic significance of the advanced lung cancer inflammation index(ALI) in patients with advanced biliary tract cancer: A retrospective study. J Clin Oncol 2020. [DOI: 10.1200/jco.2020.38.15_suppl.e16613] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
e16613 Background: Intrahepatic cholangiocarcinoma is the second most common primary cancer, but the prognosis is poor and aggressive therapies provide only limited benefit when it is in advanced stage. Many studies were conducted to find significant prognostic factors to predict clinical outcomes, but there is no definitive parameter or scoring model yet in this disease. This study is a retrospective analysis to test various kinds of prognostic scoring systems including the advanced lung cancer inflammation (ALI) index, a new prognostic model, for patients treated for advanced intrahepatic cholangiocarcinoma. Methods: We retrospectively searched medical records of patients who were diagnosed with advanced intrahepatic cholangiocarcinoma between January 2012 and December 2017 and actively treated at a single tertiary regional cancer center. Patients who received only supportive care, or had active infection concomitantly were excluded. 60 patients were identified, and we reviewed and analyzed their baseline characteristics and clinical outcomes. Various types of inflammation or nutritional scoring systems, neutrophil to lymphocyte ratio (NLR), Onodera’s prognostic nutritional index (OPNI), the advanced lung cancer inflammation (ALI) index were concurrently calculated and significance for patients’ survival was evaluated. Results: In 50 patients with metastatic stage and 10 patients with locally advanced disease, the median overall survival was 13.97 months (95% confidence interval (CI) 7.99 – 19.95). ALI of 28.5 was determined as the optimal cut-off value for prediction of 1-year survival by receiver operating characteristics (ROC) curve with an AUC value of 0.671 (sensitivity and specificity were 77.8% and 60.6%, respectively). 26 patients with ALI > 28.5 had significantly better overall survival compared with 34 patients with ALI≤28.5 (19.2 months vs. 8.73 months, p= .007). NLR above 2.8 only showed mildly significant difference for overall survival (OS), and the OPNI failed to predict prognosis of these patients. In multivariate analysis, there was no independent prognostic factor observed to have association with overall survival. Conclusions: The advanced lung cancer inflammation (ALI) index showed a potential to be a new prognostic model for advanced intrahepatic cholangiocarcinoma. Further cohort studies to expand population size may be worth.
Collapse
Affiliation(s)
- Jung Hoon Kim
- Gyeongsang National University Hospital, Jinju-Si, South Korea
| | - Sung Yong Oh
- Department of Internal Medicine, Dong-A University College of Medicine, Busan, South Korea
| | - Jung Hun Kang
- Division of Hematology/Oncology, Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University School of Medicine, Jinju, South Korea
| | - Myoung-Hee Kang
- Division of Hematology/Oncology, Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University School of Medicine, Jinju, South Korea
| | - Chi-Young Jeong
- Department of Surgery, Gyeongsang National University Hospital, Jinju, South Korea
| | - Jun Ho Ji
- Division of Hemato-Oncology, Department of Internal Medicine, Changwon Samsung Medical Center, Changwon, South Korea
| |
Collapse
|
42
|
Chon H, Park HS, Kang B, Im HS, Lee CK, Kim I, Kang MJ, Hwang JE, Bae WK, Cheon J, Hong JY, Kang JH, Kim JH, Lim SH, Kim JW, Kim JW, Yoo C, Choi HJ, Park JO. Liposomal irinotecan plus fluorouracil/leucovorin versus FOLFIRINOX as the second-line chemotherapy for patients with metastatic pancreatic cancer: Multicenter study of the Korean Cancer Study Group (KCSG). J Clin Oncol 2020. [DOI: 10.1200/jco.2020.38.15_suppl.4624] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
4624 Background: There is no clear consensus on the second-line treatment for patients with metastatic pancreatic cancer (mPC). The aim of this study was to compare the efficacy and tolerability between liposomal irinotecan (nal-IRI) plus fluorouralcil/leucovorin (FL) and FOLFIRINOX (oxaliplatin/irinotecan/leucovorin/fluorouracil) in patients who failed to first-line gemcitabine-based therapy. Methods: In this retrospective study, 378 mPC patients who received nal-IRI/FL (n = 104) or FOLFIRINOX (n = 274) as the second-line treatment across 11 institutions from January 2015 to August 2019 were analyzed. The primary end point was progression free survival (PFS), and secondary end points were overall survival (OS), overall response rate, and tolerability. Results: There were no significant differences between the two groups in terms of baseline characteristics, except first-line regimen (previous gemcitabine/nab-paclitaxel, nal-IRI/FL, 85.6% vs. FOLFIRINOX, 51.5%; previous gemcitabine monotherapy, 5.8% vs. 24.5%). The median follow-up time was 6.0 months. The median PFS (nal-IRI/FL, 3.7 months vs. FOLFIRINOX, 5.0 months) and OS (nal-IRI/FL, 7.7 months vs. FOLFRINOX, 9.7 months) were comparable between two groups (P = 0.40 and 0.13, respectively). The overall response rate was not significantly different between two groups (nal-IRI/FL, 14% vs. FOLFRINOX, 16%; P = 0.644). In multivariate analysis, poor ECOG status, presence of liver metastasis, high NLR, and high CA19-9 were independent prognostic factors for PFS and OS, but chemotherapy regimen (nal-IRI/FL vs. FOLFRINOX) was not. In a subgroup analysis of patients with liver metastasis, FOLFIRINOX exerted significant PFS (median: 2.1 months vs. 4.1 months for nal-IRI/FL vs. FOLFIRINOX, respectively; P = 0.02) and OS (median: 6.7 months vs. 8.4 months for nal-IRI/FL vs. FOLFIRINOX, respectively; P = 0.04) benefit compared with nal-IRI/FL. Grade 3 neutropenia or higher were more frequently observed in FOLFIRINOX (47.2%) than nal-IRI/FL (35%) (P = 0.033). Grade 3 peripheral neuropathy was also common in FOLFIRIONX (5.9%) group compared with nal-IRI/FL (1.0%) (P = 0.049). Conclusions: In second-line setting for mPC after progression on gemcitabine-based therapy, both nal-IRI/FL and FOLFIRINOX regimen showed comparable efficacy and acceptable safety outcomes. FOLFIRINOX regimen might be preferentially considered in patients with liver metastasis.
Collapse
Affiliation(s)
| | - Hyung Soon Park
- Division of Medical Oncology, St. Vincent's Hospital, The Catholic University of Korea, Suwon, South Korea
| | - Beodeul Kang
- Yonsei University College of Medicine, Seoul, South Korea
| | - Hyeon-Su Im
- Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
| | - Choong-kun Lee
- Yonsei Cancer Center, Division of Medical Oncology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea
| | - Ilhwan Kim
- Haeundae Paik Hospital, Busan, South Korea
| | - Myoung Joo Kang
- Department of Oncology, Inje University Haeundae Paik Hospital, Busan, South Korea
| | - Jun-Eul Hwang
- Chonnam National University Medical School, Gwangju, South Korea
| | - Woo Kyun Bae
- Chonnam National University Medical School, Gwangju, South Korea
| | - Jaekyung Cheon
- Division of Hematology and Oncology, Department of Internal Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, South Korea
| | - Jung Yong Hong
- Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
| | - Jung Hun Kang
- Division of Hematology/Oncology, Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University School of Medicine, Jinju, South Korea
| | - Jung Hoon Kim
- Gyeongsang National University Hospital, Jinju-Si, South Korea
| | - Sung Hee Lim
- Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
| | - Jin Won Kim
- Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seognnam, South Korea
| | - Ji-Won Kim
- Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea
| | - Changhoon Yoo
- Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
| | | | - Joon Oh Park
- Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
| |
Collapse
|
43
|
Kang E, Keam B, Lee NR, Kang JH, Kim YJ, Shim HJ, Jung KH, Koh SJ, Ryu H, Lee J, Choo J, Yoo SH, Yun YH. Impact of family caregivers' awareness of the prognosis on their quality of life/depression and those of patients with advanced cancer: a prospective cohort study. Support Care Cancer 2020; 29:397-407. [PMID: 32372177 DOI: 10.1007/s00520-020-05489-8] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/12/2019] [Accepted: 04/20/2020] [Indexed: 12/13/2022]
Abstract
PURPOSE A caregiver's prognostic awareness can affect clinical decisions for the patient. The purpose of this study was to examine the impact of family caregivers' prognostic awareness on the quality of life (QOL) and emotional state of both patients with advanced cancer and their caregivers. METHODS This prospective cohort study was conducted from December of 2016 to January of 2018. A total of 159 patients with advanced cancer and an equal number of caregivers participated. The investigation tools used include the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C15-Palliative, the McGill Quality of Life Questionnaire, and the Patient Health Questionnaire-9, and evaluation was performed at baseline, 3 months, and 6 months. Covariance analysis with a general linear modeling was used to compare changes in quality of life scores according to the caregivers' awareness of the prognosis. RESULTS Mean patient overall QOL score increased in the group of caregivers who were aware of prognosis and decreased in the caregivers who were not aware of the prognosis (p = 0.018). The changes over time in the patients' QOL scores associated with symptoms improved with caregiver awareness (pain, p = 0.017; dyspnea, p = 0.048; appetite loss, p = 0.045). The percentage of depressed patients was smaller after 3 months in the group with caregivers aware of the prognosis (baseline to 3 months p = 0.028). Caregivers who did not understand their patients' prognosis exhibited better existential well-being (p = 0.036), and the incidence of depression was lower in this group at 3 months (p = 0.024). CONCLUSION Caregivers' prognostic awareness may improve the quality of life and mood in patients with advanced cancer; however, this awareness may harm the quality of life and mood of the caregivers. These results may aid in developing in-depth interventions regarding prognosis for both patients and their caregivers.
Collapse
Affiliation(s)
- EunKyo Kang
- Department of Family Medicine, Seoul National University Hospital, Seoul, South Korea.,Institute for Public Health and Medical Service, Seoul National University Hospital, Seoul, South Korea
| | - Bhumsuk Keam
- Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea
| | - Na-Ri Lee
- Department of Internal Medicine, Chonbuk National University Medical School, Jeonju, South Korea
| | - Jung Hun Kang
- Department of Internal Medicine, Gyeongsang University Hospital, Jinju, South Korea
| | - Yu Jung Kim
- Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea
| | - Hyun-Jeong Shim
- Department of Internal Medicine, Chonnam National University Medical School, Gwangju, South Korea
| | - Kyung Hae Jung
- Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
| | - Su-Jin Koh
- Department of Hematology and Oncology, Ulsan University Hospital, Ulsan University College of Medicine, Ulsan, South Korea
| | - Hyewon Ryu
- Internal Medicine, Chungnam National University College of Medicine, Chungnam, South Korea
| | - Jihye Lee
- Department of Medical Informatics, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul, South Korea
| | - Jiyeon Choo
- Department of Medical Informatics, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul, South Korea
| | - Shin Hye Yoo
- Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea
| | - Young Ho Yun
- Department of Family Medicine, Seoul National University Hospital, Seoul, South Korea. .,Department of Medical Informatics, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul, South Korea.
| |
Collapse
|
44
|
Won YW, Kang JH. Debatable Issues in Palliative Sedation; Authors' Reply to the Response by Robert Twycross. J Pain Symptom Manage 2020; 59:e2-e3. [PMID: 32007486 DOI: 10.1016/j.jpainsymman.2020.01.010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/11/2020] [Revised: 01/18/2020] [Accepted: 01/20/2020] [Indexed: 11/28/2022]
Affiliation(s)
- Young-Woong Won
- Division of Hematology and Oncology, Department of Internal Medicine, Hanyang University Guri Hospital, Guri, Republic of Korea
| | - Jung Hun Kang
- Department of Internal Medicine, College of Medicine, Gyeongsang National University, Jinju, Republic of Korea.
| |
Collapse
|
45
|
Acharya S, Adamová D, Adhya SP, Adler A, Adolfsson J, Aggarwal MM, Aglieri Rinella G, Agnello M, Agrawal N, Ahammed Z, Ahmad S, Ahn SU, Aiola S, Akindinov A, Al-Turany M, Alam SN, Albuquerque DSD, Aleksandrov D, Alessandro B, Alfanda HM, Alfaro Molina R, Ali B, Ali Y, Alici A, Alkin A, Alme J, Alt T, Altenkamper L, Altsybeev I, Anaam MN, Andrei C, Andreou D, Andrews HA, Andronic A, Angeletti M, Anguelov V, Anson C, Antičić T, Antinori F, Antonioli P, Anwar R, Apadula N, Aphecetche L, Appelshäuser H, Arcelli S, Arnaldi R, Arratia M, Arsene IC, Arslandok M, Augustinus A, Averbeck R, Aziz S, Azmi MD, Badalà A, Baek YW, Bagnasco S, Bailhache R, Bala R, Baldisseri A, Ball M, Baral RC, Barbera R, Barioglio L, Barnaföldi GG, Barnby LS, Barret V, Bartalini P, Barth K, Bartsch E, Baruffaldi F, Bastid N, Basu S, Batigne G, Batyunya B, Batzing PC, Bauri D, Bazo Alba JL, Bearden IG, Bedda C, Behera NK, Belikov I, Bellini F, Bellwied R, Belyaev V, Bencedi G, Beole S, Bercuci A, Berdnikov Y, Berenyi D, Bertens RA, Berzano D, Betev L, Bhasin A, Bhat IR, Bhatt H, Bhattacharjee B, Bianchi A, Bianchi L, Bianchi N, Bielčík J, Bielčíková J, Bilandzic A, Biro G, Biswas R, Biswas S, Blair JT, Blau D, Blume C, Boca G, Bock F, Bogdanov A, Boldizsár L, Bolozdynya A, Bombara M, Bonomi G, Bonora M, Borel H, Borissov A, Borri M, Bossi H, Botta E, Bourjau C, Bratrud L, Braun-Munzinger P, Bregant M, Broker TA, Broz M, Brucken EJ, Bruna E, Bruno GE, Buckland MD, Budnikov D, Buesching H, Bufalino S, Bugnon O, Buhler P, Buncic P, Busch O, Buthelezi Z, Butt JB, Buxton JT, Caffarri D, Caliva A, Calvo Villar E, Camacho RS, Camerini P, Capon AA, Carnesecchi F, Castillo Castellanos J, Castro AJ, Casula EAR, Catalano F, Ceballos Sanchez C, Chakraborty P, Chandra S, Chang B, Chang W, Chapeland S, Chartier M, Chattopadhyay S, Chattopadhyay S, Chauvin A, Cheshkov C, Cheynis B, Chibante Barroso V, Chinellato DD, Cho S, Chochula P, Chowdhury T, Christakoglou P, Christensen CH, Christiansen P, Chujo T, Cicalo C, Cifarelli L, Cindolo F, Cleymans J, Colamaria F, Colella D, Collu A, Colocci M, Concas M, Conesa Balbastre G, Conesa Del Valle Z, Contin G, Contreras JG, Cormier TM, Corrales Morales Y, Cortese P, Cosentino MR, Costa F, Costanza S, Crkovská J, Crochet P, Cuautle E, Cunqueiro L, Dabrowski D, Dahms T, Dainese A, Damas FPA, Dani S, Danisch MC, Danu A, Das D, Das I, Das S, Dash A, Dash S, Dashi A, De S, De Caro A, de Cataldo G, de Conti C, de Cuveland J, De Falco A, De Gruttola D, De Marco N, De Pasquale S, De Souza RD, Deb S, Degenhardt HF, Deisting A, Deja KR, Deloff A, Delsanto S, Dhankher P, Di Bari D, Di Mauro A, Diaz RA, Dietel T, Dillenseger P, Ding Y, Divià R, Djuvsland Ø, Dmitrieva U, Dobrin A, Dönigus B, Dordic O, Dubey AK, Dubla A, Dudi S, Duggal AK, Dukhishyam M, Dupieux P, Ehlers RJ, Elia D, Engel H, Epple E, Erazmus B, Erhardt F, Erokhin A, Ersdal MR, Espagnon B, Eulisse G, Eum J, Evans D, Evdokimov S, Fabbietti L, Faggin M, Faivre J, Fantoni A, Fasel M, Fecchio P, Feldkamp L, Feliciello A, Feofilov G, Fernández Téllez A, Ferrero A, Ferretti A, Festanti A, Feuillard VJG, Figiel J, Filchagin S, Finogeev D, Fionda FM, Fiorenza G, Flor F, Foertsch S, Foka P, Fokin S, Fragiacomo E, Francisco A, Frankenfeld U, Fronze GG, Fuchs U, Furget C, Furs A, Fusco Girard M, Gaardhøje JJ, Gagliardi M, Gago AM, Gal A, Galvan CD, Ganoti P, Garabatos C, Garcia-Solis E, Garg K, Gargiulo C, Garner K, Gasik P, Gauger EF, Gay Ducati MB, Germain M, Ghosh J, Ghosh P, Ghosh SK, Gianotti P, Giubellino P, Giubilato P, Glässel P, Goméz Coral DM, Gomez Ramirez A, Gonzalez V, González-Zamora P, Gorbunov S, Görlich L, Gotovac S, Grabski V, Graczykowski LK, Graham KL, Greiner L, Grelli A, Grigoras C, Grigoriev V, Grigoryan A, Grigoryan S, Groettvik OS, Gronefeld JM, Grosa F, Grosse-Oetringhaus JF, Grosso R, Guernane R, Guerzoni B, Guittiere M, Gulbrandsen K, Gunji T, Gupta A, Gupta R, Guzman IB, Haake R, Habib MK, Hadjidakis C, Hamagaki H, Hamar G, Hamid M, Hamon JC, Hannigan R, Haque MR, Harlenderova A, Harris JW, Harton A, Hassan H, Hatzifotiadou D, Hauer P, Hayashi S, Heckel ST, Hellbär E, Helstrup H, Herghelegiu A, Hernandez EG, Herrera Corral G, Herrmann F, Hetland KF, Hilden TE, Hillemanns H, Hills C, Hippolyte B, Hohlweger B, Horak D, Hornung S, Hosokawa R, Hristov P, Huang C, Hughes C, Huhn P, Humanic TJ, Hushnud H, Husova LA, Hussain N, Hussain SA, Hussain T, Hutter D, Hwang DS, Iddon JP, Ilkaev R, Inaba M, Ippolitov M, Islam MS, Ivanov M, Ivanov V, Izucheev V, Jacak B, Jacazio N, Jacobs PM, Jadhav MB, Jadlovska S, Jadlovsky J, Jaelani S, Jahnke C, Jakubowska MJ, Janik MA, Jercic M, Jevons O, Jimenez Bustamante RT, Jin M, Jonas F, Jones PG, Jusko A, Kalinak P, Kalweit A, Kang JH, Kaplin V, Kar S, Karasu Uysal A, Karavichev O, Karavicheva T, Karczmarczyk P, Karpechev E, Kebschull U, Keidel R, Keil M, Ketzer B, Khabanova Z, Khan AM, Khan S, Khan SA, Khanzadeev A, Kharlov Y, Khatun A, Khuntia A, Kileng B, Kim B, Kim B, Kim D, Kim DJ, Kim EJ, Kim H, Kim JS, Kim J, Kim J, Kim J, Kim M, Kim S, Kim T, Kim T, Kindra K, Kirsch S, Kisel I, Kiselev S, Kisiel A, Klay JL, Klein C, Klein J, Klein S, Klein-Bösing C, Klewin S, Kluge A, Knichel ML, Knospe AG, Kobdaj C, Köhler MK, Kollegger T, Kondratyev A, Kondratyeva N, Kondratyuk E, Konopka PJ, Koska L, Kovalenko O, Kovalenko V, Kowalski M, Králik I, Kravčáková A, Kreis L, Krivda M, Krizek F, Krizkova Gajdosova K, Krüger M, Kryshen E, Krzewicki M, Kubera AM, Kučera V, Kuhn C, Kuijer PG, Kumar L, Kumar S, Kundu S, Kurashvili P, Kurepin A, Kurepin AB, Kushpil S, Kvapil J, Kweon MJ, Kwon Y, La Pointe SL, La Rocca P, Lai YS, Langoy R, Lapidus K, Lardeux A, Larionov P, Laudi E, Lavicka R, Lazareva T, Lea R, Leardini L, Lee S, Lehas F, Lehner S, Lehrbach J, Lemmon RC, León Monzón I, Lesser ED, Lettrich M, Lévai P, Li X, Li XL, Lien J, Lietava R, Lim B, Lindal S, Lindenstruth V, Lindsay SW, Lippmann C, Lisa MA, Litichevskyi V, Liu A, Liu S, Ljunggren HM, Llope WJ, Lofnes IM, Loginov V, Loizides C, Loncar P, Lopez X, López Torres E, Luettig P, Luhder JR, Lunardon M, Luparello G, Lupi M, Maevskaya A, Mager M, Mahmood SM, Mahmoud T, Maire A, Majka RD, Malaev M, Malik QW, Malinina L, Mal'Kevich D, Malzacher P, Mamonov A, Manko V, Manso F, Manzari V, Mao Y, Marchisone M, Mareš J, Margagliotti GV, Margotti A, Margutti J, Marín A, Markert C, Marquard M, Martin NA, Martinengo P, Martinez JL, Martínez MI, Martínez García G, Martinez Pedreira M, Masciocchi S, Masera M, Masoni A, Massacrier L, Masson E, Mastroserio A, Mathis AM, Matuoka PFT, Matyja A, Mayer C, Mazzilli M, Mazzoni MA, Mechler AF, Meddi F, Melikyan Y, Menchaca-Rocha A, Meninno E, Meres M, Mhlanga S, Miake Y, Micheletti L, Mieskolainen MM, Mihaylov DL, Mikhaylov K, Mischke A, Mishra AN, Miśkowiec D, Mitu CM, Mohammadi N, Mohanty AP, Mohanty B, Mohisin Khan M, Mondal M, Mondal MM, Mordasini C, Moreira De Godoy DA, Moreno LAP, Moretto S, Morreale A, Morsch A, Mrnjavac T, Muccifora V, Mudnic E, Mühlheim D, Muhuri S, Mulligan JD, Munhoz MG, Münning K, Munzer RH, Murakami H, Murray S, Musa L, Musinsky J, Myers CJ, Myrcha JW, Naik B, Nair R, Nandi BK, Nania R, Nappi E, Naru MU, Nassirpour AF, Natal da Luz H, Nattrass C, Nayak R, Nayak TK, Nazarenko S, Negrao De Oliveira RA, Nellen L, Nesbo SV, Neskovic G, Nielsen BS, Nikolaev S, Nikulin S, Nikulin V, Noferini F, Nomokonov P, Nooren G, Norman J, Nowakowski P, Nyanin A, Nystrand J, Ogino M, Ohlson A, Oleniacz J, Oliveira Da Silva AC, Oliver MH, Onderwaater J, Oppedisano C, Orava R, Ortiz Velasquez A, Oskarsson A, Otwinowski J, Oyama K, Pachmayer Y, Pacik V, Pagano D, Paić G, Palni P, Pan J, Pandey AK, Panebianco S, Papikyan V, Pareek P, Park J, Parkkila JE, Parmar S, Passfeld A, Pathak SP, Patra RN, Paul B, Pei H, Peitzmann T, Peng X, Pereira LG, Pereira Da Costa H, Peresunko D, Perez GM, Perez Lezama E, Peskov V, Pestov Y, Petráček V, Petrovici M, Pezzi RP, Piano S, Pikna M, Pillot P, Pimentel LODL, Pinazza O, Pinsky L, Pisano S, Piyarathna DB, Płoskoń M, Planinic M, Pliquett F, Pluta J, Pochybova S, Poghosyan MG, Polichtchouk B, Poljak N, Poonsawat W, Pop A, Poppenborg H, Porteboeuf-Houssais S, Pozdniakov V, Prasad SK, Preghenella R, Prino F, Pruneau CA, Pshenichnov I, Puccio M, Punin V, Puranapanda K, Putschke J, Quishpe RE, Ragoni S, Raha S, Rajput S, Rak J, Rakotozafindrabe A, Ramello L, Rami F, Raniwala R, Raniwala S, Räsänen SS, Rascanu BT, Rath R, Ratza V, Ravasenga I, Read KF, Redlich K, Rehman A, Reichelt P, Reidt F, Ren X, Renfordt R, Reshetin A, Revol JP, Reygers K, Riabov V, Richert T, Richter M, Riedler P, Riegler W, Riggi F, Ristea C, Rode SP, Rodríguez Cahuantzi M, Røed K, Rogalev R, Rogochaya E, Rohr D, Röhrich D, Rokita PS, Ronchetti F, Rosas ED, Roslon K, Rosnet P, Rossi A, Rotondi A, Roukoutakis F, Roy A, Roy P, Rueda OV, Rui R, Rumyantsev B, Rustamov A, Ryabinkin E, Ryabov Y, Rybicki A, Rytkonen H, Saarinen S, Sadhu S, Sadovsky S, Šafařík K, Saha SK, Sahoo B, Sahoo P, Sahoo R, Sahoo S, Sahu PK, Saini J, Sakai S, Sambyal S, Samsonov V, Sandoval A, Sarkar A, Sarkar D, Sarkar N, Sarma P, Sarti VM, Sas MHP, Scapparone E, Schaefer B, Schambach J, Scheid HS, Schiaua C, Schicker R, Schmah A, Schmidt C, Schmidt HR, Schmidt MO, Schmidt M, Schmidt NV, Schmier AR, Schukraft J, Schutz Y, Schwarz K, Schweda K, Scioli G, Scomparin E, Šefčík M, Seger JE, Sekiguchi Y, Sekihata D, Selyuzhenkov I, Senyukov S, Serradilla E, Sett P, Sevcenco A, Shabanov A, Shabetai A, Shahoyan R, Shaikh W, Shangaraev A, Sharma A, Sharma A, Sharma M, Sharma N, Sheikh AI, Shigaki K, Shimomura M, Shirinkin S, Shou Q, Sibiriak Y, Siddhanta S, Siemiarczuk T, Silvermyr D, Simatovic G, Simonetti G, Singh R, Singh R, Singh VK, Singhal V, Sinha T, Sitar B, Sitta M, Skaali TB, Slupecki M, Smirnov N, Snellings RJM, Snellman TW, Sochan J, Soncco C, Song J, Songmoolnak A, Soramel F, Sorensen S, Sputowska I, Stachel J, Stan I, Stankus P, Steffanic PJ, Stenlund E, Stocco D, Storetvedt MM, Strmen P, Suaide AAP, Sugitate T, Suire C, Suleymanov M, Suljic M, Sultanov R, Šumbera M, Sumowidagdo S, Suzuki K, Swain S, Szabo A, Szarka I, Tabassam U, Taillepied G, Takahashi J, Tambave GJ, Tang S, Tarhini M, Tarzila MG, Tauro A, Tejeda Muñoz G, Telesca A, Terrevoli C, Thakur D, Thakur S, Thomas D, Thoresen F, Tieulent R, Tikhonov A, Timmins AR, Toia A, Topilskaya N, Toppi M, Torales-Acosta F, Torres SR, Tripathy S, Tripathy T, Trogolo S, Trombetta G, Tropp L, Trubnikov V, Trzaska WH, Trzcinski TP, Trzeciak BA, Tsuji T, Tumkin A, Turrisi R, Tveter TS, Ullaland K, Umaka EN, Uras A, Usai GL, Utrobicic A, Vala M, Valle N, Vallero S, van der Kolk N, van Doremalen LVR, van Leeuwen M, Vande Vyvre P, Varga D, Varga-Kofarago M, Vargas A, Vargyas M, Varma R, Vasileiou M, Vasiliev A, Vázquez Doce O, Vechernin V, Veen AM, Vercellin E, Vergara Limón S, Vermunt L, Vernet R, Vértesi R, Vickovic L, Viinikainen J, Vilakazi Z, Villalobos Baillie O, Villatoro Tello A, Vino G, Vinogradov A, Virgili T, Vislavicius V, Vodopyanov A, Volkel B, Völkl MA, Voloshin K, Voloshin SA, Volpe G, von Haller B, Vorobyev I, Voscek D, Vrláková J, Wagner B, Watanabe Y, Weber M, Weber SG, Wegrzynek A, Weiser DF, Wenzel SC, Wessels JP, Westerhoff U, Whitehead AM, Widmann E, Wiechula J, Wikne J, Wilk G, Wilkinson J, Willems GA, Willsher E, Windelband B, Witt WE, Wu Y, Xu R, Yalcin S, Yamakawa K, Yang S, Yano S, Yin Z, Yokoyama H, Yoo IK, Yoon JH, Yuan S, Yuncu A, Yurchenko V, Zaccolo V, Zaman A, Zampolli C, Zanoli HJC, Zardoshti N, Zarochentsev A, Závada P, Zaviyalov N, Zbroszczyk H, Zhalov M, Zhang X, Zhang Z, Zhao C, Zherebchevskii V, Zhigareva N, Zhou D, Zhou Y, Zhou Z, Zhu J, Zhu Y, Zichichi A, Zimmermann MB, Zinovjev G, Zurlo N. Scattering Studies with Low-Energy Kaon-Proton Femtoscopy in Proton-Proton Collisions at the LHC. Phys Rev Lett 2020; 124:092301. [PMID: 32202883 DOI: 10.1103/physrevlett.124.092301] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/18/2019] [Revised: 12/03/2019] [Accepted: 02/11/2020] [Indexed: 06/10/2023]
Abstract
The study of the strength and behavior of the antikaon-nucleon (K[over ¯]N) interaction constitutes one of the key focuses of the strangeness sector in low-energy quantum chromodynamics (QCD). In this Letter a unique high-precision measurement of the strong interaction between kaons and protons, close and above the kinematic threshold, is presented. The femtoscopic measurements of the correlation function at low pair-frame relative momentum of (K^{+}p⊕K^{-}p[over ¯]) and (K^{-}p⊕K^{+}p[over ¯]) pairs measured in pp collisions at sqrt[s]=5, 7, and 13 TeV are reported. A structure observed around a relative momentum of 58 MeV/c in the measured correlation function of (K^{-}p⊕K^{+}p[over ¯]) with a significance of 4.4σ constitutes the first experimental evidence for the opening of the (K[over ¯]^{0}n⊕K^{0}n[over ¯]) isospin breaking channel due to the mass difference between charged and neutral kaons. The measured correlation functions have been compared to Jülich and Kyoto models in addition to the Coulomb potential. The high-precision data at low relative momenta presented in this work prove femtoscopy to be a powerful complementary tool to scattering experiments and provide new constraints above the K[over ¯]N threshold for low-energy QCD chiral models.
Collapse
Affiliation(s)
- S Acharya
- Variable Energy Cyclotron Centre, Homi Bhabha National Institute, Kolkata, India
| | - D Adamová
- Nuclear Physics Institute of the Czech Academy of Sciences, Řež u Prahy, Czech Republic
| | - S P Adhya
- Variable Energy Cyclotron Centre, Homi Bhabha National Institute, Kolkata, India
| | - A Adler
- Johann-Wolfgang-Goethe Universität Frankfurt Institut für Informatik, Fachbereich Informatik und Mathematik, Frankfurt, Germany
| | - J Adolfsson
- Lund University Department of Physics, Division of Particle Physics, Lund, Sweden
| | - M M Aggarwal
- Physics Department, Panjab University, Chandigarh, India
| | - G Aglieri Rinella
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - M Agnello
- Dipartimento DISAT del Politecnico and Sezione INFN, Turin, Italy
| | - N Agrawal
- Centro Fermi-Museo Storico della Fisica e Centro Studi e Ricerche "Enrico Fermi', Rome, Italy
| | - Z Ahammed
- Variable Energy Cyclotron Centre, Homi Bhabha National Institute, Kolkata, India
| | - S Ahmad
- Department of Physics, Aligarh Muslim University, Aligarh, India
| | - S U Ahn
- Korea Institute of Science and Technology Information, Daejeon, Republic of Korea
| | - S Aiola
- Yale University, New Haven, Connecticut, USA
| | - A Akindinov
- Institute for Theoretical and Experimental Physics, Moscow, Russia
| | - M Al-Turany
- Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
| | - S N Alam
- Variable Energy Cyclotron Centre, Homi Bhabha National Institute, Kolkata, India
| | | | - D Aleksandrov
- National Research Centre Kurchatov Institute, Moscow, Russia
| | | | - H M Alfanda
- Central China Normal University, Wuhan, China
| | - R Alfaro Molina
- Instituto de Física, Universidad Nacional Autónoma de México, Mexico City, Mexico
| | - B Ali
- Department of Physics, Aligarh Muslim University, Aligarh, India
| | - Y Ali
- COMSATS University Islamabad, Islamabad, Pakistan
| | - A Alici
- Centro Fermi-Museo Storico della Fisica e Centro Studi e Ricerche "Enrico Fermi', Rome, Italy
- Dipartimento di Fisica e Astronomia dell'Università, Bologna, Italy
- Sezione INFN, Bologna, Italy
- INFN, Sezione di Bologna, Bologna, Italy
| | - A Alkin
- Bogolyubov Institute for Theoretical Physics, National Academy of Sciences of Ukraine, Kiev, Ukraine
| | - J Alme
- Department of Physics and Technology, University of Bergen, Bergen, Norway
| | - T Alt
- Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
| | - L Altenkamper
- Department of Physics and Technology, University of Bergen, Bergen, Norway
| | - I Altsybeev
- St. Petersburg State University, St. Petersburg, Russia
| | - M N Anaam
- Central China Normal University, Wuhan, China
| | - C Andrei
- Horia Hulubei National Institute of Physics and Nuclear Engineering, Bucharest, Romania
| | - D Andreou
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - H A Andrews
- School of Physics and Astronomy, University of Birmingham, Birmingham, United Kingdom
| | - A Andronic
- Westfälische Wilhelms-Universität Münster, Institut für Kernphysik, Münster, Germany
| | - M Angeletti
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - V Anguelov
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - C Anson
- Creighton University, Omaha, Nebraska, USA
| | - T Antičić
- Rudjer Bošković Institute, Zagreb, Croatia
| | | | | | - R Anwar
- University of Houston, Houston, Texas, USA
| | - N Apadula
- Lawrence Berkeley National Laboratory, Berkeley, California, USA
| | - L Aphecetche
- SUBATECH, IMT Atlantique, Université de Nantes, CNRS-IN2P3, Nantes, France
| | - H Appelshäuser
- Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
| | - S Arcelli
- Dipartimento di Fisica e Astronomia dell'Università, Bologna, Italy
- Sezione INFN, Bologna, Italy
| | - R Arnaldi
- INFN, Sezione di Torino, Turin, Italy
| | - M Arratia
- Lawrence Berkeley National Laboratory, Berkeley, California, USA
| | - I C Arsene
- Department of Physics, University of Oslo, Oslo, Norway
| | - M Arslandok
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - A Augustinus
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - R Averbeck
- Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
| | - S Aziz
- Institut de Physique Nucléaire d'Orsay (IPNO), Institut National de Physique Nucléaire et de Physique des Particules (IN2P3/CNRS), Université de Paris-Sud, Université Paris-Saclay, Orsay, France
| | - M D Azmi
- Department of Physics, Aligarh Muslim University, Aligarh, India
| | - A Badalà
- INFN, Sezione di Catania, Catania, Italy
| | - Y W Baek
- Gangneung-Wonju National University, Gangneung, Republic of Korea
| | | | - R Bailhache
- Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
| | - R Bala
- Physics Department, University of Jammu, Jammu, India
| | - A Baldisseri
- Université Paris-Saclay Centre d'Etudes de Saclay (CEA), IRFU, Départment de Physique Nucléaire (DPhN), Saclay, France
| | - M Ball
- Helmholtz-Institut für Strahlen- und Kernphysik, Rheinische Friedrich-Wilhelms-Universität Bonn, Bonn, Germany
| | - R C Baral
- National Institute of Science Education and Research, Homi Bhabha National Institute, Jatni, India
| | - R Barbera
- Dipartimento di Fisica e Astronomia dell'Università, Catania, Italy
- Sezione INFN, Catania, Italy
| | - L Barioglio
- Dipartimento di Fisica dell'Università, Turin, Italy
- Sezione INFN, Turin, Italy
| | - G G Barnaföldi
- Wigner Research Centre for Physics, Hungarian Academy of Sciences, Budapest, Hungary
| | - L S Barnby
- Nuclear Physics Group, STFC Daresbury Laboratory, Daresbury, United Kingdom
| | - V Barret
- Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
| | - P Bartalini
- Central China Normal University, Wuhan, China
| | - K Barth
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - E Bartsch
- Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
| | - F Baruffaldi
- Dipartimento di Fisica e Astronomia dell'Università, Padova, Italy
- Sezione INFN, Padova, Italy
| | - N Bastid
- Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
| | - S Basu
- Wayne State University, Detroit, Michigan, USA
| | - G Batigne
- SUBATECH, IMT Atlantique, Université de Nantes, CNRS-IN2P3, Nantes, France
| | - B Batyunya
- Joint Institute for Nuclear Research (JINR), Dubna, Russia
| | - P C Batzing
- Department of Physics, University of Oslo, Oslo, Norway
| | - D Bauri
- Indian Institute of Technology Bombay (IIT), Mumbai, India
| | - J L Bazo Alba
- Sección Física, Departamento de Ciencias, Pontificia Universidad Católica del Perú, Lima, Peru
| | - I G Bearden
- Niels Bohr Institute, University of Copenhagen, Copenhagen, Denmark
| | - C Bedda
- Institute for Subatomic Physics, Utrecht University/Nikhef, Utrecht, Netherlands
| | - N K Behera
- Inha University, Incheon, Republic of Korea
| | - I Belikov
- Université de Strasbourg, CNRS, IPHC UMR 7178, F-67000 Strasbourg, France, Strasbourg, France
| | - F Bellini
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - R Bellwied
- University of Houston, Houston, Texas, USA
| | - V Belyaev
- NRNU Moscow Engineering Physics Institute, Moscow, Russia
| | - G Bencedi
- Wigner Research Centre for Physics, Hungarian Academy of Sciences, Budapest, Hungary
| | - S Beole
- Dipartimento di Fisica dell'Università, Turin, Italy
- Sezione INFN, Turin, Italy
| | - A Bercuci
- Horia Hulubei National Institute of Physics and Nuclear Engineering, Bucharest, Romania
| | - Y Berdnikov
- Petersburg Nuclear Physics Institute, Gatchina, Russia
| | - D Berenyi
- Wigner Research Centre for Physics, Hungarian Academy of Sciences, Budapest, Hungary
| | - R A Bertens
- University of Tennessee, Knoxville, Tennessee, USA
| | - D Berzano
- INFN, Sezione di Torino, Turin, Italy
| | - L Betev
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - A Bhasin
- Physics Department, University of Jammu, Jammu, India
| | - I R Bhat
- Physics Department, University of Jammu, Jammu, India
| | - H Bhatt
- Indian Institute of Technology Bombay (IIT), Mumbai, India
| | | | - A Bianchi
- Dipartimento di Fisica dell'Università, Turin, Italy
- Sezione INFN, Turin, Italy
| | - L Bianchi
- Dipartimento di Fisica dell'Università, Turin, Italy
- Sezione INFN, Turin, Italy
- University of Houston, Houston, Texas, USA
| | - N Bianchi
- INFN, Laboratori Nazionali di Frascati, Frascati, Italy
| | - J Bielčík
- Faculty of Nuclear Sciences and Physical Engineering, Czech Technical University in Prague, Prague, Czech Republic
| | - J Bielčíková
- Nuclear Physics Institute of the Czech Academy of Sciences, Řež u Prahy, Czech Republic
| | - A Bilandzic
- Physik Department, Technische Universität München, Munich, Germany
- Technische Universität München, Excellence Cluster 'Universe', Munich, Germany
| | - G Biro
- Wigner Research Centre for Physics, Hungarian Academy of Sciences, Budapest, Hungary
| | - R Biswas
- Bose Institute, Department of Physics, Kolkata, India
- Centre for Astroparticle Physics and Space Science (CAPSS), Kolkata, India
| | - S Biswas
- Bose Institute, Department of Physics, Kolkata, India
- Centre for Astroparticle Physics and Space Science (CAPSS), Kolkata, India
| | - J T Blair
- The University of Texas at Austin, Austin, Texas, USA
| | - D Blau
- National Research Centre Kurchatov Institute, Moscow, Russia
| | - C Blume
- Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
| | - G Boca
- Università degli Studi di Pavia, Pavia, Italy
| | - F Bock
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
- Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA
| | - A Bogdanov
- NRNU Moscow Engineering Physics Institute, Moscow, Russia
| | - L Boldizsár
- Wigner Research Centre for Physics, Hungarian Academy of Sciences, Budapest, Hungary
| | - A Bolozdynya
- NRNU Moscow Engineering Physics Institute, Moscow, Russia
| | - M Bombara
- Faculty of Science, P.J. Šafárik University, Košice, Slovakia
| | - G Bonomi
- Università di Brescia, Brescia, Italy
| | - M Bonora
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - H Borel
- Université Paris-Saclay Centre d'Etudes de Saclay (CEA), IRFU, Départment de Physique Nucléaire (DPhN), Saclay, France
| | - A Borissov
- NRNU Moscow Engineering Physics Institute, Moscow, Russia
- Westfälische Wilhelms-Universität Münster, Institut für Kernphysik, Münster, Germany
| | - M Borri
- University of Liverpool, Liverpool, United Kingdom
| | - H Bossi
- Yale University, New Haven, Connecticut, USA
| | - E Botta
- Dipartimento di Fisica dell'Università, Turin, Italy
- Sezione INFN, Turin, Italy
| | - C Bourjau
- Niels Bohr Institute, University of Copenhagen, Copenhagen, Denmark
| | - L Bratrud
- Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
| | - P Braun-Munzinger
- Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
| | - M Bregant
- Universidade de São Paulo (USP), São Paulo, Brazil
| | - T A Broker
- Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
| | - M Broz
- Faculty of Nuclear Sciences and Physical Engineering, Czech Technical University in Prague, Prague, Czech Republic
| | - E J Brucken
- Helsinki Institute of Physics (HIP), Helsinki, Finland
| | - E Bruna
- INFN, Sezione di Torino, Turin, Italy
| | - G E Bruno
- Dipartimento Interateneo di Fisica 'M. Merlin', Bari, Italy
- Sezione INFN, Bari, Italy
- Politecnico di Bari, Bari, Italy
| | - M D Buckland
- University of Liverpool, Liverpool, United Kingdom
| | - D Budnikov
- Russian Federal Nuclear Center (VNIIEF), Sarov, Russia
| | - H Buesching
- Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
| | - S Bufalino
- Dipartimento DISAT del Politecnico and Sezione INFN, Turin, Italy
| | - O Bugnon
- SUBATECH, IMT Atlantique, Université de Nantes, CNRS-IN2P3, Nantes, France
| | - P Buhler
- Stefan Meyer Institut für Subatomare Physik (SMI), Vienna, Austria
| | - P Buncic
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - O Busch
- University of Tsukuba, Tsukuba, Japan
| | - Z Buthelezi
- iThemba LABS, National Research Foundation, Somerset West, South Africa
| | - J B Butt
- COMSATS University Islamabad, Islamabad, Pakistan
| | - J T Buxton
- Ohio State University, Columbus, Ohio, USA
| | - D Caffarri
- Nikhef, National institute for subatomic physics, Amsterdam, Netherlands
| | - A Caliva
- Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
| | - E Calvo Villar
- Sección Física, Departamento de Ciencias, Pontificia Universidad Católica del Perú, Lima, Peru
| | - R S Camacho
- High Energy Physics Group, Universidad Autónoma de Puebla, Puebla, Mexico
| | - P Camerini
- Dipartimento di Fisica dell'Università, Trieste, Italy
- Sezione INFN, Trieste, Italy
| | - A A Capon
- Stefan Meyer Institut für Subatomare Physik (SMI), Vienna, Austria
| | - F Carnesecchi
- Centro Fermi-Museo Storico della Fisica e Centro Studi e Ricerche "Enrico Fermi', Rome, Italy
| | - J Castillo Castellanos
- Université Paris-Saclay Centre d'Etudes de Saclay (CEA), IRFU, Départment de Physique Nucléaire (DPhN), Saclay, France
| | - A J Castro
- University of Tennessee, Knoxville, Tennessee, USA
| | | | - F Catalano
- Dipartimento DISAT del Politecnico and Sezione INFN, Turin, Italy
| | | | - P Chakraborty
- Indian Institute of Technology Bombay (IIT), Mumbai, India
| | - S Chandra
- Variable Energy Cyclotron Centre, Homi Bhabha National Institute, Kolkata, India
| | - B Chang
- University of Jyväskylä, Jyväskylä, Finland
| | - W Chang
- Central China Normal University, Wuhan, China
| | - S Chapeland
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - M Chartier
- University of Liverpool, Liverpool, United Kingdom
| | - S Chattopadhyay
- Variable Energy Cyclotron Centre, Homi Bhabha National Institute, Kolkata, India
| | - S Chattopadhyay
- Saha Institute of Nuclear Physics, Homi Bhabha National Institute, Kolkata, India
| | - A Chauvin
- Dipartimento di Fisica dell'Università, Cagliari, Italy
- Sezione INFN, Cagliari, Italy
| | - C Cheshkov
- Université de Lyon, Université Lyon 1, CNRS/IN2P3, IPN-Lyon, Villeurbanne, Lyon, France
| | - B Cheynis
- Université de Lyon, Université Lyon 1, CNRS/IN2P3, IPN-Lyon, Villeurbanne, Lyon, France
| | | | - D D Chinellato
- Universidade Estadual de Campinas (UNICAMP), Campinas, Brazil
| | - S Cho
- Inha University, Incheon, Republic of Korea
| | - P Chochula
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - T Chowdhury
- Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
| | - P Christakoglou
- Nikhef, National institute for subatomic physics, Amsterdam, Netherlands
| | - C H Christensen
- Niels Bohr Institute, University of Copenhagen, Copenhagen, Denmark
| | - P Christiansen
- Lund University Department of Physics, Division of Particle Physics, Lund, Sweden
| | - T Chujo
- University of Tsukuba, Tsukuba, Japan
| | - C Cicalo
- INFN, Sezione di Cagliari, Cagliari, Italy
| | - L Cifarelli
- Centro Fermi-Museo Storico della Fisica e Centro Studi e Ricerche "Enrico Fermi', Rome, Italy
- Dipartimento di Fisica e Astronomia dell'Università, Bologna, Italy
- Sezione INFN, Bologna, Italy
| | - F Cindolo
- INFN, Sezione di Bologna, Bologna, Italy
| | - J Cleymans
- University of Cape Town, Cape Town, South Africa
| | | | | | - A Collu
- Lawrence Berkeley National Laboratory, Berkeley, California, USA
| | - M Colocci
- Dipartimento di Fisica e Astronomia dell'Università, Bologna, Italy
- Sezione INFN, Bologna, Italy
| | - M Concas
- INFN, Sezione di Torino, Turin, Italy
| | - G Conesa Balbastre
- Laboratoire de Physique Subatomique et de Cosmologie, Université Grenoble-Alpes, CNRS-IN2P3, Grenoble, France
| | - Z Conesa Del Valle
- Institut de Physique Nucléaire d'Orsay (IPNO), Institut National de Physique Nucléaire et de Physique des Particules (IN2P3/CNRS), Université de Paris-Sud, Université Paris-Saclay, Orsay, France
| | - G Contin
- University of Liverpool, Liverpool, United Kingdom
| | - J G Contreras
- Faculty of Nuclear Sciences and Physical Engineering, Czech Technical University in Prague, Prague, Czech Republic
| | - T M Cormier
- Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA
| | - Y Corrales Morales
- Dipartimento di Fisica dell'Università, Turin, Italy
- Sezione INFN, Turin, Italy
- INFN, Sezione di Torino, Turin, Italy
| | - P Cortese
- Dipartimento di Scienze e Innovazione Tecnologica dell'Università del Piemonte Orientale and INFN Sezione di Torino, Alessandria, Italy
| | | | - F Costa
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - S Costanza
- Università degli Studi di Pavia, Pavia, Italy
| | - J Crkovská
- Institut de Physique Nucléaire d'Orsay (IPNO), Institut National de Physique Nucléaire et de Physique des Particules (IN2P3/CNRS), Université de Paris-Sud, Université Paris-Saclay, Orsay, France
| | - P Crochet
- Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
| | - E Cuautle
- Instituto de Ciencias Nucleares, Universidad Nacional Autónoma de México, Mexico City, Mexico
| | - L Cunqueiro
- Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA
| | - D Dabrowski
- Warsaw University of Technology, Warsaw, Poland
| | - T Dahms
- Physik Department, Technische Universität München, Munich, Germany
- Technische Universität München, Excellence Cluster 'Universe', Munich, Germany
| | - A Dainese
- INFN, Sezione di Padova, Padova, Italy
| | - F P A Damas
- SUBATECH, IMT Atlantique, Université de Nantes, CNRS-IN2P3, Nantes, France
- Université Paris-Saclay Centre d'Etudes de Saclay (CEA), IRFU, Départment de Physique Nucléaire (DPhN), Saclay, France
| | - S Dani
- Institute of Physics, Homi Bhabha National Institute, Bhubaneswar, India
| | - M C Danisch
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - A Danu
- Institute of Space Science (ISS), Bucharest, Romania
| | - D Das
- Saha Institute of Nuclear Physics, Homi Bhabha National Institute, Kolkata, India
| | - I Das
- Saha Institute of Nuclear Physics, Homi Bhabha National Institute, Kolkata, India
| | - S Das
- Bose Institute, Department of Physics, Kolkata, India
- Centre for Astroparticle Physics and Space Science (CAPSS), Kolkata, India
| | - A Dash
- National Institute of Science Education and Research, Homi Bhabha National Institute, Jatni, India
| | - S Dash
- Indian Institute of Technology Bombay (IIT), Mumbai, India
| | - A Dashi
- Physik Department, Technische Universität München, Munich, Germany
| | - S De
- Indian Institute of Technology Indore, Indore, India
- National Institute of Science Education and Research, Homi Bhabha National Institute, Jatni, India
| | - A De Caro
- Dipartimento di Fisica 'E.R. Caianiello' dell'Università, Salerno, Italy
- Gruppo Collegato INFN, Salerno, Italy
| | | | - C de Conti
- Universidade de São Paulo (USP), São Paulo, Brazil
| | - J de Cuveland
- Frankfurt Institute for Advanced Studies, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
| | - A De Falco
- Dipartimento di Fisica dell'Università, Cagliari, Italy
- Sezione INFN, Cagliari, Italy
| | - D De Gruttola
- Centro Fermi-Museo Storico della Fisica e Centro Studi e Ricerche "Enrico Fermi', Rome, Italy
| | | | - S De Pasquale
- Dipartimento di Fisica 'E.R. Caianiello' dell'Università, Salerno, Italy
- Gruppo Collegato INFN, Salerno, Italy
| | - R D De Souza
- Universidade Estadual de Campinas (UNICAMP), Campinas, Brazil
| | - S Deb
- Indian Institute of Technology Indore, Indore, India
| | | | - A Deisting
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
- Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
| | - K R Deja
- Warsaw University of Technology, Warsaw, Poland
| | - A Deloff
- National Centre for Nuclear Research, Warsaw, Poland
| | - S Delsanto
- Dipartimento di Fisica dell'Università, Turin, Italy
- Sezione INFN, Turin, Italy
- University of the Witwatersrand, Johannesburg, South Africa
| | - P Dhankher
- Indian Institute of Technology Bombay (IIT), Mumbai, India
| | - D Di Bari
- Dipartimento Interateneo di Fisica 'M. Merlin', Bari, Italy
- Sezione INFN, Bari, Italy
| | - A Di Mauro
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - R A Diaz
- Centro de Aplicaciones Tecnológicas y Desarrollo Nuclear (CEADEN), Havana, Cuba
| | - T Dietel
- University of Cape Town, Cape Town, South Africa
| | - P Dillenseger
- Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
| | - Y Ding
- Central China Normal University, Wuhan, China
| | - R Divià
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - Ø Djuvsland
- Department of Physics and Technology, University of Bergen, Bergen, Norway
| | - U Dmitrieva
- Institute for Nuclear Research, Academy of Sciences, Moscow, Russia
| | - A Dobrin
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
- Institute of Space Science (ISS), Bucharest, Romania
| | - B Dönigus
- Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
| | - O Dordic
- Department of Physics, University of Oslo, Oslo, Norway
| | - A K Dubey
- Variable Energy Cyclotron Centre, Homi Bhabha National Institute, Kolkata, India
| | - A Dubla
- Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
| | - S Dudi
- Physics Department, Panjab University, Chandigarh, India
| | - A K Duggal
- Physics Department, Panjab University, Chandigarh, India
| | - M Dukhishyam
- National Institute of Science Education and Research, Homi Bhabha National Institute, Jatni, India
| | - P Dupieux
- Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
| | - R J Ehlers
- Yale University, New Haven, Connecticut, USA
| | - D Elia
- INFN, Sezione di Bari, Bari, Italy
| | - H Engel
- Johann-Wolfgang-Goethe Universität Frankfurt Institut für Informatik, Fachbereich Informatik und Mathematik, Frankfurt, Germany
| | - E Epple
- Yale University, New Haven, Connecticut, USA
| | - B Erazmus
- SUBATECH, IMT Atlantique, Université de Nantes, CNRS-IN2P3, Nantes, France
| | - F Erhardt
- Physics department, Faculty of science, University of Zagreb, Zagreb, Croatia
| | - A Erokhin
- St. Petersburg State University, St. Petersburg, Russia
| | - M R Ersdal
- Department of Physics and Technology, University of Bergen, Bergen, Norway
| | - B Espagnon
- Institut de Physique Nucléaire d'Orsay (IPNO), Institut National de Physique Nucléaire et de Physique des Particules (IN2P3/CNRS), Université de Paris-Sud, Université Paris-Saclay, Orsay, France
| | - G Eulisse
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - J Eum
- Department of Physics, Pusan National University, Pusan, Republic of Korea
| | - D Evans
- School of Physics and Astronomy, University of Birmingham, Birmingham, United Kingdom
| | - S Evdokimov
- NRC Kurchatov Institute IHEP, Protvino, Russia
| | - L Fabbietti
- Physik Department, Technische Universität München, Munich, Germany
- Technische Universität München, Excellence Cluster 'Universe', Munich, Germany
| | - M Faggin
- Dipartimento di Fisica e Astronomia dell'Università, Padova, Italy
- Sezione INFN, Padova, Italy
| | - J Faivre
- Laboratoire de Physique Subatomique et de Cosmologie, Université Grenoble-Alpes, CNRS-IN2P3, Grenoble, France
| | - A Fantoni
- INFN, Laboratori Nazionali di Frascati, Frascati, Italy
| | - M Fasel
- Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA
| | - P Fecchio
- Dipartimento DISAT del Politecnico and Sezione INFN, Turin, Italy
| | - L Feldkamp
- Westfälische Wilhelms-Universität Münster, Institut für Kernphysik, Münster, Germany
| | | | - G Feofilov
- St. Petersburg State University, St. Petersburg, Russia
| | - A Fernández Téllez
- High Energy Physics Group, Universidad Autónoma de Puebla, Puebla, Mexico
| | - A Ferrero
- Université Paris-Saclay Centre d'Etudes de Saclay (CEA), IRFU, Départment de Physique Nucléaire (DPhN), Saclay, France
| | - A Ferretti
- Dipartimento di Fisica dell'Università, Turin, Italy
- Sezione INFN, Turin, Italy
| | - A Festanti
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - V J G Feuillard
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - J Figiel
- The Henryk Niewodniczanski Institute of Nuclear Physics, Polish Academy of Sciences, Cracow, Poland
| | - S Filchagin
- Russian Federal Nuclear Center (VNIIEF), Sarov, Russia
| | - D Finogeev
- Institute for Nuclear Research, Academy of Sciences, Moscow, Russia
| | - F M Fionda
- Department of Physics and Technology, University of Bergen, Bergen, Norway
| | | | - F Flor
- University of Houston, Houston, Texas, USA
| | - S Foertsch
- iThemba LABS, National Research Foundation, Somerset West, South Africa
| | - P Foka
- Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
| | - S Fokin
- National Research Centre Kurchatov Institute, Moscow, Russia
| | | | - A Francisco
- SUBATECH, IMT Atlantique, Université de Nantes, CNRS-IN2P3, Nantes, France
| | - U Frankenfeld
- Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
| | - G G Fronze
- Dipartimento di Fisica dell'Università, Turin, Italy
- Sezione INFN, Turin, Italy
| | - U Fuchs
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - C Furget
- Laboratoire de Physique Subatomique et de Cosmologie, Université Grenoble-Alpes, CNRS-IN2P3, Grenoble, France
| | - A Furs
- Institute for Nuclear Research, Academy of Sciences, Moscow, Russia
| | - M Fusco Girard
- Dipartimento di Fisica 'E.R. Caianiello' dell'Università, Salerno, Italy
- Gruppo Collegato INFN, Salerno, Italy
| | - J J Gaardhøje
- Niels Bohr Institute, University of Copenhagen, Copenhagen, Denmark
| | - M Gagliardi
- Dipartimento di Fisica dell'Università, Turin, Italy
- Sezione INFN, Turin, Italy
| | - A M Gago
- Sección Física, Departamento de Ciencias, Pontificia Universidad Católica del Perú, Lima, Peru
| | - A Gal
- Université de Strasbourg, CNRS, IPHC UMR 7178, F-67000 Strasbourg, France, Strasbourg, France
| | - C D Galvan
- Universidad Autónoma de Sinaloa, Culiacán, Mexico
| | - P Ganoti
- National and Kapodistrian University of Athens, School of Science, Department of Physics, Athens, Greece
| | - C Garabatos
- Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
| | | | - K Garg
- Dipartimento di Fisica e Astronomia dell'Università, Catania, Italy
- Sezione INFN, Catania, Italy
| | - C Gargiulo
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - K Garner
- Westfälische Wilhelms-Universität Münster, Institut für Kernphysik, Münster, Germany
| | - P Gasik
- Physik Department, Technische Universität München, Munich, Germany
- Technische Universität München, Excellence Cluster 'Universe', Munich, Germany
| | - E F Gauger
- The University of Texas at Austin, Austin, Texas, USA
| | - M B Gay Ducati
- Instituto de Física, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil
| | - M Germain
- SUBATECH, IMT Atlantique, Université de Nantes, CNRS-IN2P3, Nantes, France
| | - J Ghosh
- Saha Institute of Nuclear Physics, Homi Bhabha National Institute, Kolkata, India
| | - P Ghosh
- Variable Energy Cyclotron Centre, Homi Bhabha National Institute, Kolkata, India
| | - S K Ghosh
- Bose Institute, Department of Physics, Kolkata, India
- Centre for Astroparticle Physics and Space Science (CAPSS), Kolkata, India
| | - P Gianotti
- INFN, Laboratori Nazionali di Frascati, Frascati, Italy
| | - P Giubellino
- INFN, Sezione di Torino, Turin, Italy
- Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
| | - P Giubilato
- Dipartimento di Fisica e Astronomia dell'Università, Padova, Italy
- Sezione INFN, Padova, Italy
| | - P Glässel
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - D M Goméz Coral
- Instituto de Física, Universidad Nacional Autónoma de México, Mexico City, Mexico
| | - A Gomez Ramirez
- Johann-Wolfgang-Goethe Universität Frankfurt Institut für Informatik, Fachbereich Informatik und Mathematik, Frankfurt, Germany
| | - V Gonzalez
- Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
| | - P González-Zamora
- High Energy Physics Group, Universidad Autónoma de Puebla, Puebla, Mexico
| | - S Gorbunov
- Frankfurt Institute for Advanced Studies, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
| | - L Görlich
- The Henryk Niewodniczanski Institute of Nuclear Physics, Polish Academy of Sciences, Cracow, Poland
| | - S Gotovac
- Faculty of Electrical Engineering, Mechanical Engineering and Naval Architecture, University of Split, Split, Croatia
| | - V Grabski
- Instituto de Física, Universidad Nacional Autónoma de México, Mexico City, Mexico
| | | | - K L Graham
- School of Physics and Astronomy, University of Birmingham, Birmingham, United Kingdom
| | - L Greiner
- Lawrence Berkeley National Laboratory, Berkeley, California, USA
| | - A Grelli
- Institute for Subatomic Physics, Utrecht University/Nikhef, Utrecht, Netherlands
| | - C Grigoras
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - V Grigoriev
- NRNU Moscow Engineering Physics Institute, Moscow, Russia
| | - A Grigoryan
- A.I. Alikhanyan National Science Laboratory (Yerevan Physics Institute) Foundation, Yerevan, Armenia
| | - S Grigoryan
- Joint Institute for Nuclear Research (JINR), Dubna, Russia
| | - O S Groettvik
- Department of Physics and Technology, University of Bergen, Bergen, Norway
| | - J M Gronefeld
- Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
| | - F Grosa
- Dipartimento DISAT del Politecnico and Sezione INFN, Turin, Italy
| | | | - R Grosso
- Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
| | - R Guernane
- Laboratoire de Physique Subatomique et de Cosmologie, Université Grenoble-Alpes, CNRS-IN2P3, Grenoble, France
| | - B Guerzoni
- Dipartimento di Fisica e Astronomia dell'Università, Bologna, Italy
- Sezione INFN, Bologna, Italy
| | - M Guittiere
- SUBATECH, IMT Atlantique, Université de Nantes, CNRS-IN2P3, Nantes, France
| | - K Gulbrandsen
- Niels Bohr Institute, University of Copenhagen, Copenhagen, Denmark
| | - T Gunji
- University of Tokyo, Tokyo, Japan
| | - A Gupta
- Physics Department, University of Jammu, Jammu, India
| | - R Gupta
- Physics Department, University of Jammu, Jammu, India
| | - I B Guzman
- High Energy Physics Group, Universidad Autónoma de Puebla, Puebla, Mexico
| | - R Haake
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
- Yale University, New Haven, Connecticut, USA
| | - M K Habib
- Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
| | - C Hadjidakis
- Institut de Physique Nucléaire d'Orsay (IPNO), Institut National de Physique Nucléaire et de Physique des Particules (IN2P3/CNRS), Université de Paris-Sud, Université Paris-Saclay, Orsay, France
| | - H Hamagaki
- Nagasaki Institute of Applied Science, Nagasaki, Japan
| | - G Hamar
- Wigner Research Centre for Physics, Hungarian Academy of Sciences, Budapest, Hungary
| | - M Hamid
- Central China Normal University, Wuhan, China
| | - J C Hamon
- Université de Strasbourg, CNRS, IPHC UMR 7178, F-67000 Strasbourg, France, Strasbourg, France
| | - R Hannigan
- The University of Texas at Austin, Austin, Texas, USA
| | - M R Haque
- Institute for Subatomic Physics, Utrecht University/Nikhef, Utrecht, Netherlands
| | - A Harlenderova
- Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
| | - J W Harris
- Yale University, New Haven, Connecticut, USA
| | - A Harton
- Chicago State University, Chicago, Illinois, USA
| | - H Hassan
- Laboratoire de Physique Subatomique et de Cosmologie, Université Grenoble-Alpes, CNRS-IN2P3, Grenoble, France
| | - D Hatzifotiadou
- Centro Fermi-Museo Storico della Fisica e Centro Studi e Ricerche "Enrico Fermi', Rome, Italy
- INFN, Sezione di Bologna, Bologna, Italy
| | - P Hauer
- Helmholtz-Institut für Strahlen- und Kernphysik, Rheinische Friedrich-Wilhelms-Universität Bonn, Bonn, Germany
| | | | - S T Heckel
- Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
| | - E Hellbär
- Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
| | - H Helstrup
- Faculty of Engineering and Science, Western Norway University of Applied Sciences, Bergen, Norway
| | - A Herghelegiu
- Horia Hulubei National Institute of Physics and Nuclear Engineering, Bucharest, Romania
| | - E G Hernandez
- High Energy Physics Group, Universidad Autónoma de Puebla, Puebla, Mexico
| | - G Herrera Corral
- Centro de Investigación y de Estudios Avanzados (CINVESTAV), Mexico City and Mérida, Mexico
| | - F Herrmann
- Westfälische Wilhelms-Universität Münster, Institut für Kernphysik, Münster, Germany
| | - K F Hetland
- Faculty of Engineering and Science, Western Norway University of Applied Sciences, Bergen, Norway
| | - T E Hilden
- Helsinki Institute of Physics (HIP), Helsinki, Finland
| | - H Hillemanns
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - C Hills
- University of Liverpool, Liverpool, United Kingdom
| | - B Hippolyte
- Université de Strasbourg, CNRS, IPHC UMR 7178, F-67000 Strasbourg, France, Strasbourg, France
| | - B Hohlweger
- Physik Department, Technische Universität München, Munich, Germany
| | - D Horak
- Faculty of Nuclear Sciences and Physical Engineering, Czech Technical University in Prague, Prague, Czech Republic
| | - S Hornung
- Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
| | | | - P Hristov
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - C Huang
- Institut de Physique Nucléaire d'Orsay (IPNO), Institut National de Physique Nucléaire et de Physique des Particules (IN2P3/CNRS), Université de Paris-Sud, Université Paris-Saclay, Orsay, France
| | - C Hughes
- University of Tennessee, Knoxville, Tennessee, USA
| | - P Huhn
- Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
| | | | - H Hushnud
- Saha Institute of Nuclear Physics, Homi Bhabha National Institute, Kolkata, India
| | - L A Husova
- Westfälische Wilhelms-Universität Münster, Institut für Kernphysik, Münster, Germany
| | - N Hussain
- Gauhati University, Department of Physics, Guwahati, India
| | - S A Hussain
- COMSATS University Islamabad, Islamabad, Pakistan
| | - T Hussain
- Department of Physics, Aligarh Muslim University, Aligarh, India
| | - D Hutter
- Frankfurt Institute for Advanced Studies, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
| | - D S Hwang
- Department of Physics, Sejong University, Seoul, Republic of Korea
| | - J P Iddon
- University of Liverpool, Liverpool, United Kingdom
| | - R Ilkaev
- Russian Federal Nuclear Center (VNIIEF), Sarov, Russia
| | - M Inaba
- University of Tsukuba, Tsukuba, Japan
| | - M Ippolitov
- National Research Centre Kurchatov Institute, Moscow, Russia
| | - M S Islam
- Saha Institute of Nuclear Physics, Homi Bhabha National Institute, Kolkata, India
| | - M Ivanov
- Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
| | - V Ivanov
- Petersburg Nuclear Physics Institute, Gatchina, Russia
| | - V Izucheev
- NRC Kurchatov Institute IHEP, Protvino, Russia
| | - B Jacak
- Lawrence Berkeley National Laboratory, Berkeley, California, USA
| | - N Jacazio
- Dipartimento di Fisica e Astronomia dell'Università, Bologna, Italy
- Sezione INFN, Bologna, Italy
| | - P M Jacobs
- Lawrence Berkeley National Laboratory, Berkeley, California, USA
| | - M B Jadhav
- Indian Institute of Technology Bombay (IIT), Mumbai, India
| | - S Jadlovska
- Technical University of Košice, Košice, Slovakia
| | - J Jadlovsky
- Technical University of Košice, Košice, Slovakia
| | - S Jaelani
- Institute for Subatomic Physics, Utrecht University/Nikhef, Utrecht, Netherlands
| | - C Jahnke
- Universidade de São Paulo (USP), São Paulo, Brazil
| | | | - M A Janik
- Warsaw University of Technology, Warsaw, Poland
| | - M Jercic
- Physics department, Faculty of science, University of Zagreb, Zagreb, Croatia
| | - O Jevons
- School of Physics and Astronomy, University of Birmingham, Birmingham, United Kingdom
| | - R T Jimenez Bustamante
- Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
| | - M Jin
- University of Houston, Houston, Texas, USA
| | - F Jonas
- Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA
- Westfälische Wilhelms-Universität Münster, Institut für Kernphysik, Münster, Germany
| | - P G Jones
- School of Physics and Astronomy, University of Birmingham, Birmingham, United Kingdom
| | - A Jusko
- School of Physics and Astronomy, University of Birmingham, Birmingham, United Kingdom
| | - P Kalinak
- Institute of Experimental Physics, Slovak Academy of Sciences, Košice, Slovakia
| | - A Kalweit
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - J H Kang
- Yonsei University, Seoul, Republic of Korea
| | - V Kaplin
- NRNU Moscow Engineering Physics Institute, Moscow, Russia
| | - S Kar
- Central China Normal University, Wuhan, China
| | | | - O Karavichev
- Institute for Nuclear Research, Academy of Sciences, Moscow, Russia
| | - T Karavicheva
- Institute for Nuclear Research, Academy of Sciences, Moscow, Russia
| | - P Karczmarczyk
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - E Karpechev
- Institute for Nuclear Research, Academy of Sciences, Moscow, Russia
| | - U Kebschull
- Johann-Wolfgang-Goethe Universität Frankfurt Institut für Informatik, Fachbereich Informatik und Mathematik, Frankfurt, Germany
| | - R Keidel
- Hochschule Worms, Zentrum für Technologietransfer und Telekommunikation (ZTT), Worms, Germany
| | - M Keil
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - B Ketzer
- Helmholtz-Institut für Strahlen- und Kernphysik, Rheinische Friedrich-Wilhelms-Universität Bonn, Bonn, Germany
| | - Z Khabanova
- Nikhef, National institute for subatomic physics, Amsterdam, Netherlands
| | - A M Khan
- Central China Normal University, Wuhan, China
| | - S Khan
- Department of Physics, Aligarh Muslim University, Aligarh, India
| | - S A Khan
- Variable Energy Cyclotron Centre, Homi Bhabha National Institute, Kolkata, India
| | - A Khanzadeev
- Petersburg Nuclear Physics Institute, Gatchina, Russia
| | - Y Kharlov
- NRC Kurchatov Institute IHEP, Protvino, Russia
| | - A Khatun
- Department of Physics, Aligarh Muslim University, Aligarh, India
| | - A Khuntia
- Indian Institute of Technology Indore, Indore, India
- The Henryk Niewodniczanski Institute of Nuclear Physics, Polish Academy of Sciences, Cracow, Poland
| | - B Kileng
- Faculty of Engineering and Science, Western Norway University of Applied Sciences, Bergen, Norway
| | - B Kim
- Inha University, Incheon, Republic of Korea
| | - B Kim
- University of Tsukuba, Tsukuba, Japan
| | - D Kim
- Yonsei University, Seoul, Republic of Korea
| | - D J Kim
- University of Jyväskylä, Jyväskylä, Finland
| | - E J Kim
- Chonbuk National University, Jeonju, Republic of Korea
| | - H Kim
- Yonsei University, Seoul, Republic of Korea
| | - J S Kim
- Gangneung-Wonju National University, Gangneung, Republic of Korea
| | - J Kim
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - J Kim
- Yonsei University, Seoul, Republic of Korea
| | - J Kim
- Chonbuk National University, Jeonju, Republic of Korea
| | - M Kim
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - S Kim
- Department of Physics, Sejong University, Seoul, Republic of Korea
| | - T Kim
- Yonsei University, Seoul, Republic of Korea
| | - T Kim
- Yonsei University, Seoul, Republic of Korea
| | - K Kindra
- Physics Department, Panjab University, Chandigarh, India
| | - S Kirsch
- Frankfurt Institute for Advanced Studies, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
| | - I Kisel
- Frankfurt Institute for Advanced Studies, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
| | - S Kiselev
- Institute for Theoretical and Experimental Physics, Moscow, Russia
| | - A Kisiel
- Warsaw University of Technology, Warsaw, Poland
| | - J L Klay
- California Polytechnic State University, San Luis Obispo, California, USA
| | - C Klein
- Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
| | - J Klein
- INFN, Sezione di Torino, Turin, Italy
| | - S Klein
- Lawrence Berkeley National Laboratory, Berkeley, California, USA
| | - C Klein-Bösing
- Westfälische Wilhelms-Universität Münster, Institut für Kernphysik, Münster, Germany
| | - S Klewin
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - A Kluge
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - M L Knichel
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - A G Knospe
- University of Houston, Houston, Texas, USA
| | - C Kobdaj
- Suranaree University of Technology, Nakhon Ratchasima, Thailand
| | - M K Köhler
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - T Kollegger
- Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
| | - A Kondratyev
- Joint Institute for Nuclear Research (JINR), Dubna, Russia
| | - N Kondratyeva
- NRNU Moscow Engineering Physics Institute, Moscow, Russia
| | | | - P J Konopka
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - L Koska
- Technical University of Košice, Košice, Slovakia
| | - O Kovalenko
- National Centre for Nuclear Research, Warsaw, Poland
| | - V Kovalenko
- St. Petersburg State University, St. Petersburg, Russia
| | - M Kowalski
- The Henryk Niewodniczanski Institute of Nuclear Physics, Polish Academy of Sciences, Cracow, Poland
| | - I Králik
- Institute of Experimental Physics, Slovak Academy of Sciences, Košice, Slovakia
| | - A Kravčáková
- Faculty of Science, P.J. Šafárik University, Košice, Slovakia
| | - L Kreis
- Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
| | - M Krivda
- Institute of Experimental Physics, Slovak Academy of Sciences, Košice, Slovakia
- School of Physics and Astronomy, University of Birmingham, Birmingham, United Kingdom
| | - F Krizek
- Nuclear Physics Institute of the Czech Academy of Sciences, Řež u Prahy, Czech Republic
| | - K Krizkova Gajdosova
- Faculty of Nuclear Sciences and Physical Engineering, Czech Technical University in Prague, Prague, Czech Republic
| | - M Krüger
- Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
| | - E Kryshen
- Petersburg Nuclear Physics Institute, Gatchina, Russia
| | - M Krzewicki
- Frankfurt Institute for Advanced Studies, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
| | - A M Kubera
- Ohio State University, Columbus, Ohio, USA
| | - V Kučera
- Inha University, Incheon, Republic of Korea
| | - C Kuhn
- Université de Strasbourg, CNRS, IPHC UMR 7178, F-67000 Strasbourg, France, Strasbourg, France
| | - P G Kuijer
- Nikhef, National institute for subatomic physics, Amsterdam, Netherlands
| | - L Kumar
- Physics Department, Panjab University, Chandigarh, India
| | - S Kumar
- Indian Institute of Technology Bombay (IIT), Mumbai, India
| | - S Kundu
- National Institute of Science Education and Research, Homi Bhabha National Institute, Jatni, India
| | - P Kurashvili
- National Centre for Nuclear Research, Warsaw, Poland
| | - A Kurepin
- Institute for Nuclear Research, Academy of Sciences, Moscow, Russia
| | - A B Kurepin
- Institute for Nuclear Research, Academy of Sciences, Moscow, Russia
| | - S Kushpil
- Nuclear Physics Institute of the Czech Academy of Sciences, Řež u Prahy, Czech Republic
| | - J Kvapil
- School of Physics and Astronomy, University of Birmingham, Birmingham, United Kingdom
| | - M J Kweon
- Inha University, Incheon, Republic of Korea
| | - Y Kwon
- Yonsei University, Seoul, Republic of Korea
| | - S L La Pointe
- Frankfurt Institute for Advanced Studies, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
| | - P La Rocca
- Dipartimento di Fisica e Astronomia dell'Università, Catania, Italy
- Sezione INFN, Catania, Italy
| | - Y S Lai
- Lawrence Berkeley National Laboratory, Berkeley, California, USA
| | - R Langoy
- University College of Southeast Norway, Tonsberg, Norway
| | - K Lapidus
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
- Yale University, New Haven, Connecticut, USA
| | - A Lardeux
- Department of Physics, University of Oslo, Oslo, Norway
| | - P Larionov
- INFN, Laboratori Nazionali di Frascati, Frascati, Italy
| | - E Laudi
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - R Lavicka
- Faculty of Nuclear Sciences and Physical Engineering, Czech Technical University in Prague, Prague, Czech Republic
| | - T Lazareva
- St. Petersburg State University, St. Petersburg, Russia
| | - R Lea
- Dipartimento di Fisica dell'Università, Trieste, Italy
- Sezione INFN, Trieste, Italy
| | - L Leardini
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - S Lee
- Yonsei University, Seoul, Republic of Korea
| | - F Lehas
- Nikhef, National institute for subatomic physics, Amsterdam, Netherlands
| | - S Lehner
- Stefan Meyer Institut für Subatomare Physik (SMI), Vienna, Austria
| | - J Lehrbach
- Frankfurt Institute for Advanced Studies, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
| | - R C Lemmon
- Nuclear Physics Group, STFC Daresbury Laboratory, Daresbury, United Kingdom
| | | | - E D Lesser
- Department of Physics, University of California, Berkeley, California, USA
| | - M Lettrich
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - P Lévai
- Wigner Research Centre for Physics, Hungarian Academy of Sciences, Budapest, Hungary
| | - X Li
- China Institute of Atomic Energy, Beijing, China
| | - X L Li
- Central China Normal University, Wuhan, China
| | - J Lien
- University College of Southeast Norway, Tonsberg, Norway
| | - R Lietava
- School of Physics and Astronomy, University of Birmingham, Birmingham, United Kingdom
| | - B Lim
- Department of Physics, Pusan National University, Pusan, Republic of Korea
| | - S Lindal
- Department of Physics, University of Oslo, Oslo, Norway
| | - V Lindenstruth
- Frankfurt Institute for Advanced Studies, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
| | - S W Lindsay
- University of Liverpool, Liverpool, United Kingdom
| | - C Lippmann
- Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
| | - M A Lisa
- Ohio State University, Columbus, Ohio, USA
| | | | - A Liu
- Lawrence Berkeley National Laboratory, Berkeley, California, USA
| | - S Liu
- Ohio State University, Columbus, Ohio, USA
| | - H M Ljunggren
- Lund University Department of Physics, Division of Particle Physics, Lund, Sweden
| | - W J Llope
- Wayne State University, Detroit, Michigan, USA
| | - I M Lofnes
- Department of Physics and Technology, University of Bergen, Bergen, Norway
| | - V Loginov
- NRNU Moscow Engineering Physics Institute, Moscow, Russia
| | - C Loizides
- Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA
| | - P Loncar
- Faculty of Electrical Engineering, Mechanical Engineering and Naval Architecture, University of Split, Split, Croatia
| | - X Lopez
- Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
| | - E López Torres
- Centro de Aplicaciones Tecnológicas y Desarrollo Nuclear (CEADEN), Havana, Cuba
| | - P Luettig
- Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
| | - J R Luhder
- Westfälische Wilhelms-Universität Münster, Institut für Kernphysik, Münster, Germany
| | - M Lunardon
- Dipartimento di Fisica e Astronomia dell'Università, Padova, Italy
- Sezione INFN, Padova, Italy
| | | | - M Lupi
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - A Maevskaya
- Institute for Nuclear Research, Academy of Sciences, Moscow, Russia
| | - M Mager
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - S M Mahmood
- Department of Physics, University of Oslo, Oslo, Norway
| | - T Mahmoud
- Helmholtz-Institut für Strahlen- und Kernphysik, Rheinische Friedrich-Wilhelms-Universität Bonn, Bonn, Germany
| | - A Maire
- Université de Strasbourg, CNRS, IPHC UMR 7178, F-67000 Strasbourg, France, Strasbourg, France
| | - R D Majka
- Yale University, New Haven, Connecticut, USA
| | - M Malaev
- Petersburg Nuclear Physics Institute, Gatchina, Russia
| | - Q W Malik
- Department of Physics, University of Oslo, Oslo, Norway
| | - L Malinina
- Joint Institute for Nuclear Research (JINR), Dubna, Russia
| | - D Mal'Kevich
- Institute for Theoretical and Experimental Physics, Moscow, Russia
| | - P Malzacher
- Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
| | - A Mamonov
- Russian Federal Nuclear Center (VNIIEF), Sarov, Russia
| | - V Manko
- National Research Centre Kurchatov Institute, Moscow, Russia
| | - F Manso
- Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
| | | | - Y Mao
- Central China Normal University, Wuhan, China
| | - M Marchisone
- Université de Lyon, Université Lyon 1, CNRS/IN2P3, IPN-Lyon, Villeurbanne, Lyon, France
| | - J Mareš
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - G V Margagliotti
- Dipartimento di Fisica dell'Università, Trieste, Italy
- Sezione INFN, Trieste, Italy
| | - A Margotti
- INFN, Sezione di Bologna, Bologna, Italy
| | - J Margutti
- Institute for Subatomic Physics, Utrecht University/Nikhef, Utrecht, Netherlands
| | - A Marín
- Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
| | - C Markert
- The University of Texas at Austin, Austin, Texas, USA
| | - M Marquard
- Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
| | - N A Martin
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - P Martinengo
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | | | - M I Martínez
- High Energy Physics Group, Universidad Autónoma de Puebla, Puebla, Mexico
| | - G Martínez García
- SUBATECH, IMT Atlantique, Université de Nantes, CNRS-IN2P3, Nantes, France
| | | | - S Masciocchi
- Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
| | - M Masera
- Dipartimento di Fisica dell'Università, Turin, Italy
- Sezione INFN, Turin, Italy
| | - A Masoni
- INFN, Sezione di Cagliari, Cagliari, Italy
| | - L Massacrier
- Institut de Physique Nucléaire d'Orsay (IPNO), Institut National de Physique Nucléaire et de Physique des Particules (IN2P3/CNRS), Université de Paris-Sud, Université Paris-Saclay, Orsay, France
| | - E Masson
- SUBATECH, IMT Atlantique, Université de Nantes, CNRS-IN2P3, Nantes, France
| | - A Mastroserio
- INFN, Sezione di Bari, Bari, Italy
- Università degli Studi di Foggia, Foggia, Italy
| | - A M Mathis
- Physik Department, Technische Universität München, Munich, Germany
- Technische Universität München, Excellence Cluster 'Universe', Munich, Germany
| | | | - A Matyja
- The Henryk Niewodniczanski Institute of Nuclear Physics, Polish Academy of Sciences, Cracow, Poland
| | - C Mayer
- The Henryk Niewodniczanski Institute of Nuclear Physics, Polish Academy of Sciences, Cracow, Poland
| | - M Mazzilli
- Dipartimento Interateneo di Fisica 'M. Merlin', Bari, Italy
- Sezione INFN, Bari, Italy
| | | | - A F Mechler
- Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
| | - F Meddi
- Dipartimento di Fisica dell'Università 'La Sapienza', Rome, Italy
- Sezione INFN, Rome, Italy
| | - Y Melikyan
- NRNU Moscow Engineering Physics Institute, Moscow, Russia
| | - A Menchaca-Rocha
- Instituto de Física, Universidad Nacional Autónoma de México, Mexico City, Mexico
| | - E Meninno
- Dipartimento di Fisica 'E.R. Caianiello' dell'Università, Salerno, Italy
- Gruppo Collegato INFN, Salerno, Italy
| | - M Meres
- Comenius University Bratislava, Faculty of Mathematics, Physics and Informatics, Bratislava, Slovakia
| | - S Mhlanga
- University of Cape Town, Cape Town, South Africa
| | - Y Miake
- University of Tsukuba, Tsukuba, Japan
| | - L Micheletti
- Dipartimento di Fisica dell'Università, Turin, Italy
- Sezione INFN, Turin, Italy
| | | | - D L Mihaylov
- Physik Department, Technische Universität München, Munich, Germany
| | - K Mikhaylov
- Institute for Theoretical and Experimental Physics, Moscow, Russia
- Joint Institute for Nuclear Research (JINR), Dubna, Russia
| | - A Mischke
- Institute for Subatomic Physics, Utrecht University/Nikhef, Utrecht, Netherlands
| | - A N Mishra
- Instituto de Ciencias Nucleares, Universidad Nacional Autónoma de México, Mexico City, Mexico
| | - D Miśkowiec
- Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
| | - C M Mitu
- Institute of Space Science (ISS), Bucharest, Romania
| | - N Mohammadi
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - A P Mohanty
- Institute for Subatomic Physics, Utrecht University/Nikhef, Utrecht, Netherlands
| | - B Mohanty
- National Institute of Science Education and Research, Homi Bhabha National Institute, Jatni, India
| | - M Mohisin Khan
- Department of Physics, Aligarh Muslim University, Aligarh, India
| | - M Mondal
- Variable Energy Cyclotron Centre, Homi Bhabha National Institute, Kolkata, India
| | - M M Mondal
- Institute of Physics, Homi Bhabha National Institute, Bhubaneswar, India
| | - C Mordasini
- Physik Department, Technische Universität München, Munich, Germany
| | - D A Moreira De Godoy
- Westfälische Wilhelms-Universität Münster, Institut für Kernphysik, Münster, Germany
| | - L A P Moreno
- High Energy Physics Group, Universidad Autónoma de Puebla, Puebla, Mexico
| | - S Moretto
- Dipartimento di Fisica e Astronomia dell'Università, Padova, Italy
- Sezione INFN, Padova, Italy
| | - A Morreale
- SUBATECH, IMT Atlantique, Université de Nantes, CNRS-IN2P3, Nantes, France
| | - A Morsch
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - T Mrnjavac
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - V Muccifora
- INFN, Laboratori Nazionali di Frascati, Frascati, Italy
| | - E Mudnic
- Faculty of Electrical Engineering, Mechanical Engineering and Naval Architecture, University of Split, Split, Croatia
| | - D Mühlheim
- Westfälische Wilhelms-Universität Münster, Institut für Kernphysik, Münster, Germany
| | - S Muhuri
- Variable Energy Cyclotron Centre, Homi Bhabha National Institute, Kolkata, India
| | - J D Mulligan
- Lawrence Berkeley National Laboratory, Berkeley, California, USA
- Yale University, New Haven, Connecticut, USA
| | - M G Munhoz
- Universidade de São Paulo (USP), São Paulo, Brazil
| | - K Münning
- Helmholtz-Institut für Strahlen- und Kernphysik, Rheinische Friedrich-Wilhelms-Universität Bonn, Bonn, Germany
| | - R H Munzer
- Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
| | | | - S Murray
- iThemba LABS, National Research Foundation, Somerset West, South Africa
| | - L Musa
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - J Musinsky
- Institute of Experimental Physics, Slovak Academy of Sciences, Košice, Slovakia
| | - C J Myers
- University of Houston, Houston, Texas, USA
| | - J W Myrcha
- Warsaw University of Technology, Warsaw, Poland
| | - B Naik
- Indian Institute of Technology Bombay (IIT), Mumbai, India
| | - R Nair
- National Centre for Nuclear Research, Warsaw, Poland
| | - B K Nandi
- Indian Institute of Technology Bombay (IIT), Mumbai, India
| | - R Nania
- Centro Fermi-Museo Storico della Fisica e Centro Studi e Ricerche "Enrico Fermi', Rome, Italy
- INFN, Sezione di Bologna, Bologna, Italy
| | - E Nappi
- INFN, Sezione di Bari, Bari, Italy
| | - M U Naru
- COMSATS University Islamabad, Islamabad, Pakistan
| | - A F Nassirpour
- Lund University Department of Physics, Division of Particle Physics, Lund, Sweden
| | | | - C Nattrass
- University of Tennessee, Knoxville, Tennessee, USA
| | - R Nayak
- Indian Institute of Technology Bombay (IIT), Mumbai, India
| | - T K Nayak
- National Institute of Science Education and Research, Homi Bhabha National Institute, Jatni, India
- Variable Energy Cyclotron Centre, Homi Bhabha National Institute, Kolkata, India
| | - S Nazarenko
- Russian Federal Nuclear Center (VNIIEF), Sarov, Russia
| | - R A Negrao De Oliveira
- Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
| | - L Nellen
- Instituto de Ciencias Nucleares, Universidad Nacional Autónoma de México, Mexico City, Mexico
| | - S V Nesbo
- Faculty of Engineering and Science, Western Norway University of Applied Sciences, Bergen, Norway
| | - G Neskovic
- Frankfurt Institute for Advanced Studies, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
| | - B S Nielsen
- Niels Bohr Institute, University of Copenhagen, Copenhagen, Denmark
| | - S Nikolaev
- National Research Centre Kurchatov Institute, Moscow, Russia
| | - S Nikulin
- National Research Centre Kurchatov Institute, Moscow, Russia
| | - V Nikulin
- Petersburg Nuclear Physics Institute, Gatchina, Russia
| | - F Noferini
- Centro Fermi-Museo Storico della Fisica e Centro Studi e Ricerche "Enrico Fermi', Rome, Italy
- INFN, Sezione di Bologna, Bologna, Italy
| | - P Nomokonov
- Joint Institute for Nuclear Research (JINR), Dubna, Russia
| | - G Nooren
- Institute for Subatomic Physics, Utrecht University/Nikhef, Utrecht, Netherlands
| | - J Norman
- Laboratoire de Physique Subatomique et de Cosmologie, Université Grenoble-Alpes, CNRS-IN2P3, Grenoble, France
| | | | - A Nyanin
- National Research Centre Kurchatov Institute, Moscow, Russia
| | - J Nystrand
- Department of Physics and Technology, University of Bergen, Bergen, Norway
| | - M Ogino
- Nagasaki Institute of Applied Science, Nagasaki, Japan
| | - A Ohlson
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - J Oleniacz
- Warsaw University of Technology, Warsaw, Poland
| | | | - M H Oliver
- Yale University, New Haven, Connecticut, USA
| | - J Onderwaater
- Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
| | | | - R Orava
- Helsinki Institute of Physics (HIP), Helsinki, Finland
| | - A Ortiz Velasquez
- Instituto de Ciencias Nucleares, Universidad Nacional Autónoma de México, Mexico City, Mexico
| | - A Oskarsson
- Lund University Department of Physics, Division of Particle Physics, Lund, Sweden
| | - J Otwinowski
- The Henryk Niewodniczanski Institute of Nuclear Physics, Polish Academy of Sciences, Cracow, Poland
| | - K Oyama
- Nagasaki Institute of Applied Science, Nagasaki, Japan
| | - Y Pachmayer
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - V Pacik
- Niels Bohr Institute, University of Copenhagen, Copenhagen, Denmark
| | - D Pagano
- Università di Brescia, Brescia, Italy
| | - G Paić
- Instituto de Ciencias Nucleares, Universidad Nacional Autónoma de México, Mexico City, Mexico
| | - P Palni
- Central China Normal University, Wuhan, China
| | - J Pan
- Wayne State University, Detroit, Michigan, USA
| | - A K Pandey
- Indian Institute of Technology Bombay (IIT), Mumbai, India
| | - S Panebianco
- Université Paris-Saclay Centre d'Etudes de Saclay (CEA), IRFU, Départment de Physique Nucléaire (DPhN), Saclay, France
| | - V Papikyan
- A.I. Alikhanyan National Science Laboratory (Yerevan Physics Institute) Foundation, Yerevan, Armenia
| | - P Pareek
- Indian Institute of Technology Indore, Indore, India
| | - J Park
- Inha University, Incheon, Republic of Korea
| | | | - S Parmar
- Physics Department, Panjab University, Chandigarh, India
| | - A Passfeld
- Westfälische Wilhelms-Universität Münster, Institut für Kernphysik, Münster, Germany
| | - S P Pathak
- University of Houston, Houston, Texas, USA
| | - R N Patra
- Variable Energy Cyclotron Centre, Homi Bhabha National Institute, Kolkata, India
| | - B Paul
- INFN, Sezione di Torino, Turin, Italy
| | - H Pei
- Central China Normal University, Wuhan, China
| | - T Peitzmann
- Institute for Subatomic Physics, Utrecht University/Nikhef, Utrecht, Netherlands
| | - X Peng
- Central China Normal University, Wuhan, China
| | - L G Pereira
- Instituto de Física, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil
| | - H Pereira Da Costa
- Université Paris-Saclay Centre d'Etudes de Saclay (CEA), IRFU, Départment de Physique Nucléaire (DPhN), Saclay, France
| | - D Peresunko
- National Research Centre Kurchatov Institute, Moscow, Russia
| | - G M Perez
- Centro de Aplicaciones Tecnológicas y Desarrollo Nuclear (CEADEN), Havana, Cuba
| | - E Perez Lezama
- Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
| | - V Peskov
- Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
| | - Y Pestov
- Budker Institute for Nuclear Physics, Novosibirsk, Russia
| | - V Petráček
- Faculty of Nuclear Sciences and Physical Engineering, Czech Technical University in Prague, Prague, Czech Republic
| | - M Petrovici
- Horia Hulubei National Institute of Physics and Nuclear Engineering, Bucharest, Romania
| | - R P Pezzi
- Instituto de Física, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil
| | - S Piano
- INFN, Sezione di Trieste, Trieste, Italy
| | - M Pikna
- Comenius University Bratislava, Faculty of Mathematics, Physics and Informatics, Bratislava, Slovakia
| | - P Pillot
- SUBATECH, IMT Atlantique, Université de Nantes, CNRS-IN2P3, Nantes, France
| | - L O D L Pimentel
- Niels Bohr Institute, University of Copenhagen, Copenhagen, Denmark
| | - O Pinazza
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
- INFN, Sezione di Bologna, Bologna, Italy
| | - L Pinsky
- University of Houston, Houston, Texas, USA
| | - S Pisano
- INFN, Laboratori Nazionali di Frascati, Frascati, Italy
| | | | - M Płoskoń
- Lawrence Berkeley National Laboratory, Berkeley, California, USA
| | - M Planinic
- Physics department, Faculty of science, University of Zagreb, Zagreb, Croatia
| | - F Pliquett
- Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
| | - J Pluta
- Warsaw University of Technology, Warsaw, Poland
| | - S Pochybova
- Wigner Research Centre for Physics, Hungarian Academy of Sciences, Budapest, Hungary
| | - M G Poghosyan
- Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA
| | | | - N Poljak
- Physics department, Faculty of science, University of Zagreb, Zagreb, Croatia
| | - W Poonsawat
- Suranaree University of Technology, Nakhon Ratchasima, Thailand
| | - A Pop
- Horia Hulubei National Institute of Physics and Nuclear Engineering, Bucharest, Romania
| | - H Poppenborg
- Westfälische Wilhelms-Universität Münster, Institut für Kernphysik, Münster, Germany
| | | | - V Pozdniakov
- Joint Institute for Nuclear Research (JINR), Dubna, Russia
| | - S K Prasad
- Bose Institute, Department of Physics, Kolkata, India
- Centre for Astroparticle Physics and Space Science (CAPSS), Kolkata, India
| | | | - F Prino
- INFN, Sezione di Torino, Turin, Italy
| | - C A Pruneau
- Wayne State University, Detroit, Michigan, USA
| | - I Pshenichnov
- Institute for Nuclear Research, Academy of Sciences, Moscow, Russia
| | - M Puccio
- Dipartimento di Fisica dell'Università, Turin, Italy
- Sezione INFN, Turin, Italy
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - V Punin
- Russian Federal Nuclear Center (VNIIEF), Sarov, Russia
| | - K Puranapanda
- Variable Energy Cyclotron Centre, Homi Bhabha National Institute, Kolkata, India
| | - J Putschke
- Wayne State University, Detroit, Michigan, USA
| | | | - S Ragoni
- School of Physics and Astronomy, University of Birmingham, Birmingham, United Kingdom
| | - S Raha
- Bose Institute, Department of Physics, Kolkata, India
- Centre for Astroparticle Physics and Space Science (CAPSS), Kolkata, India
| | - S Rajput
- Physics Department, University of Jammu, Jammu, India
| | - J Rak
- University of Jyväskylä, Jyväskylä, Finland
| | - A Rakotozafindrabe
- Université Paris-Saclay Centre d'Etudes de Saclay (CEA), IRFU, Départment de Physique Nucléaire (DPhN), Saclay, France
| | - L Ramello
- Dipartimento di Scienze e Innovazione Tecnologica dell'Università del Piemonte Orientale and INFN Sezione di Torino, Alessandria, Italy
| | - F Rami
- Université de Strasbourg, CNRS, IPHC UMR 7178, F-67000 Strasbourg, France, Strasbourg, France
| | - R Raniwala
- Physics Department, University of Rajasthan, Jaipur, India
| | - S Raniwala
- Physics Department, University of Rajasthan, Jaipur, India
| | - S S Räsänen
- Helsinki Institute of Physics (HIP), Helsinki, Finland
| | - B T Rascanu
- Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
| | - R Rath
- Indian Institute of Technology Indore, Indore, India
| | - V Ratza
- Helmholtz-Institut für Strahlen- und Kernphysik, Rheinische Friedrich-Wilhelms-Universität Bonn, Bonn, Germany
| | - I Ravasenga
- Dipartimento DISAT del Politecnico and Sezione INFN, Turin, Italy
| | - K F Read
- Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA
- University of Tennessee, Knoxville, Tennessee, USA
| | - K Redlich
- National Centre for Nuclear Research, Warsaw, Poland
| | - A Rehman
- Department of Physics and Technology, University of Bergen, Bergen, Norway
| | - P Reichelt
- Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
| | - F Reidt
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - X Ren
- Central China Normal University, Wuhan, China
| | - R Renfordt
- Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
| | - A Reshetin
- Institute for Nuclear Research, Academy of Sciences, Moscow, Russia
| | - J-P Revol
- Centro Fermi-Museo Storico della Fisica e Centro Studi e Ricerche "Enrico Fermi', Rome, Italy
| | - K Reygers
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - V Riabov
- Petersburg Nuclear Physics Institute, Gatchina, Russia
| | - T Richert
- Lund University Department of Physics, Division of Particle Physics, Lund, Sweden
- Niels Bohr Institute, University of Copenhagen, Copenhagen, Denmark
| | - M Richter
- Department of Physics, University of Oslo, Oslo, Norway
| | - P Riedler
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - W Riegler
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - F Riggi
- Dipartimento di Fisica e Astronomia dell'Università, Catania, Italy
- Sezione INFN, Catania, Italy
| | - C Ristea
- Institute of Space Science (ISS), Bucharest, Romania
| | - S P Rode
- Indian Institute of Technology Indore, Indore, India
| | | | - K Røed
- Department of Physics, University of Oslo, Oslo, Norway
| | - R Rogalev
- NRC Kurchatov Institute IHEP, Protvino, Russia
| | - E Rogochaya
- Joint Institute for Nuclear Research (JINR), Dubna, Russia
| | - D Rohr
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - D Röhrich
- Department of Physics and Technology, University of Bergen, Bergen, Norway
| | - P S Rokita
- Warsaw University of Technology, Warsaw, Poland
| | - F Ronchetti
- INFN, Laboratori Nazionali di Frascati, Frascati, Italy
| | - E D Rosas
- Instituto de Ciencias Nucleares, Universidad Nacional Autónoma de México, Mexico City, Mexico
| | - K Roslon
- Warsaw University of Technology, Warsaw, Poland
| | - P Rosnet
- Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
| | - A Rossi
- Dipartimento di Fisica e Astronomia dell'Università, Padova, Italy
- Sezione INFN, Padova, Italy
- INFN, Sezione di Padova, Padova, Italy
| | - A Rotondi
- Università degli Studi di Pavia, Pavia, Italy
| | - F Roukoutakis
- National and Kapodistrian University of Athens, School of Science, Department of Physics, Athens, Greece
| | - A Roy
- Indian Institute of Technology Indore, Indore, India
| | - P Roy
- Saha Institute of Nuclear Physics, Homi Bhabha National Institute, Kolkata, India
| | - O V Rueda
- Lund University Department of Physics, Division of Particle Physics, Lund, Sweden
| | - R Rui
- Dipartimento di Fisica dell'Università, Trieste, Italy
- Sezione INFN, Trieste, Italy
| | - B Rumyantsev
- Joint Institute for Nuclear Research (JINR), Dubna, Russia
| | - A Rustamov
- National Nuclear Research Center, Baku, Azerbaijan
| | - E Ryabinkin
- National Research Centre Kurchatov Institute, Moscow, Russia
| | - Y Ryabov
- Petersburg Nuclear Physics Institute, Gatchina, Russia
| | - A Rybicki
- The Henryk Niewodniczanski Institute of Nuclear Physics, Polish Academy of Sciences, Cracow, Poland
| | - H Rytkonen
- University of Jyväskylä, Jyväskylä, Finland
| | - S Saarinen
- Helsinki Institute of Physics (HIP), Helsinki, Finland
| | - S Sadhu
- Variable Energy Cyclotron Centre, Homi Bhabha National Institute, Kolkata, India
| | - S Sadovsky
- NRC Kurchatov Institute IHEP, Protvino, Russia
| | - K Šafařík
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
- Faculty of Nuclear Sciences and Physical Engineering, Czech Technical University in Prague, Prague, Czech Republic
| | - S K Saha
- Variable Energy Cyclotron Centre, Homi Bhabha National Institute, Kolkata, India
| | - B Sahoo
- Indian Institute of Technology Bombay (IIT), Mumbai, India
| | - P Sahoo
- Indian Institute of Technology Indore, Indore, India
| | - R Sahoo
- Indian Institute of Technology Indore, Indore, India
| | - S Sahoo
- Institute of Physics, Homi Bhabha National Institute, Bhubaneswar, India
| | - P K Sahu
- Institute of Physics, Homi Bhabha National Institute, Bhubaneswar, India
| | - J Saini
- Variable Energy Cyclotron Centre, Homi Bhabha National Institute, Kolkata, India
| | - S Sakai
- University of Tsukuba, Tsukuba, Japan
| | - S Sambyal
- Physics Department, University of Jammu, Jammu, India
| | - V Samsonov
- NRNU Moscow Engineering Physics Institute, Moscow, Russia
- Petersburg Nuclear Physics Institute, Gatchina, Russia
| | - A Sandoval
- Instituto de Física, Universidad Nacional Autónoma de México, Mexico City, Mexico
| | - A Sarkar
- iThemba LABS, National Research Foundation, Somerset West, South Africa
| | - D Sarkar
- Variable Energy Cyclotron Centre, Homi Bhabha National Institute, Kolkata, India
- Wayne State University, Detroit, Michigan, USA
| | - N Sarkar
- Variable Energy Cyclotron Centre, Homi Bhabha National Institute, Kolkata, India
| | - P Sarma
- Gauhati University, Department of Physics, Guwahati, India
| | - V M Sarti
- Physik Department, Technische Universität München, Munich, Germany
| | - M H P Sas
- Institute for Subatomic Physics, Utrecht University/Nikhef, Utrecht, Netherlands
| | | | - B Schaefer
- Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA
| | - J Schambach
- The University of Texas at Austin, Austin, Texas, USA
| | - H S Scheid
- Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
| | - C Schiaua
- Horia Hulubei National Institute of Physics and Nuclear Engineering, Bucharest, Romania
| | - R Schicker
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - A Schmah
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - C Schmidt
- Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
| | - H R Schmidt
- Physikalisches Institut, Eberhard-Karls-Universität Tübingen, Tübingen, Germany
| | - M O Schmidt
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - M Schmidt
- Physikalisches Institut, Eberhard-Karls-Universität Tübingen, Tübingen, Germany
| | - N V Schmidt
- Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
- Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA
| | - A R Schmier
- University of Tennessee, Knoxville, Tennessee, USA
| | - J Schukraft
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
- Niels Bohr Institute, University of Copenhagen, Copenhagen, Denmark
| | - Y Schutz
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
- Université de Strasbourg, CNRS, IPHC UMR 7178, F-67000 Strasbourg, France, Strasbourg, France
| | - K Schwarz
- Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
| | - K Schweda
- Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
| | - G Scioli
- Dipartimento di Fisica e Astronomia dell'Università, Bologna, Italy
- Sezione INFN, Bologna, Italy
| | | | - M Šefčík
- Faculty of Science, P.J. Šafárik University, Košice, Slovakia
| | - J E Seger
- Creighton University, Omaha, Nebraska, USA
| | | | | | - I Selyuzhenkov
- NRNU Moscow Engineering Physics Institute, Moscow, Russia
- Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
| | - S Senyukov
- Université de Strasbourg, CNRS, IPHC UMR 7178, F-67000 Strasbourg, France, Strasbourg, France
| | - E Serradilla
- Instituto de Física, Universidad Nacional Autónoma de México, Mexico City, Mexico
| | - P Sett
- Indian Institute of Technology Bombay (IIT), Mumbai, India
| | - A Sevcenco
- Institute of Space Science (ISS), Bucharest, Romania
| | - A Shabanov
- Institute for Nuclear Research, Academy of Sciences, Moscow, Russia
| | - A Shabetai
- SUBATECH, IMT Atlantique, Université de Nantes, CNRS-IN2P3, Nantes, France
| | - R Shahoyan
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - W Shaikh
- Saha Institute of Nuclear Physics, Homi Bhabha National Institute, Kolkata, India
| | | | - A Sharma
- Physics Department, Panjab University, Chandigarh, India
| | - A Sharma
- Physics Department, University of Jammu, Jammu, India
| | - M Sharma
- Physics Department, University of Jammu, Jammu, India
| | - N Sharma
- Physics Department, Panjab University, Chandigarh, India
| | - A I Sheikh
- Variable Energy Cyclotron Centre, Homi Bhabha National Institute, Kolkata, India
| | - K Shigaki
- Hiroshima University, Hiroshima, Japan
| | | | - S Shirinkin
- Institute for Theoretical and Experimental Physics, Moscow, Russia
| | - Q Shou
- Shanghai Institute of Applied Physics, Shanghai, China
| | - Y Sibiriak
- National Research Centre Kurchatov Institute, Moscow, Russia
| | | | - T Siemiarczuk
- National Centre for Nuclear Research, Warsaw, Poland
| | - D Silvermyr
- Lund University Department of Physics, Division of Particle Physics, Lund, Sweden
| | - G Simatovic
- Nikhef, National institute for subatomic physics, Amsterdam, Netherlands
| | - G Simonetti
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
- Physik Department, Technische Universität München, Munich, Germany
| | - R Singh
- National Institute of Science Education and Research, Homi Bhabha National Institute, Jatni, India
| | - R Singh
- Physics Department, University of Jammu, Jammu, India
| | - V K Singh
- Variable Energy Cyclotron Centre, Homi Bhabha National Institute, Kolkata, India
| | - V Singhal
- Variable Energy Cyclotron Centre, Homi Bhabha National Institute, Kolkata, India
| | - T Sinha
- Saha Institute of Nuclear Physics, Homi Bhabha National Institute, Kolkata, India
| | - B Sitar
- Comenius University Bratislava, Faculty of Mathematics, Physics and Informatics, Bratislava, Slovakia
| | - M Sitta
- Dipartimento di Scienze e Innovazione Tecnologica dell'Università del Piemonte Orientale and INFN Sezione di Torino, Alessandria, Italy
| | - T B Skaali
- Department of Physics, University of Oslo, Oslo, Norway
| | - M Slupecki
- University of Jyväskylä, Jyväskylä, Finland
| | - N Smirnov
- Yale University, New Haven, Connecticut, USA
| | - R J M Snellings
- Institute for Subatomic Physics, Utrecht University/Nikhef, Utrecht, Netherlands
| | | | - J Sochan
- Technical University of Košice, Košice, Slovakia
| | - C Soncco
- Sección Física, Departamento de Ciencias, Pontificia Universidad Católica del Perú, Lima, Peru
| | - J Song
- Inha University, Incheon, Republic of Korea
- University of Houston, Houston, Texas, USA
| | - A Songmoolnak
- Suranaree University of Technology, Nakhon Ratchasima, Thailand
| | - F Soramel
- Dipartimento di Fisica e Astronomia dell'Università, Padova, Italy
- Sezione INFN, Padova, Italy
| | - S Sorensen
- University of Tennessee, Knoxville, Tennessee, USA
| | - I Sputowska
- The Henryk Niewodniczanski Institute of Nuclear Physics, Polish Academy of Sciences, Cracow, Poland
| | - J Stachel
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - I Stan
- Institute of Space Science (ISS), Bucharest, Romania
| | - P Stankus
- Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA
| | | | - E Stenlund
- Lund University Department of Physics, Division of Particle Physics, Lund, Sweden
| | - D Stocco
- SUBATECH, IMT Atlantique, Université de Nantes, CNRS-IN2P3, Nantes, France
| | - M M Storetvedt
- Faculty of Engineering and Science, Western Norway University of Applied Sciences, Bergen, Norway
| | - P Strmen
- Comenius University Bratislava, Faculty of Mathematics, Physics and Informatics, Bratislava, Slovakia
| | - A A P Suaide
- Universidade de São Paulo (USP), São Paulo, Brazil
| | | | - C Suire
- Institut de Physique Nucléaire d'Orsay (IPNO), Institut National de Physique Nucléaire et de Physique des Particules (IN2P3/CNRS), Université de Paris-Sud, Université Paris-Saclay, Orsay, France
| | - M Suleymanov
- COMSATS University Islamabad, Islamabad, Pakistan
| | - M Suljic
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - R Sultanov
- Institute for Theoretical and Experimental Physics, Moscow, Russia
| | - M Šumbera
- Nuclear Physics Institute of the Czech Academy of Sciences, Řež u Prahy, Czech Republic
| | - S Sumowidagdo
- Indonesian Institute of Sciences, Jakarta, Indonesia
| | - K Suzuki
- Stefan Meyer Institut für Subatomare Physik (SMI), Vienna, Austria
| | - S Swain
- Institute of Physics, Homi Bhabha National Institute, Bhubaneswar, India
| | - A Szabo
- Comenius University Bratislava, Faculty of Mathematics, Physics and Informatics, Bratislava, Slovakia
| | - I Szarka
- Comenius University Bratislava, Faculty of Mathematics, Physics and Informatics, Bratislava, Slovakia
| | - U Tabassam
- COMSATS University Islamabad, Islamabad, Pakistan
| | - G Taillepied
- Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
| | - J Takahashi
- Universidade Estadual de Campinas (UNICAMP), Campinas, Brazil
| | - G J Tambave
- Department of Physics and Technology, University of Bergen, Bergen, Norway
| | - S Tang
- Central China Normal University, Wuhan, China
- Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
| | - M Tarhini
- SUBATECH, IMT Atlantique, Université de Nantes, CNRS-IN2P3, Nantes, France
| | - M G Tarzila
- Horia Hulubei National Institute of Physics and Nuclear Engineering, Bucharest, Romania
| | - A Tauro
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - G Tejeda Muñoz
- High Energy Physics Group, Universidad Autónoma de Puebla, Puebla, Mexico
| | - A Telesca
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - C Terrevoli
- Dipartimento di Fisica e Astronomia dell'Università, Padova, Italy
- Sezione INFN, Padova, Italy
- University of Houston, Houston, Texas, USA
| | - D Thakur
- Indian Institute of Technology Indore, Indore, India
| | - S Thakur
- Variable Energy Cyclotron Centre, Homi Bhabha National Institute, Kolkata, India
| | - D Thomas
- The University of Texas at Austin, Austin, Texas, USA
| | - F Thoresen
- Niels Bohr Institute, University of Copenhagen, Copenhagen, Denmark
| | - R Tieulent
- Université de Lyon, Université Lyon 1, CNRS/IN2P3, IPN-Lyon, Villeurbanne, Lyon, France
| | - A Tikhonov
- Institute for Nuclear Research, Academy of Sciences, Moscow, Russia
| | | | - A Toia
- Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
| | - N Topilskaya
- Institute for Nuclear Research, Academy of Sciences, Moscow, Russia
| | - M Toppi
- INFN, Laboratori Nazionali di Frascati, Frascati, Italy
| | - F Torales-Acosta
- Department of Physics, University of California, Berkeley, California, USA
| | - S R Torres
- Universidad Autónoma de Sinaloa, Culiacán, Mexico
| | - S Tripathy
- Indian Institute of Technology Indore, Indore, India
| | - T Tripathy
- Indian Institute of Technology Bombay (IIT), Mumbai, India
| | - S Trogolo
- Dipartimento di Fisica dell'Università, Turin, Italy
- Sezione INFN, Turin, Italy
- Dipartimento di Fisica e Astronomia dell'Università, Padova, Italy
- Sezione INFN, Padova, Italy
| | - G Trombetta
- Dipartimento Interateneo di Fisica 'M. Merlin', Bari, Italy
- Sezione INFN, Bari, Italy
| | - L Tropp
- Faculty of Science, P.J. Šafárik University, Košice, Slovakia
| | - V Trubnikov
- Bogolyubov Institute for Theoretical Physics, National Academy of Sciences of Ukraine, Kiev, Ukraine
| | | | | | - B A Trzeciak
- Institute for Subatomic Physics, Utrecht University/Nikhef, Utrecht, Netherlands
| | - T Tsuji
- University of Tokyo, Tokyo, Japan
| | - A Tumkin
- Russian Federal Nuclear Center (VNIIEF), Sarov, Russia
| | - R Turrisi
- INFN, Sezione di Padova, Padova, Italy
| | - T S Tveter
- Department of Physics, University of Oslo, Oslo, Norway
| | - K Ullaland
- Department of Physics and Technology, University of Bergen, Bergen, Norway
| | - E N Umaka
- University of Houston, Houston, Texas, USA
| | - A Uras
- Université de Lyon, Université Lyon 1, CNRS/IN2P3, IPN-Lyon, Villeurbanne, Lyon, France
| | - G L Usai
- Dipartimento di Fisica dell'Università, Cagliari, Italy
- Sezione INFN, Cagliari, Italy
| | - A Utrobicic
- Physics department, Faculty of science, University of Zagreb, Zagreb, Croatia
| | - M Vala
- Faculty of Science, P.J. Šafárik University, Košice, Slovakia
- Technical University of Košice, Košice, Slovakia
| | - N Valle
- Università degli Studi di Pavia, Pavia, Italy
| | - S Vallero
- INFN, Sezione di Torino, Turin, Italy
| | - N van der Kolk
- Institute for Subatomic Physics, Utrecht University/Nikhef, Utrecht, Netherlands
| | - L V R van Doremalen
- Institute for Subatomic Physics, Utrecht University/Nikhef, Utrecht, Netherlands
| | - M van Leeuwen
- Institute for Subatomic Physics, Utrecht University/Nikhef, Utrecht, Netherlands
| | - P Vande Vyvre
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - D Varga
- Wigner Research Centre for Physics, Hungarian Academy of Sciences, Budapest, Hungary
| | - M Varga-Kofarago
- Wigner Research Centre for Physics, Hungarian Academy of Sciences, Budapest, Hungary
| | - A Vargas
- High Energy Physics Group, Universidad Autónoma de Puebla, Puebla, Mexico
| | - M Vargyas
- University of Jyväskylä, Jyväskylä, Finland
| | - R Varma
- Indian Institute of Technology Bombay (IIT), Mumbai, India
| | - M Vasileiou
- National and Kapodistrian University of Athens, School of Science, Department of Physics, Athens, Greece
| | - A Vasiliev
- National Research Centre Kurchatov Institute, Moscow, Russia
| | - O Vázquez Doce
- Physik Department, Technische Universität München, Munich, Germany
- Technische Universität München, Excellence Cluster 'Universe', Munich, Germany
| | - V Vechernin
- St. Petersburg State University, St. Petersburg, Russia
| | - A M Veen
- Institute for Subatomic Physics, Utrecht University/Nikhef, Utrecht, Netherlands
| | - E Vercellin
- Dipartimento di Fisica dell'Università, Turin, Italy
- Sezione INFN, Turin, Italy
| | - S Vergara Limón
- High Energy Physics Group, Universidad Autónoma de Puebla, Puebla, Mexico
| | - L Vermunt
- Institute for Subatomic Physics, Utrecht University/Nikhef, Utrecht, Netherlands
| | - R Vernet
- Centre de Calcul de l'IN2P3, Villeurbanne, Lyon, France
| | - R Vértesi
- Wigner Research Centre for Physics, Hungarian Academy of Sciences, Budapest, Hungary
| | - L Vickovic
- Faculty of Electrical Engineering, Mechanical Engineering and Naval Architecture, University of Split, Split, Croatia
| | | | - Z Vilakazi
- University of the Witwatersrand, Johannesburg, South Africa
| | - O Villalobos Baillie
- School of Physics and Astronomy, University of Birmingham, Birmingham, United Kingdom
| | - A Villatoro Tello
- High Energy Physics Group, Universidad Autónoma de Puebla, Puebla, Mexico
| | - G Vino
- INFN, Sezione di Bari, Bari, Italy
| | - A Vinogradov
- National Research Centre Kurchatov Institute, Moscow, Russia
| | - T Virgili
- Dipartimento di Fisica 'E.R. Caianiello' dell'Università, Salerno, Italy
- Gruppo Collegato INFN, Salerno, Italy
| | - V Vislavicius
- Niels Bohr Institute, University of Copenhagen, Copenhagen, Denmark
| | - A Vodopyanov
- Joint Institute for Nuclear Research (JINR), Dubna, Russia
| | - B Volkel
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - M A Völkl
- Physikalisches Institut, Eberhard-Karls-Universität Tübingen, Tübingen, Germany
| | - K Voloshin
- Institute for Theoretical and Experimental Physics, Moscow, Russia
| | | | - G Volpe
- Dipartimento Interateneo di Fisica 'M. Merlin', Bari, Italy
- Sezione INFN, Bari, Italy
| | - B von Haller
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - I Vorobyev
- Physik Department, Technische Universität München, Munich, Germany
- Technische Universität München, Excellence Cluster 'Universe', Munich, Germany
| | - D Voscek
- Technical University of Košice, Košice, Slovakia
| | - J Vrláková
- Faculty of Science, P.J. Šafárik University, Košice, Slovakia
| | - B Wagner
- Department of Physics and Technology, University of Bergen, Bergen, Norway
| | | | - M Weber
- Stefan Meyer Institut für Subatomare Physik (SMI), Vienna, Austria
| | - S G Weber
- Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
| | - A Wegrzynek
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - D F Weiser
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - S C Wenzel
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - J P Wessels
- Westfälische Wilhelms-Universität Münster, Institut für Kernphysik, Münster, Germany
| | - U Westerhoff
- Westfälische Wilhelms-Universität Münster, Institut für Kernphysik, Münster, Germany
| | | | - E Widmann
- Stefan Meyer Institut für Subatomare Physik (SMI), Vienna, Austria
| | - J Wiechula
- Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
| | - J Wikne
- Department of Physics, University of Oslo, Oslo, Norway
| | - G Wilk
- National Centre for Nuclear Research, Warsaw, Poland
| | | | - G A Willems
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - E Willsher
- School of Physics and Astronomy, University of Birmingham, Birmingham, United Kingdom
| | - B Windelband
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - W E Witt
- University of Tennessee, Knoxville, Tennessee, USA
| | - Y Wu
- University of Science and Techonology of China, Hefei, China
| | - R Xu
- Central China Normal University, Wuhan, China
| | - S Yalcin
- KTO Karatay University, Konya, Turkey
| | | | - S Yang
- Department of Physics and Technology, University of Bergen, Bergen, Norway
| | - S Yano
- Université Paris-Saclay Centre d'Etudes de Saclay (CEA), IRFU, Départment de Physique Nucléaire (DPhN), Saclay, France
| | - Z Yin
- Central China Normal University, Wuhan, China
| | - H Yokoyama
- Institute for Subatomic Physics, Utrecht University/Nikhef, Utrecht, Netherlands
| | - I-K Yoo
- Department of Physics, Pusan National University, Pusan, Republic of Korea
| | - J H Yoon
- Inha University, Incheon, Republic of Korea
| | - S Yuan
- Department of Physics and Technology, University of Bergen, Bergen, Norway
| | - A Yuncu
- Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
| | - V Yurchenko
- Bogolyubov Institute for Theoretical Physics, National Academy of Sciences of Ukraine, Kiev, Ukraine
| | - V Zaccolo
- Dipartimento di Fisica dell'Università, Trieste, Italy
- Sezione INFN, Trieste, Italy
- INFN, Sezione di Torino, Turin, Italy
| | - A Zaman
- COMSATS University Islamabad, Islamabad, Pakistan
| | - C Zampolli
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - H J C Zanoli
- Universidade de São Paulo (USP), São Paulo, Brazil
| | - N Zardoshti
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
- School of Physics and Astronomy, University of Birmingham, Birmingham, United Kingdom
| | | | - P Závada
- Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
| | - N Zaviyalov
- Russian Federal Nuclear Center (VNIIEF), Sarov, Russia
| | | | - M Zhalov
- Petersburg Nuclear Physics Institute, Gatchina, Russia
| | - X Zhang
- Central China Normal University, Wuhan, China
| | - Z Zhang
- Central China Normal University, Wuhan, China
- Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
| | - C Zhao
- Department of Physics, University of Oslo, Oslo, Norway
| | | | - N Zhigareva
- Institute for Theoretical and Experimental Physics, Moscow, Russia
| | - D Zhou
- Central China Normal University, Wuhan, China
| | - Y Zhou
- Niels Bohr Institute, University of Copenhagen, Copenhagen, Denmark
| | - Z Zhou
- Department of Physics and Technology, University of Bergen, Bergen, Norway
| | - J Zhu
- Central China Normal University, Wuhan, China
| | - Y Zhu
- Central China Normal University, Wuhan, China
| | - A Zichichi
- Centro Fermi-Museo Storico della Fisica e Centro Studi e Ricerche "Enrico Fermi', Rome, Italy
- Dipartimento di Fisica e Astronomia dell'Università, Bologna, Italy
- Sezione INFN, Bologna, Italy
| | - M B Zimmermann
- European Organization for Nuclear Research (CERN), Geneva, Switzerland
| | - G Zinovjev
- Bogolyubov Institute for Theoretical Physics, National Academy of Sciences of Ukraine, Kiev, Ukraine
| | - N Zurlo
- Università di Brescia, Brescia, Italy
| |
Collapse
|
46
|
Kim MS, Lee J, Sim JA, Kwon JH, Kang EJ, Kim YJ, Lee J, Song EK, Kang JH, Nam EM, Kim SY, Yun HJ, Jung KH, Park JD, Yun YH. Erratum: Correction of the Text in the Article "Table": Discordance between Physician and the General Public Perceptions of Prognostic Disclosure to Children with Serious Illness: a Korean Nationwide Study. J Korean Med Sci 2020; 35:e74. [PMID: 32056405 PMCID: PMC7025909 DOI: 10.3346/jkms.2020.35.e74] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
This corrects the article on e327 in vol. 33, PMID: 30505258.
Collapse
Affiliation(s)
- Min Sun Kim
- Department of Pediatrics, Seoul National University College of Medicine, Seoul, Korea
| | - Jihye Lee
- Department of Biomedical Informatics, Seoul National University College of Medicine, Seoul, Korea
| | - Jin Ah Sim
- Department of Biomedical Science, Seoul National University College of Medicine, Seoul, Korea
| | - Jung Hye Kwon
- Department of Internal Medicine, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea
| | - Eun Joo Kang
- Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea
| | - Yu Jung Kim
- Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea
| | - Junglim Lee
- Department of Hemato-Oncology, Daegu Fatima Hospital, Daegu, Korea
| | - Eun Kee Song
- Division of Hematology and Oncology, Department of Internal Medicine, Chonbuk National University Medical School, Jeonju, Korea
| | - Jung Hun Kang
- Department of Internal Medicine, Gyeongsang National University, Jinju, Korea
| | - Eun Mi Nam
- Department of Internal Medicine, Ewha Womans University College of Medicine, Seoul, Korea
| | - Si Young Kim
- Department of Medical Oncology and Hematology, Kyung Hee University Hospital, Seoul, Korea
| | - Hwan Jung Yun
- Department of Internal Medicine, Chungnam National University Hospital, Daejeon, Korea
| | - Kyung Hae Jung
- Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
| | - June Dong Park
- Department of Pediatrics, Seoul National University College of Medicine, Seoul, Korea
| | - Young Ho Yun
- Department of Biomedical Informatics, Seoul National University College of Medicine, Seoul, Korea
- Department of Biomedical Science, Seoul National University College of Medicine, Seoul, Korea
- Department of Family Medicine, Seoul National University College of Medicine, Seoul, Korea.
| |
Collapse
|
47
|
Kang JH, Koh SJ, Oh SY, Kim RB, Shin SH, Lee YG, Kim BS, Ryoo HM, Yoon SY, Jang JS, Oh HS, Choi YJ, Lee MH, Lee KH. Interference with daily functioning by breakthrough pain in patients with cancer. Support Care Cancer 2020; 28:5177-5183. [PMID: 32056013 DOI: 10.1007/s00520-020-05329-9] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/25/2019] [Accepted: 01/27/2020] [Indexed: 11/26/2022]
Abstract
PURPOSE To investigate the association between quality of life (QOL) and breakthrough cancer pain (BTCP) intensity in patients who met the commonly accepted definition of BTCP. METHODS This study was a subset analysis of a South Korean multicenter, non-interventional, cross-sectional, nationwide survey. Participants were recruited from March 2016 to December 2017. BTCP was defined as a controlled background pain of less than a numeric rating scale (NRS) of 3 and any flare-up pain intensity. Pain intensity data were collected using the Brief Pain Inventory (BPI), which includes an interference assessment of the affective and physical domains. Patients were categorized by BTCP intensity into mild (NRS 1-3), moderate (4-6), and severe (7-10) groups. RESULTS Of the 969 screened patients with cancer, 679 had ≤ NRS 3 background pain, of whom 438 completed the BPI. Of these 438 patients, 40, 204, and 194 were in the mild, moderate, and severe BTCP groups, respectively. The median NRS of BTCP was 6.0 (interquartile range = 5.0-8.0). Patients with moderate-severe BTCP had significantly higher interference with daily functioning (IDF) scores than did mild BTCP patients (3.3 vs. 5.7; p < 0.01). Both domains of IDF were significantly hampered proportionally by increased BTCP intensity (p < 0.001). The median total IDF scores of the no, moderate, and severe BTCP groups were 3.3, 5.0, and 6.9, respectively. Furthermore, IDF depended on BTCP intensity, duration, and frequency (p < 0.01) but not on pain type and cause. CONCLUSION An increase in BTCP intensity is likely to result in IDF, regardless of the cause or type of BTCP.
Collapse
Affiliation(s)
- Jung Hun Kang
- Department of Internal Medicine, Gyeongsang National University, Jinju, Republic of Korea
| | - Su-Jin Koh
- Department of Hematology and Oncology, Ulsan University Hospital, Ulsan University College of Medicine, Ulsan, Republic of Korea
| | - So Yeon Oh
- Department of Internal medicine, Pusan National University Yangsan Hospital, Yangsan, Republic of Korea
| | - Rock Bum Kim
- Department of Preventive Medicine, Regional Cardiocerebrovascular Disease Center, Gyeongsang National University Hospital, Jinju, Republic of Korea
| | - Seong Hoon Shin
- Department of Internal Medicine, Division of Hemato-Oncology, Kosin University Gospel Hospital, Busan, Republic of Korea
| | - Yun-Gyoo Lee
- Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
| | - Bong-Seog Kim
- Department of Internal Medicine, Veterans Health Service Medical Center, Seoul, Republic of Korea
| | - Hun Mo Ryoo
- Department of Internal Medicine, School of Medicine, Catholic University of Daegu, Daegu, Republic of Korea
| | - So Young Yoon
- Department of Internal Medicine, Konkuk University School of Medicine, Seoul, South Korea
| | - Joung Soon Jang
- Department of Internal Medicine, Chung-Ang University, Seoul, Republic of Korea
| | - Ho-Suk Oh
- Department of Internal Medicine, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gangneung, Republic of Korea
| | - Young Jin Choi
- Department of Internal Medicine, School of Medicine, Pusan National University, Busan, Republic of Korea
| | - Moon Hee Lee
- Department of Internal Medicine, Inha University Hospital, College of Medicine, Inha University, Incheon, Republic of Korea
| | - Kyung-Hee Lee
- Department of Internal Medicine, Yeungnam University, Daegu, Republic of Korea.
| |
Collapse
|
48
|
Kang E, Kang JH, Koh SJ, Song EK, Shim HJ, Keam B, Maeng CH, Kim YJ, Yun HJ, Jung KH, Kwon JH, Lee SN, Lee JL, Do YR, Min J, Lee J, Choo J, Yun YH. The Impacts of Prognostic Awareness on Mood and Quality of Life Among Patients With Advanced Cancer. Am J Hosp Palliat Care 2020; 37:904-912. [PMID: 32052654 DOI: 10.1177/1049909120905789] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022] Open
Abstract
BACKGROUND Accurate awareness of the prognosis is an important factor in the treatment decision of patients with advanced cancer; however, prognostic disclosure is still subject to debate because it can reduce patient's satisfaction and increase depression. AIM The purpose of this study is to assess whether patients' prognostic awareness is associated with decreased quality of life (QoL) or increased depressive mood in patients with advanced cancer. DESIGN AND PARTICIPANTS In this cohort study, 386 patients with advanced cancer were recruited across 3 periods from December 2016 to August 2018. The outcome of this study was a change in QoL and depression according to the patients' prognostic awareness at baseline, 3 months, and 6 months. RESULTS This study found significant differences in changes of QoL based on patients' prognostic awareness. From baseline to 3 months, emotional functioning (P = .039), pain (P = .042), existential well-being (P = .025), and social support (P = .038) subscale scores improved significantly more in those with lack of prognostic awareness. Over 6 months, the group without prognostic awareness improved significantly in terms of physical functioning (P = .037), emotional functioning (P = .002), nausea/vomiting (P = .048), and constipation (P = .039) subscale scores and existential well-being scores (P = .025). No significant difference between the groups was found in terms of depression. CONCLUSION Accurate prognostic awareness may pose harm and may provide no additional benefits in terms of QoL and mood among patients with advanced cancer for a short period of time.
Collapse
Affiliation(s)
- EunKyo Kang
- Department of Family Medicine, Seoul National University Hospital, Seoul, Korea.,Institute for Public Health and Medical Service, Seoul National University Hospital, Seoul, Korea
| | - Jung Hun Kang
- Department of Internal Medicine, School of Medicine, Gyeongsang University, Jinju, Korea
| | - Su-Jin Koh
- Department of Hematology and Oncology, Ulsan University Hospital, Ulsan University College of Medicine, Ulsan, Korea
| | - Eun-Kee Song
- Department of Internal Medicine, Chonbuk National University Medical School, Jeonju, Korea
| | - Hyun-Jeong Shim
- Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea
| | - Bhumsuk Keam
- Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea
| | - Chi-Hoon Maeng
- Division of Hemato-Oncology, Department of Internal Medicine, Kyung Hee University School of Medicine, Seoul, Korea
| | - Yu Jung Kim
- Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea
| | - Hwan Jung Yun
- Department of Internal Medicine, Chungnam National University College of Medicine, Chungnam, Korea
| | - Kyung Hae Jung
- Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
| | - Jung Hye Kwon
- Department of Internal Medicine, Kangdong Sacred Heart Hospital, Hallym University, Seoul, Korea
| | - Soon Nam Lee
- Department of Internal Medicine, Ewha Womans University College of Medicine, Seoul, Korea
| | - Jung Lim Lee
- Department of Hemato-Oncology, Daegu Fatima Hospital, Daegu, Korea
| | - Young Rok Do
- Department of Internal Medicine, Dongsan Medical Center, Keimyung University School of Medicine, Daegu, Korea
| | - JeongHee Min
- Department of Biomedical Science, Seoul National University College of Medicine, Seoul, Korea
| | - Jihye Lee
- Department of Biomedical Science, Seoul National University College of Medicine, Seoul, Korea
| | - Jiyeon Choo
- Department of Biomedical Science, Seoul National University College of Medicine, Seoul, Korea
| | - Young Ho Yun
- Department of Family Medicine, Seoul National University Hospital, Seoul, Korea.,Department of Biomedical Science, Seoul National University College of Medicine, Seoul, Korea
| |
Collapse
|
49
|
Kim YS, Ji JH, Oh SY, Lee S, Huh SJ, Lee JH, Song K, Son CH, Roh MS, Lee GW, Lee J, Kim ST, Kim CK, Jang JS, Hwang IG, Ahn HK, Park LC, Oh SY, Kim S, Lee S, Lim D, Lee SI, Kang JH. A Randomized Controlled Trial of Epidermal Growth Factor Ointment for Treating Epidermal Growth Factor Receptor Inhibitor-Induced Skin Toxicities. Oncologist 2020; 25:e186-e193. [PMID: 31492766 PMCID: PMC6964120 DOI: 10.1634/theoncologist.2019-0221] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/27/2019] [Accepted: 07/18/2019] [Indexed: 01/01/2023] Open
Abstract
BACKGROUND The efficacy of epidermal growth factor (EGF) receptor (EGFR) inhibitors in patients with non-small cell lung cancer (NSCLC), pancreatic cancer (PC), or colorectal cancer (CRC) has been demonstrated. However, dermatological reactions to these inhibitors can cause significant physical and psychosocial discomfort. The objective of the present study was to evaluate the efficacy of EGF ointment for EGFR inhibitor-related skin adverse events (ERSEs). MATERIALS AND METHODS This placebo-controlled, double-blind, multicenter, pilot phase III trial enrolled patients with NSCLC, PC, or CRC treated with EGFR inhibitors. Patients with grade ≥2 ERSEs were included. Patients were randomized to three treatment arms: arm 1, placebo; arm 2, 1 ppm of EGF ointment; and arm 3, 20 ppm of EGF ointment. Patients applied ointment to their skin lesions twice daily. RESULTS Efficacy evaluation was available for 80 patients (9 for PC, 28 for NSCLC, and 43 for CRC). Responses were 44.4% in arm 1, 61.5% in arm 2, and 77.8% in arm 3. There was a linear correlation between EGF concentrations and responses (p = .012). Quality of life (QoL) was assessed for 74 patients. Maximum changes in composite scores by Skindex-16 after treatment were significantly different among arms (mean ± SD: -5.2 ± 8.6 for arm 1, -11.7 ± 14.2 for arm 2, and - 18.6 ± 17.7 for arm 3; p = .008). EGF arms showed significant improvement in emotions (p = .005) and functioning (p = .044) scores over the placebo arm. CONCLUSION EGF ointment is effective for managing ERSEs. It can also improve patients' QoL compared with placebo. Clinical trial identification number. NCT02284139 IMPLICATIONS FOR PRACTICE: Patients with non-small cell lung cancer, pancreatic cancer, or colorectal cancer who are treated with epidermal growth factor (EGF) receptor (EGFR) inhibitors may experience dermatologic reactions to their treatment. This study investigated the benefit of an EGF ointment in the treatment of these adverse events and observed the ointment to be effective in managing EGFR inhibitor-related skin adverse events.
Collapse
Affiliation(s)
- Young Saing Kim
- Department of Internal Medicine, Gachon University Gil Medical CenterIncheonRepublic of Korea
| | - Jun Ho Ji
- Division of Hematology‐Oncology, Samsung Changwon Hospital, Sungkyunkwan University School of MedicineChangwonRepublic of Korea
| | - Sung Yong Oh
- Department of Internal Medicine, Dong‐A University HospitalBusanRepublic of Korea
| | - Suee Lee
- Department of Internal Medicine, Dong‐A University HospitalBusanRepublic of Korea
| | - Seok Jae Huh
- Department of Internal Medicine, Dong‐A University HospitalBusanRepublic of Korea
| | - Ji Hyun Lee
- Department of Internal Medicine, Dong‐A University HospitalBusanRepublic of Korea
| | - Ki‐Hoon Song
- Department of Dermatology, National Cancer CenterGoyangRepublic of Korea
| | - Choon Hee Son
- Department of Pulmonology, Dong‐A University HospitalBusanRepublic of Korea
| | - Mee Sook Roh
- Department of Pathology, Dong‐A University College of MedicineBusanRepublic of Korea
| | - Gyeong Won Lee
- Department of Internal Medicine, Gyeongsang National University HospitalJinjuRepublic of Korea
| | - Jeeyun Lee
- Department of Medicine, Samsung Medical CenterSeoulRepublic of Korea
| | - Seung Tae Kim
- Department of Medicine, Samsung Medical CenterSeoulRepublic of Korea
| | - Chan Kyu Kim
- Department of Internal Medicine, Soonchunhyang University Bucheon HospitalBucheonRepublic of Korea
| | - Joung Soon Jang
- Department of Internal Medicine, Chung‐Ang University College of MedicineSeoulRepublic of Korea
| | - In Gyu Hwang
- Department of Internal Medicine, Chung‐Ang University College of MedicineSeoulRepublic of Korea
| | - Hee Kyung Ahn
- Department of Internal Medicine, Gachon University Gil Medical CenterIncheonRepublic of Korea
| | - Lee Chun Park
- Division of Hematology‐Oncology, Department of Medicine, Kosin University College of MedicineBusanRepublic of Korea
| | - So Yeon Oh
- Department of Internal Medicine, Pusan National University Yangsan HospitalYangsanRepublic of Korea
| | - Seong‐Geun Kim
- Department of Internal Medicine, Pusan National University Yangsan HospitalYangsanRepublic of Korea
| | - Sang‐Cheol Lee
- Department of Internal Medicine, Soonchunhyang University Hospital CheonanCheonanRepublic of Korea
| | - Do‐Hyoung Lim
- Department of Internal Medicine, Dankook University College of MedicineCheonanRepublic of Korea
| | - Soon Il Lee
- Department of Internal Medicine, Dankook University College of MedicineCheonanRepublic of Korea
| | - Jung Hun Kang
- Department of Internal Medicine, Gyeongsang National University HospitalJinjuRepublic of Korea
| |
Collapse
|
50
|
Kim ST, Oh SY, Lee J, Kang JH, Lee HW, Lee MA, Sohn BS, Hong JH, Park YS, Park JO, Lim HY. Capecitabine plus Oxaliplatin as a Second-Line Therapy for Advanced Biliary Tract Cancers: A Multicenter, Open-Label, Phase II Trial. J Cancer 2019; 10:6185-6190. [PMID: 31772650 PMCID: PMC6856733 DOI: 10.7150/jca.37610] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/14/2019] [Accepted: 09/14/2019] [Indexed: 12/27/2022] Open
Abstract
Background: Although biliary tract cancer (BTC) has a very aggressive nature, some patients maintain a relatively good performance status after failure with first-line treatment of gemcitabine plus cisplatin (GC). Thus, tolerable, feasible, and useful second-line treatments are needed for these patients. We investigated the efficacy of capecitabine plus oxaliplatin (XELOX) as a second-line therapy for patients with advanced BTC who failed first-line GC treatment. Methods: In this prospective, phase II trial, we investigated XELOX (capecitabine 1,000 mg/m2 twice daily on days 1-14 and oxaliplatin 130 mg/m2 on day 1) as a second-line treatment, given every 3 weeks, totaling 8 cycles in patients with metastatic BTC who failed first-line GC treatment. The primary outcome was progression-free survival (PFS). Results: From December 2015 to November 2016, 50 patients with metastatic intrahepatic or extrahepatic cholangiocarcinoma or gall bladder (GB) cancer were enrolled. The regimen was well tolerated. Toxicities mainly consisted of grade 1 or 2 events, and thrombocytopenia and neuropathy had the highest incidence. In intent-to-treat analysis, one complete response (CR) and six partial responses (PRs) were recorded with XELOX treatment. The overall response rate and the disease control rate from the intent-to-treat analysis were 14% and 52%, respectively. With a median follow-up of 15.6 months, PFS after XELOX was a median of 15.4 weeks (95% CI, 8.5-22.3). This PFS value supported the statistical hypothesis of this study. The median overall survival was 32.7 weeks (95% CI, 21.4-43.9). Conclusion: This phase II trial showed that XELOX treatment was efficacious and had a tolerable toxicity profile in patients with advanced BTC who failed first-line treatment of gemcitabine and cisplatin.
Collapse
Affiliation(s)
- Seung Tae Kim
- Department of Medicine, Sungkyunkwan University School of Medicine, Samsung Medical Centre, Seoul, South Korea
| | - Sung Yong Oh
- Department of Medicine, Dong-A University School of Medicine, Busan, South Korea
| | - Jeeyun Lee
- Department of Medicine, Sungkyunkwan University School of Medicine, Samsung Medical Centre, Seoul, South Korea
| | - Jung Hun Kang
- Department of Medicine, Gyeongsang National University Hospital, Jinju, South Korea
| | - Hyun Woo Lee
- Department of Medicine, Ajou University School of Medicine, Suwon, South Korea
| | - Myung Ah Lee
- Department of Medicine, Seoul St Mary's Hospital, Catholic University, Seoul, South Korea
| | - Byeong Seok Sohn
- Department of Medicine, Sanggye Paik Hospital, Inje University College of Medicine, Seoul, South Korea
| | - Ji Hyong Hong
- Department of Medicine, Incheon St Mary's Hospital, Catholic University, Incheon, South Korea
| | - Young Suk Park
- Department of Medicine, Sungkyunkwan University School of Medicine, Samsung Medical Centre, Seoul, South Korea
| | - Joon Oh Park
- Department of Medicine, Sungkyunkwan University School of Medicine, Samsung Medical Centre, Seoul, South Korea
| | - Ho Yeong Lim
- Department of Medicine, Sungkyunkwan University School of Medicine, Samsung Medical Centre, Seoul, South Korea
| |
Collapse
|